• Aagaard BD, Heyworth MF, Oesterle AL, Jones AL, Way LW. Intestinal immunisation with Escherichia coli protects rats against Escherichia coli induced cholangitis. Gut 39: 136-140 (1996). *

• Abbate R, Gori AM, Martini F, Brunelli T, Filippini M, Francalanci I, Paniccia R, Prisco D, Gensini GF, Neri Serneri GG. n-3 PUFA supplementation, monocyte PCA expression and interleukin-6 production. Prostaglandins Leukot. Essent. Fatty Acids 54: 439-444 (1996).

• Abedi MR, Hammarstrom L, Broome U, Angelin B, Smith CI, Christensson B. Reduction in serum levels of antimitochondrial (M2) antibodies following immunoglobulin therapy in severe combined immunodeficient (SCID) mice reconstituted with lymphocytes from patients with primary biliary cirrhosis (PBC). Clin. Exp. Immunol. 105: 266-273 (1996). *

• Abrams GA, Concato J, Fallon MB. Muscle cramps in patients with cirrhosis. Am. J. Gastroenterol. 91: 1363-1366 (1996).

• Accardo-Palumbo A, Triolo G, Giardina E, Carbone MC, Ferrante A, Triolo G. Detection of anti-myeloperoxidase antibodies in the serum of patients with type 1 diabetes mellitus. Acta Diabetol. 33: 103-107 (1996).

• Accatino L, Pizarro M, Solis N, Koenig CS, Vollrath V, Chianale J. Modulation of hepatic content and biliary excretion of P-glycoproteins in hepatocellular and obstructive cholestasis in the rat. J. Hepatol. 25: 349-361 (1996). *

• Acciuffi S, Ghosh S, Ferguson A. Strengths and limitations of the Crohn's disease activity index, revealed by an objective gut lavage test of gastrointestinal protein loss. Aliment. Pharmacol. Ther. 10: 321-326 (1996). *

• Adachi Y, Hinoda Y, Takahashi H, Nakagawa N, Sakamoto H, Itoh F, Endo T, Suzuki S, Imai K. Rheumatoid arthritis associated with ulcerative colitis. J. Gastroenterol. 31: 590-595 (1996).

• Adachi Y, Kamisako T. Intrahepatic cholestasis. Nippon Rinsho 54: 788-793 (1996).

• Adachi Y, Kamisako T, Okuyama Y, Miya H. Hepatic metabolism and transport of bilirubin and other organic anions. Nippon Rinsho 54: 2276-2290 (1996).

• Adams DH, Hubscher SG, Fisher NC, Williams A, Robinson M. Expression of E-selectin and E-selectin ligands in human liver inflammation. Hepatology 24: 533-538 (1996). *

• Agrons GA, Corse WR, Markowitz RI, Suarez ES, Perry DR. Gastrointestinal manifestations of cystic fibrosis: radiologic-pathologic correlation. Radiographics 16: 871-893 (1996). *

• Ahnen DJ. Controlled clinical trials: the controls are the key. Gastroenterology 110: 628-630 (1996). *

• Alam I, Ferrell LD, Bass NM. Vanishing bile duct syndrome temporally associated with ibuprofen use. Am. J. Gastroenterol. 91: 1626-1630 (1996).

• Albertella MR, Jones H, Thomson W, Olavesen MG, Campbell RD. Localization of eight additional genes in the human major histocompatibility complex, including the gene encoding the casein kinase II beta subunit (CSNK2B). Genomics 36: 240-251 (1996). *

• Alexander RJ, Panja A, Kaplan-Liss E, Mayer L, Raicht RF. Expression of protooncogene-encoded mRNA by colonic epithelial cells in inflammatory bowel disease. Dig. Dis. Sci. 41: 660-669 (1996).

• Alican I, Kubes P. A critical role for nitric oxide in intestinal barrier function and dysfunction. Am. J. Physiol. 270: G225-G237 (1996).

• Allikmets R, Gerrard B, Hutchinson A, Dean M. Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database. Hum. Mol. Genet. 5: 1649-1655 (1996). *

• Alvaro D, Piat C, Francia C, Franchitto A, Furfaro S, Valente C, Capocaccia L, Gaudio E. Ultrastructural features of danazol-induced cholestasis: a case study. Ultrastruct. Pathol. 20: 491-495 (1996).

• Aman MJ, Tayebi N, Obiri NI, Puri RK, Modi WS, Leonard WJ. cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J. Biol. Chem. 271: 29265-29270 (1996). *

• Amesty-Valbuena A, Diez-Ewald M, de Villarroel M, Montiel N, Granados A, Díaz S, Salas D, Rivero M. Immunologic characteristics of undernutrition. I. The undernourished patient in nutritional recovery. Invest. Clin. 37: 95-111 (1996).

• Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, Patel IR, Abramson SB. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc. Natl. Acad. Sci. U.S.A. 93: 14014-14019 (1996). *

• Anand AC, Elias E, Neuberger JM. End-stage primary biliary cirrhosis in a first generation migrant south Asian population. Eur. J. Gastroenterol. Hepatol. 8: 663-666 (1996).

• Andreani ML, Frasca G, Brusco G, Borgnino L, Biagi F, Gasbarrini G, Corazza GR. Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: diagnostic tool or research procedure?. Ann. Ital. Med. Int. 11: 254-257 (1996).

• Angeli P, Albino G, Carraro P, Dalla Pria M, Merkel C, Caregaro L, De Bei E, Bortoluzzi A, Plebani M, Gatta A. Cirrhosis and muscle cramps: evidence of a causal relationship. Hepatology 23: 264-273 (1996). *

• Appelmelk BJ, Simoons-Smit I, Negrini R, Moran AP, Aspinall GO, Forte JG, De Vries T, Quan H, Verboom T, Maaskant JJ, Ghiara P, Kuipers EJ, Bloemena E, Tadema TM, Townsend RR, Tyagarajan K, Crothers JM Jr, Monteiro MA, Savio A, De Graaff J. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect. Immun. 64: 2031-2040 (1996). *

• Arcangeli C, Squillantini G, Santoro G, Marioni C, Forte P, Chibbaro G, Dolara A. Association of pulmonary and portal hypertension. Minerva Cardioangiol. 44: 343-352 (1996).

• Arnaiz-Villena A, Martinez-Laso J, Corell A, Allende L, Rosal M, Gomez-Reino JJ, Vicario JL. Frequencies of HLA-A24 and HLA-DR4-DQ8 are increased and that of HLA-B blank is decreased in chronic toxic oil syndrome. Eur. J. Immunogenet. 23: 211-219 (1996).

• Arnett FC, Howard RF, Tan F, Moulds JM, Bias WB, Durban E, Cameron HD, Paxton G, Hodge TJ, Weathers PE, Reveille JD. Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. Arthritis Rheum. 39: 1362-1370 (1996).

• Arranz MI, Lasuncion MA, Perales J, Herrera E, Lorenzo I, Carcamo C, Concostrina L, Villar J, Gasalla R. Fatty acid composition of lipoprotein lipids in hepatobiliary diseases. Eur. J. Clin. Chem. Clin. Biochem. 34: 701-709 (1996).

• Artlett CM, Black CM, Briggs DC, Stephens C, Welsh KI. DNA allelic alterations within VNTR loci of scleroderma families. Br. J. Rheumatol. 35: 1216-1222 (1996). *

• Artlett CM, Black CM, Briggs DC, Stevens CO, Welsh KI. Telomere reduction in scleroderma patients: a possible cause for chromosomal instability. Br. J. Rheumatol. 35: 732-737 (1996).

• Asakura H, Sugimura K, Funakoshi K. Molecular pathoimmunology of ulcerative colitis. Nippon Rinsho 54: 1170-1175 (1996).

• Audrain MA, Gourbil A, Muller JY, Esnault LM. Anti-lactoferrin autoantibodies: relation between epitopes and iron-binding domain. J. Autoimmun. 9: 569-574 (1996).

• Auwerx J, Schoonjans K, Fruchart JC, Staels B. Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects. J. Atheroscler. Thromb. 3: 81-89 (1996).

• Axelsson LG, Landstrom E, Goldschmidt TJ, Gronberg A, Bylund-Fellenius AC. Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(+) -cell depleted, athymic and NK-cell depleted SCID mice. Inflamm. Res. 45: 181-191 (1996).

• Azer SA, Coverdale SA, Byth K, Farrell GC, Stacey NH. Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease. J. Gastroenterol. Hepatol. 11: 208-215 (1996).

• Azer SA, Stacey NH. Current concepts of hepatic uptake, intracellular transport and biliary secretion of bile acids: physiological basis and pathophysiological changes in cholestatic liver dysfunction. J. Gastroenterol. Hepatol. 11: 396-407 (1996).

• Babyatsky MW, Rossiter G, Podolsky DK. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology 110: 975-984 (1996). *

• Bachmeyer C, de la Blanchardiere A, Lepercq J, Dhote R, Grateau G, Detilleux M, Tournaire M, Christoforov B. Recurring episodes of meningitis (Mollaret's meningitis) with one showing an association with herpes simplex virus type 2. J. Infect. 32: 247-248 (1996).

• Badenhoop K, Tonjes RR, Rau H, Donner H, Rieker W, Braun J, Herwig J, Mytilineos J, Kurth R, Usadel KH. Endogenous retroviral long terminal repeats of the HLA-DQ region are associated with susceptibility to insulin-dependent diabetes mellitus. Hum. Immunol. 50: 103-110 (1996).

• Baillie RA, Jump DB, Clarke SD. Specific effects of polyunsaturated fatty acids on gene expression. Curr. Opin. Lipidol. 7: 53-55 (1996).

• Ballot E, Desbos A, Auger C, Monier JC. Detection on immunoblot of new proteins from the microsomal fraction recognized by anti-liver-kidney microsome antibodies type 1. Clin. Immunol. Immunopathol. 80: 255-265 (1996). *

• Ballow M, Xiang S, Wang W, Brodsky L. The effects of retinoic acid on immunoglobulin synthesis: role of interleukin 6. J. Clin. Immunol. 16: 171-179 (1996).

• Bandin O, Courvalin JC, Poupon R, Dubel L, Homberg JC, Johanet C. Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis. Hepatology 23: 1020-1024 (1996). *

• Bansal P, Sonnenberg A. Risk factors of colorectal cancer in inflammatory bowel disease. Am. J. Gastroenterol. 91: 44-48 (1996).

• Bansi D, Chapman R, Fleming K. Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass. J. Hepatol. 24: 581-586 (1996). *

• Bansi DS, Chapman RW, Fleming KA. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 8: 881-885 (1996).

• Bansi DS, Fleming KA, Chapman RW. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass. Gut 38: 384-389 (1996). *

• Bansi DS, Lo S, Chapman RW, Fleming KA. Absence of antineutrophil cytoplasmic antibodies in relatives of UK patients with primary sclerosing cholangitis and ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 8: 111-116 (1996).

• Barak AJ, Beckenhauer HC, Tuma DJ. Betaine, ethanol, and the liver: a review. Alcohol 13: 395-398 (1996). *

• Barnes KC. Genetic studies of cystic fibrosis and atopic asthma: current approaches and future aspects. Pediatr. Allergy Immunol. 7: S74-S81 (1996).

• Barnes KC, Neely JD, Duffy DL, Freidhoff LR, Breazeale DR, Schou C, Naidu RP, Levett PN, Renault B, Kucherlapati R, Iozzino S, Ehrlich E, Beaty TH, Marsh DG. Linkage of asthma and total serum IgE concentration to markers on chromosome 12q: evidence from Afro-Caribbean and Caucasian populations. Genomics 37: 41-50 (1996). *

• Barnes PJ. Transcription factors and inflammatory disease. Hosp. Pract. (Off. Ed.) 31: 93-100, 105-106 (1996).

• Batts KP, Jorgensen RA, Dickson ER, Lindor KD. Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis. Am. J. Gastroenterol. 91: 2314-2317 (1996).

• Bell RG. IgE, allergies and helminth parasites: a new perspective on an old conundrum. Immunol. Cell Biol. 74: 337-345 (1996). *

• Bellinger DL, Lorton D, Brouxhon S, Felten S, Felten DL. The significance of vasoactive intestinal polypeptide (VIP) in immunomodulation. Adv. Neuroimmunol. 6: 5-27 (1996).

• Benhidjeb T, Muller JM, Gellert K, Zanow J, Rudolph B. Current therapy of bile duct cysts. II. Intrahepatic cysts (Caroli syndrome). Chirurg. 67: 238-243 (1996).

• Bennett ST, Wilson AJ, Cucca F, Nerup J, Pociot F, McKinney PA, Barnett AH, Bain SC, Todd JA. IDDM2-VNTR-encoded susceptibility to type 1 diabetes: dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus. J. Autoimmun. 9: 415-421 (1996).

• Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJ. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology 110: 821-831 (1996). *

• Bergasa NV, Jones A, Kleiner DE, Rabin L, Park Y, Wells MC, Hoofnagle JH. Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis. Am. J. Gastroenterol. 91: 295-299 (1996).

• Berlakovich GA, Imhof M, Karner-Hanusch J, Gotzinger P, Gollackner B, Gnant M, Hanelt S, Laufer G, Muhlbacher F, Steininger R. The importance of the effect of underlying disease on rejection outcomes following orthotopic liver transplantation. Transplantation 61: 554-560 (1996).

• Bernstein CN, Pettigrew NM, el-Gabalawy HS, Sargent M, Meu Y, Wilkins J. The differential expression of a novel intestinal epithelial glycoprotein in various forms of inflammatory bowel disease. Am. J. Clin. Pathol. 106: 42-51 (1996).

• Bernstein CN, Seeger LL, Anton PA, Artinian L, Geffrey S, Goodman W, Belin TR, Shanahan F. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study. Aliment. Pharmacol. Ther. 10: 777-786 (1996).

• Bernstein D, Rogers A. Malignancy in Crohn's disease. Am. J. Gastroenterol. 91: 434-440 (1996).

• Beukeveld GJ, In 't Veld G, Havinga R, Groen AK, Wolthers BG, Kuipers F. Relationship between biliary lipid and protoporphyrin secretion; potential role of mdr2 P-glycoprotein in hepatobiliary organic anion transport. J. Hepatol. 24: 343-352 (1996). *

• Beyeler C, Armstrong M, Bird HA, Idle JR, Daly AK. Relationship between genotype for the cytochrome P450 CYP2D6 and susceptibility to ankylosing spondylitis and rheumatoid arthritis. Ann. Rheum. Dis. 55: 66-68 (1996). *

• Beylot M. Regulation of in vivo ketogenesis: role of free fatty acids and control by epinephrine, thyroid hormones, insulin and glucagon. Diabetes Metab. 22: 299-304 (1996).

• Binder V, Orholm M. Familial occurrence and inheritance studies in inflammatory bowel disease. Neth. J. Med. 48: 53-56 (1996).

• Bioque G, Bouma G, Crusius JB, Koutroubakis I, Kostense PJ, Meuwissen SG, Pena AS. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 8: 105-110 (1996).

• Birtwistle J. The role of cigarettes and nicotine in the onset and treatment of ulcerative colitis. Postgrad. Med. J. 72: 714-718 (1996). *

• Bitton A, Peppercorn MA, Hanrahan JP, Upton MP. Mesalamine-induced lung toxicity. Am. J. Gastroenterol. 91: 1039-1040 (1996).

• Bjoro K, Schrumpf E, Bergan A, Flatmark A, Mathisen O, Sodal G, Soreide O, Sanengen T, Innes R, Osnes S. Liver transplantation in Norway. Results after 10 years and 114 transplantations. Tidsskr. Nor. Laegeforen. 116: 19-24 (1996).

• Blackwell JM. Structure and function of the natural-resistance-associated macrophage protein (Nramp1), a candidate protein for infectious and autoimmune disease susceptibility. Mol. Med. Today 2: 205-211 (1996).

• Bloch DB, de la Monte SM, Guigaouri P, Filippov A, Bloch KD. Identification and characterization of a leukocyte-specific component of the nuclear body. J. Biol. Chem. 271: 29198-29204 (1996). *

• Bluestone JA. Costimulation and its role in organ transplantation. Clin. Transplant. 10: 104-109 (1996).

• Boberg KM, Fausa O, Haaland T, Holter E, Mellbye OJ, Spurkland A, Schrumpf E. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. Hepatology 23: 1369-1376 (1996). *

• Bogstedt AK, Nava S, Wadstrom T, Hammarstrom L. Helicobacter pylori infections in IgA deficiency: lack of role for the secretory immune system. Clin. Exp. Immunol. 105: 202-204 (1996). *

• Bollag G, Clapp DW, Shih S, Adler F, Zhang YY, Thompson P, Lange BJ, Freedman MH, McCormick F, Jacks T, Shannon K. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat. Genet. 12: 144-148 (1996). *

• Bollag W. The retinoid revolution. Overview. FASEB J. 10: 938-939 (1996). *

• Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, Kostense PJ, Giphart MJ, Schreuder GM, Meuwissen SG, Pena AS. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand. J. Immunol. 43: 456-463 (1996).

• Bouma G, Xia B, Crusius JB, Bioque G, Koutroubakis I, Von Blomberg BM, Meuwissen SG, Pena AS. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin. Exp. Immunol. 103: 391-396 (1996). *

• Bourke B, Goggin N, Walsh D, Kennedy S, Setchell KD, Drumm B. Byler-like familial cholestasis in an extended kindred. Arch. Dis. Child. 75: 223-227 (1996).

• Bowling TE, Price AB, al-Adnani M, Fairclough PD, Menzies-Gow N, Silk DB. Interchange between collagenous and lymphocytic colitis in severe disease with autoimmune associations requiring colectomy: a case report. Gut 38: 788-791 (1996). *

• Boyer JL. Bile duct epithelium: frontiers in transport physiology. Am. J. Physiol. 270: G1-G5 (1996).

• Braegger CP, MacDonald TT. The immunologic basis for celiac disease and related disorders. Semin. Gastrointest. Dis. 7: 124-133 (1996).

• Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137: 354-366 (1996). *

• Bralet MP, Zafrani ES. Hepatitis caused by the amoxicillin-clavulanic acid combination. An example of drug-induced biliary hepatotoxicity. Ann. Pathol. 16: 425-429 (1996).

• Brandtzaeg P. The human intestinal immune system: basic cellular and humoral mechanisms. Baillieres Clin. Rheumatol. 10: 1-24 (1996).

• Brennan P, Ollier B, Worthington J, Hajeer A, Silman A. Are both genetic and reproductive associations with rheumatoid arthritis linked to prolactin? Lancet 348: 106-109 (1996). *

• Brentnall TA, Haggitt RC, Rabinovitch PS, Kimmey MB, Bronner MP, Levine DS, Kowdley KV, Stevens AC, Crispin DA, Emond M, Rubin CE. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 110: 331-338 (1996). *

• Brett PM, Yasuda N, Yiannakou JY, Herbst F, Ellis HJ, Vaughan R, Nicholls RJ, Ciclitira PJ. Genetic and immunological markers in pouchitis. Eur. J. Gastroenterol. Hepatol. 8: 951-955 (1996).

• Brooks CJ, King WJ, Radford DJ, Adu D, McGrath M, Savage CO. IL-1 beta production by human polymorphonuclear leucocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: relevance to systemic vasculitis. Clin. Exp. Immunol. 106: 273-279 (1996). *

• Broome U, Hauzenberger D, Klominek J. Adhesion molecules in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatogastroenterology 43: 1109-1112 (1996).

• Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, Prytz H, Sandberg-Gertzen H, Wallerstedt S, Lindberg G. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 38: 610-615 (1996). *

• Bross DA, Leichtner AM, Zurakowski D, Law T, Bousvaros A. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease. J. Pediatr. Gastroenterol. Nutr. 23: 164-171 (1996). *

• Buc M. Immunogenetic mechanisms in autoimmune processes: disorders of immune regulatory mechanisms, genetic determination of autoimmunity, effector mechanisms of autoimmune processes and their therapy. Bratisl. Lek. Listy. 97: 660-668 (1996).

• Buckley SE, DiPalma JA. Recognizing primary biliary cirrhosis and primary sclerosing cholangitis. Am. Fam. Physician 53: 195-200 (1996).

• Burrows NP, Zhao MH, Norris PG, Lockwood CM. ANCA associated with Behcet's disease. J. R. Soc. Med. 89: 47P-48P (1996). *

• Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 272: 60-66 (1996). *

• Buts JP, De Keyser N, Collette E, Bonsignore M, Lambotte L, Desjeux JF, Sokal EM. Intestinal transport of calcium in rat biliary cirrhosis. Pediatr. Res. 40: 533-541 (1996).

• Byron D, Minuk GY. Clinical hepatology: profile of an urban, hospital-based practice. Hepatology 24: 813-815 (1996). *

• Caccavo D, Afeltra A, Guido F, Di Monaco C, Ferri GM, Amoroso A, Vaccaro F, Bonomo L. Two spatially distant epitopes of human lactoferrin. Hybridoma 15: 263-269 (1996).

• Caldwell SH, Oelsner DH, Bickston SJ, Mays K, Yeaton P. Intrahepatic biliary endoscopy in sclerosing cholangitis. J. Clin. Gastroenterol. 23: 152-256 (1996).

• Camargo CA Jr, Washington MK, Fitz JG, Clavien PA. Adult presentation of diffuse bile duct stenosis: therapy with liver transplantation. Liver Transpl. Surg. 2: 235-237 (1996).

• Campana C, Regazzi MB, Buggia I, Molinaro M. Clinically significant drug interactions with cyclosporin. An update. Clin. Pharmacokinet. 30: 141-179 (1996).

• Cantorna MT, Nashold FE, Chun TY, Hayes CE. Vitamin A down-regulation of IFN-gamma synthesis in cloned mouse Th1 lymphocytes depends on the CD28 costimulatory pathway. J. Immunol. 156: 2674-2679 (1996).

• Cao MY, Thonnard J, Deggouj N, Gersdorff M, Philippe M, Osselaer JC, Tomasi JP. HLA class II-associated genetic susceptibility in idiopathic progressive sensorineural hearing loss. Ann. Otol. Rhinol. Laryngol. 105: 628-633 (1996).

• Capodici C, Weiss J. Both N- and C-terminal regions of the bioactive N-terminal fragment of the neutrophil granule bactericidal/permeability-increasing protein are required for stability and function. J. Immunol. 156: 4789-4796 (1996).

• Caradonna P, Costamagna G, Benedetti G, Gentiloni N, Gasbarrini GB. Chronic pancreatitis prevalence in liver cirrhosis. Morphological and functional study. Ital. J. Gastroenterol. 28: 91-94 (1996).

• Carey HV, Martin SL. Preservation of intestinal gene expression during hibernation. Am. J. Physiol. 271: G804-G813 (1996).

• Castello-Branco LR, Lewis DJ, Ortigo-de-Sampaio MB, Griffin GE. Gastrointestinal immune responses in HIV infected subjects. Mem. Inst. Oswaldo Cruz 91: 363-366 (1996).

• Caygill CP, Charlett A, Hill MJ. Fat, fish, fish oil and cancer. Br. J. Cancer 74: 159-164 (1996).

• Cereghini S. Liver-enriched transcription factors and hepatocyte differentiation. FASEB J. 10: 267-282 (1996). *

• Cha S, Leung PS, Van de Water J, Tsuneyama K, Joplin RE, Ansari AA, Nakanuma Y, Schatz PJ, Cwirla S, Fabris LE, Neuberger JM, Gershwin ME, Coppel RL. Random phage mimotopes recognized by monoclonal antibodies against the pyruvate dehydrogenase complex-E2 (PDC-E2). Proc. Natl. Acad. Sci. U.S.A. 93: 10949-10954 (1996). *

• Chabot F, Mestiri H, Sabry S, Dall'Ava-Santucci J, Lockhart A, Dinh-Xuan AT. Role of NO in the pulmonary artery hyporeactivity to phenylephrine in experimental biliary cirrhosis. Eur. Respir. J. 9: 560-564 (1996).

• Chamba A, Neuberger J, Strain A, Hopkins J, Sheppard MC, Franklyn JA. Expression and function of thyroid hormone receptor variants in normal and chronically diseased human liver. J. Clin. Endocrinol. Metab. 81: 360-367 (1996). *

• Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 10: 940-954 (1996). *

• Chan JK. Gastrointestinal lymphomas: an overview with emphasis on new findings and diagnostic problems. Semin. Diagn. Pathol. 13: 260-296 (1996).

• Chazouilleres O, Marteau P, Haniche M, Jian R, Poupon R. Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA). Dig. Dis. Sci. 41: 2417-2422 (1996).

• Cheema SP, Webster NR, Dunn F, Bellamy MC. Mediators of fibrinolysis in orthotopic liver transplantation. Clin. Transplant. 10: 24-27 (1996).

• Chen CC, Meng HC, Chang FY, Yang WG, Ng WW, Lee SD. Characteristics of endoscopic retrograde cholangiopancreatogram in patients with primary biliary cirrhosis. Zhonghua Yi Xue Za Zhi (Taipei) 57: 254-259 (1996).

• Chen D, Radford-Smith G, Dipaolo MC, McGowan I, Jewell DP. Cytokine gene transcription of human colonic intraepithelial lymphocytes costimulated with epithelial cells bearing HLA-DR and its inhibition by 5-aminosalicylic acid. J. Clin. Immunol. 16: 237-241 (1996).

• Chen J, Giovannucci E, Kelsey K, Rimm EB, Stampfer MJ, Colditz GA, Spiegelman D, Willett WC, Hunter DJ. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 56: 4862-4864 (1996). *

• Chen S, Sawicka J, Betterle C, Powell M, Prentice L, Volpato M, Rees Smith B, Furmaniak J. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure. J. Clin. Endocrinol. Metab. 81: 1871-1876 (1996). *

• Chen Y, Inobe J, Kuchroo VK, Baron JL, Janeway CA Jr, Weiner HL. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc. Natl. Acad. Sci. U.S.A. 93: 388-391 (1996). *

• Chianale J, Vollrath V, Wielandt AM, Amigo L, Rigotti A, Nervi F, Gonzalez S, Andrade L, Pizarro M, Accatino L. Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse. Biochem. J. 314: 781-786 (1996). *

• Chong AS. Receptors that turn on and turn off natural killer cells. J. Heart Lung Transplant. 15: 675-683 (1996).

• Chow A, Zhou W, Jacobson R. Regulation of AE2 Cl-/HCO3- exchanger during intestinal development. Am. J. Physiol. 271: G330-G337 (1996).

• Christakos S, Raval-Pandya M, Wernyj RP, Yang W. Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3. Biochem. J. 316: 361-371 (1996). *

• Christl SU, Eisner HD, Dusel G, Kasper H, Scheppach W. Antagonistic effects of sulfide and butyrate on proliferation of colonic mucosa: a potential role for these agents in the pathogenesis of ulcerative colitis. Dig. Dis. Sci. 41: 2477-2481 (1996).

• Chuang LM, Wu HP, Jang MH, Wang TR, Sue WC, Lin BJ, Cox DW, Tai TY. High frequency of two mutations in codon 778 in exon 8 of the ATP7B gene in Taiwanese families with Wilson disease. J. Med. Genet. 33: 521-523 (1996).

• Cid MC. New developments in the pathogenesis of systemic vasculitis. Curr. Opin. Rheumatol. 8: 1-11 (1996).

• Cippitelli M, Ye J, Viggiano V, Sica A, Ghosh P, Gulino A, Santoni A, Young HA. Retinoic acid-induced transcriptional modulation of the human interferon-gamma promoter. J. Biol. Chem. 271: 26783-26793 (1996). *

• Claise C, Johanet C, Bouhnik Y, Kapel N, Homberg JC, Poupon R. Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases. Liver 16: 28-34 (1996).

• Clarke SD, Jump DB. Polyunsaturated fatty acid regulation of hepatic gene transcription. Lipids 31: S7-S11 (1996).

• Claudepierre P, Clerc D, Cariou D, Lavabre C, Venencie PY, Bisson M. SAPHO syndrome and pyoderma gangrenosum: is it fortuitous? J. Rheumatol. 23: 400-402 (1996).

• Clavel C, Pennaforte F, Pigeon F, Mozelle M, Boutterin MC, Duval-Binninger I, F-erec C, Birembaut P. Epidemiologic study of the cystic fibrosis gene in the Champagne-Ardenne region. Ann. Biol. Clin. (Paris) 54: 67-74 (1996).

• Clavien PA, Sharara AI, Camargo CA Jr, Harland RC, Fitz JG. Evidence that ursodeoxycholic acid prevents steroid-resistant rejection in adult liver transplantation. Clin. Transplant. 10: 658-662 (1996).

• Clayton PT, Mills KA, Johnson AW, Barabino A, Marazzi MG. Delta 4-3-oxosteroid 5 beta-reductase deficiency: failure of ursodeoxycholic acid treatment and response to chenodeoxycholic acid plus cholic acid. Gut 38: 623-628 (1996). *

• Cohen AD, Shoenfeld Y. Vaccine-induced autoimmunity. J. Autoimmun. 9: 699-703 (1996).

• Cohen RD, Hanauer SB. Protection from primary sclerosing cholangitis: smoke trails or just coattails? Gastroenterology 110: 1658-1662 (1996). *

• Cohen SA, Siegel JH, Kasmin FE. Complications of diagnostic and therapeutic ERCP. Abdom. Imaging 21: 385-394 (1996). *

• Colombo C, Battezzati PM. Hepatobiliary manifestations of cystic fibrosis. Eur. J. Gastroenterol. Hepatol. 8: 748-754 (1996).

• Colombo C, Battezzati PM, Podda M, Bettinardi N, Giunta A. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis. Hepatology 23: 1484-1490 (1996). *

• Colonna M. Natural killer cell receptors specific for MHC class I molecules. Curr. Opin. Immunol. 8: 101-107 (1996).

• Cominelli F, Pizarro TT. Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease. Aliment. Pharmacol. Ther. 10 Suppl. 2: 49-53 (1996).

• Cong Y, Bowdon HR, Elson CO. Identification of an immunodominant T cell epitope on cholera toxin. Eur. J. Immunol. 26: 2587-2594 (1996).

• Conley BA, Ord RA. Current status of retinoids in chemoprevention of oral squamous cell carcinoma: an overview. J. Craniomaxillofac. Surg. 24: 339-345 (1996).

• Corfield AP, Myerscough N, Bradfield N, Corfield Cdo A, Gough M, Clamp JR, Durdey P, Warren BF, Bartolo DC, King KR, Williams JM. Colonic mucins in ulcerative colitis: evidence for loss of sulfation. Glycoconj. J. 13: 809-822 (1996).

• Cork MJ, Crane AM, Duff GW. Genetic control of cytokines. Cytokine gene polymorphisms in alopecia areata. Dermatol. Clin. 14: 671-678 (1996).

• Cotch MF, Hoffman GS, Yerg DE, Kaufman GI, Targonski P, Kaslow RA. The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum. 39: 87-92 (1996).

• Cotten JF, Ostedgaard LS, Carson MR, Welsh MJ. Effect of cystic fibrosis-associated mutations in the fourth intracellular loop of cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 271: 21279-21284 (1996). *

• Croft NM, Marshall TG, Ferguson A. Direct assessment of gastrointestinal inflammation and mucosal immunity in children with cystic fibrosis. Postgrad. Med. J. 72 Suppl. 2: S32-S36 (1996).

• Crosignani A, Battezzati PM, Setchell KD, Invernizzi P, Covini G, Zuin M, Podda M. Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis. A dose-response study. Dig. Dis. Sci. 41: 809-815 (1996).

• Crosignani A, Setchell KD, Invernizzi P, Larghi A, Rodrigues CM, Podda M. Clinical pharmacokinetics of therapeutic bile acids. Clin. Pharmacokinet. 30: 333-358 (1996).

• Csernok E, Szymkowiak CH, Mistry N, Daha MR, Gross WL, Kekow J. Transforming growth factor-beta (TGF-beta) expression and interaction with proteinase 3 (PR3) in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Clin. Exp. Immunol. 105: 104-111 (1996). *

• Cuddihy RM, Bahn RS. Lack of an association between alleles of interleukin-1 alpha and interleukin-1 receptor antagonist genes and Graves' disease in a North American Caucasian population. J. Clin. Endocrinol. Metab. 81: 4476-4478 (1996). *

• Cuddihy RM, Schaid DS, Bahn RS. Multivariate analysis of HLA loci in conjunction with a thyrotropin receptor codon 52 polymorphism in conferring risk of Graves' disease. Thyroid 6: 261-265 (1996).

• Cummins RE, Mullins D, Smith LJ, Ford MJ. Metastatic Crohn's disease: a case report. Pediatr. Dermatol. 13: 25-28 (1996).

• Czaja AJ. The variant forms of autoimmune hepatitis. Ann. Intern. Med. 125: 588-598 (1996). *

• Czaja AJ. Diagnosis and therapy of autoimmune liver disease. Med. Clin. North Am. 80: 973-994 (1996).

• Czaja AJ, Carpenter H, Santrach PJ, Moore SB. DR human leukocyte antigens and disease severity in chronic hepatitis C. J. Hepatol. 24: 666-673 (1996). *

• Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis. J. Hepatol. 24: 52-59 (1996). *

• Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 24: 1068-1073 (1996). *

• Czaja AJ, Pfeifer KD, Decker RH, Vallari AS. Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis. Dig. Dis. Sci. 41: 1733-1740 (1996).

• Dady IM, Thomas AG, Miller V, Kelsey AJ. Inflammatory bowel disease in infancy: an increasing problem? J. Pediatr. Gastroenterol. Nutr. 23: 569-576 (1996). *

• Daig R, Andus T, Aschenbrenner E, Falk W, Scholmerich J, Gross V. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 38: 216-222 (1996). *

• Danze PM, Colombel JF, Jacquot S, Loste MN, Heresbach D, Ategbo S, Khamassi S, Perichon B, Semana G, Charron D, Cezard JP. Association of HLA class II genes with susceptibility to Crohn's disease. Gut 39: 69-72 (1996). *

• Darwish HM, DeLuca HF. Recent advances in the molecular biology of vitamin D action. Prog. Nucleic Acid Res. Mol. Biol. 53: 321-344 (1996).

• Das JB, Poulos ND, Ansari GG. Biliary lipid composition and bile acid profiles during and after enteral fast of total parenteral nutrition in the rabbit. J. Pediatr. Gastroenterol. Nutr. 22: 85-91 (1996). *

• Daser A, Mitchison H, Mitchison A, Muller B. Non-classical-MHC genetics of immunological disease in man and mouse. The key role of pro-inflammatory cytokine genes. Cytokine 8: 593-597 (1996).

• Davidson NJ, Leach MW, Fort MM, Thompson-Snipes L, Kuhn R, Muller W, Berg DJ, Rennick DM. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J. Exp. Med. 184: 241-251 (1996). *

• De Keyser F, Elewaut D, De Wever N, Bensbaho K, Cuvelier C. The gut associated addressins: lymphocyte homing in the gut. Baillieres Clin. Rheumatol. 10: 25-39 (1996).

• De Maria N, Colantoni A, Rosenbloom E, Van Thiel DH. Ursodeoxycholic acid does not improve the clinical course of primary sclerosing cholangitis over a 2-year period. Hepatogastroenterology 43: 1472-1479 (1996).

• De Stavola BL, Christensen E. Multilevel models for longitudinal variables prognostic for survival. Lifetime Data Anal. 2: 329-347 (1996).

• de The H. Altered retinoic acid receptors. FASEB J. 10: 955-960 (1996). *

• De Vita S, Ferraccioli GF, Dolcetti R, Marzotto A, Pivetta B, Pomponi F, Boiocchi M. The role of molecular analyses of B-cell and T-cell clonality in the study of B-cell lymphomagenesis. Clin. Exp. Rheumatol. 14 Suppl. 14: S21-S29 (1996).

• de Wilt JH, de Man RA, Lameris JS, Ijzermans JN. Focal nodular hyperplasia of the liver: assessment of diagnosis and treatment in 31 patients in 15 years. Ned. Tijdschr. Geneeskd. 140: 18-22 (1996).

• Deleuze JF, Jacquemin E, Dubuisson C, Cresteil D, Dumont M, Erlinger S, Bernard O, Hadchouel M. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology 23: 904-908 (1996). *

• Demoulins-Giacco N, Gagey V, Teillac-Hamel D, Fraitag S, Caillat-Zucman S, Schmitz J, de Prost Y. Dermatitis herpetiformis occuring in patients with celiac disease in childhood. Arch. Pediatr. 3: 541-548 (1996).

• Dentener MA, Francot GJ, Buurman WA. Bactericidal/permeability-increasing protein, a lipopolysaccharide-specific protein on the surface of human peripheral blood monocytes. J. Infect. Dis. 173: 252-255 (1996).

• Deplaix P, Barthelemy C, Vedrines P, Perrot JL, Lanthier K, Pignato F, Audigier JC. Probable acute hemorrhagic colitis caused by isotretinoin with a test of repeated administration. Gastroenterol. Clin. Biol. 20: 113-114 (1996).

• Dessoukey MW, Omar MF, Dayem HA. Pyoderma faciale: manifestation of inflammatory bowel disease. Int. J. Dermatol. 35: 724-726 (1996).

• Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, Wahli W. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature 384: 39-43 (1996). *

• Deviere J. Therapeutic endoscopy and primary sclerosing cholangitis. Endoscopy 28: 576-577 (1996).

• Diaferia A, Nicastri PL, Tartagni M, Loizzi P, Iacovizzi C, Di Leo A. Ursodeoxycholic acid therapy in pregnant women with cholestasis. Int. J. Gynaecol. Obstet. 52: 133-140 (1996).

• Diebel LN, Raafat AM, Dulchavsky SA, Brown WJ. Gallbladder and biliary tract candidiasis. Surgery 120: 760-764 (1996).

• Dieleman LA, Elson CO, Tennyson GS, Beagley KW. Kinetics of cytokine expression during healing of acute colitis in mice. Am. J. Physiol. 271: G130-G136 (1996).

• DiIulio NA, Xu H, Fairchild RL. Diversion of CD4+ T cell development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response. Eur. J. Immunol. 26: 2606-2612 (1996).

• Distante V, Farouk M, Kurzawinski TR, Ahmed SW, Burroughs AK, Davidson BR, Rolles K. Duct-to-duct biliary reconstruction following liver transplantation for primary sclerosing cholangitis. Transpl. Int. 9: 126-130 (1996).

• Djakoure C, Guibourdenche J, Porquet D, Pagesy P, Peillon F, Li JY, Evain-Brion D. Vitamin A and retinoic acid stimulate within minutes cAMP release and growth hormone secretion in human pituitary cells. J. Clin. Endocrinol. Metab. 81: 3123-3126 (1996). *

• Djilali-Saiah I, Benini V, Daniel S, Assan R, Bach JF, Caillat-Zucman S. Linkage disequilibrium between HLA class II (DR, DQ, DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex. Tissue Antigens 48: 87-92 (1996).

• Djilali-Saiah I, Benini V, Schmitz J, Timsit J, Assan R, Boitard C, Bach JF, Caillat-Zucman S. Absence of primary association between DM gene polymorphism and insulin-dependent diabetes mellitus or celiac disease. Hum. Immunol. 49: 22-27 (1996).

• Dmitrewski J, Hubscher SG, Mayer AD, Neuberger JM. Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression. J. Hepatol. 24: 253-257 (1996). *

• Donaldson PT. Immunogenetics in liver disease. Baillieres Clin. Gastroenterol. 10: 533-549 (1996).

• Dorner T, Feist E, Wagenmann A, Kato T, Yamamoto K, Nishioka K, Burmester GR, Hiepe F. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen. J. Rheumatol. 23: 462-468 (1996).

• Doull I, Langton-Hewer S. Gut inflammation in children with cystic fibrosis on high-dose enzyme supplementation. Lancet 347: 327 (1996).

• Downes M, Burke LJ, Muscat GE. Transcriptional repression by Rev-erbA alpha is dependent on the signature motif and helix 5 in the ligand binding domain: silencing does not involve an interaction with N-CoR. Nucleic Acids Res. 24: 3490-3498 (1996). *

• Duchmann R, May E, Ackermann B, Goergen B, Meyer zum Buschenfelde KH, Marker-Hermann E. HLA-B27-restricted cytotoxic T lymphocyte responses to arthritogenic enterobacteria or self-antigens are dominated by closely related TCRBV gene segments. A study in patients with reactive arthritis. Scand. J. Immunol. 43: 101-108 (1996).

• Duchmann R, Schmitt E, Knolle P, Meyer zum Buschenfelde KH, Neurath M. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur. J. Immunol. 26: 934-938 (1996).

• Duell EA, Kang S, Voorhees JJ. Retinoic acid isomers applied to human skin in vivo each induce a 4-hydroxylase that inactivates only trans retinoic acid. J. Invest. Dermatol. 106: 316-320 (1996).

• Duester G. Involvement of alcohol dehydrogenase, short-chain dehydrogenase/reductase, aldehyde dehydrogenase, and cytochrome P450 in the control of retinoid signaling by activation of retinoic acid synthesis. Biochemistry 35: 12221-12227 (1996). *

• Dufour JF, Kaplan MM. Methotrexate therapy and liver disease. N. Engl. J. Med. 335: 898-899 (1996).

• Dumonceau JM, Van Gossum A, Adler M, Fonteyne PA, Van Vooren JP, Deviere J, Portaels F. No Mycobacterium paratuberculosis found in Crohn's disease using polymerase chain reaction. Dig. Dis. Sci. 41: 421-426 (1996).

• Durupinar B, Okten G. HLA tissue types in nonresponders to hepatitis B vaccine. Indian J. Pediatr. 63: 369-373 (1996).

• Duszka C, Grolier P, Azim EM, Alexandre-Gouabau MC, Borel P, Azais-Braesco V. Rat intestinal beta-carotene dioxygenase activity is located primarily in the cytosol of mature jejunal enterocytes. J. Nutr. 126: 2550-2556 (1996). *

• Eastwood GL. Pharmacologic prevention of colonic neoplasms. Effects of calcium, vitamins, omega fatty acids, and nonsteroidal anti-inflammatory drugs. Dig. Dis. 14: 119-128 (1996).

• Eberhardt K, Fex E, Johnson U, Wollheim FA. Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis. Ann. Rheum. Dis. 55: 34-39 (1996). *

• Ebers GC, Kukay K, Bulman DE, Sadovnick AD, Rice G, Anderson C, Armstrong H, Cousin K, Bell RB, Hader W, Paty DW, Hashimoto S, Oger J, Duquette P, Warren S, Gray T, O'Connor P, Nath A, Auty A, Metz L, Francis G, Paulseth JE, Murray TJ, et al. A full genome search in multiple sclerosis. Nat. Genet. 13: 472-476 (1996). *

• Ebringer A, Ahmadi K, Fielder M, Rashid T, Tiwana H, Wilson C, Collado A, Tani Y. Molecular mimicry: the geographical distribution of immune responses to Klebsiella in ankylosing spondylitis and its relevance to therapy. Clin. Rheumatol. 15 Suppl. 1: 57-61 (1996).

• Ebringer A, Wilson C. The use of a low starch diet in the treatment of patients suffering from ankylosing spondylitis. Clin. Rheumatol. 15 Suppl. 1: 62-66 (1996).

• Edwards CK 3rd, Zhou T, Zhang J, Baker TJ, De M, Long RE, Borcherding DR, Bowlin TL, Bluethmann H, Mountz JD. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha. J. Immunol. 157: 1758-1772 (1996).

• Egan LJ, Sandborn WJ. Methotrexate for inflammatory bowel disease: pharmacology and preliminary results. Mayo Clin. Proc. 71: 69-80 (1996). *

• Eggena M, Targan SR, Iwanczyk L, Vidrich A, Gordon LK, Braun J. Phage display cloning and characterization of an immunogenetic marker (perinuclear anti-neutrophil cytoplasmic antibody) in ulcerative colitis. J. Immunol. 156: 4005-4011 (1996).

• Eggermont E. Gastrointestinal manifestations in cystic fibrosis. Eur. J. Gastroenterol. Hepatol. 8: 731-738 (1996).

• Ehrhardt RO. New insights into the immunopathology of chronic inflammatory bowel disease. Semin. Gastrointest. Dis. 7: 144-150 (1996).

• Ekbom A, Daszak P, Kraaz W, Wakefield AJ. Crohn's disease after in-utero measles virus exposure. Lancet 348: 515-517 (1996). *

• el-Zaatari FA, Naser SA, Markesich DC, Kalter DC, Engstand L, Graham DY. Identification of Mycobacterium avium complex in sarcoidosis. J. Clin. Microbiol. 34: 2240-2245 (1996). *

• Elsing C, Kassner A, Stremmel W. Sodium, hydrogen antiporter activation by extracellular adenosine triphosphate in biliary epithelial cells. Gastroenterology 111: 1321-1332 (1996). *

• Elson CO. The basis of current and future therapy for inflammatory bowel disease. Am. J. Med. 100: 656-662 (1996). *

• Elson CO. The effects of immunosuppressive agents on cytokines. Aliment. Pharmacol. Ther. 10 Suppl. 2: 100-105 (1996).

• Elson CO, Beagley KW, Sharmanov AT, Fujihashi K, Kiyono H, Tennyson GS, Cong Y, Black CA, Ridwan BW, McGhee JR. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. J. Immunol. 157: 2174-2185 (1996).

• Erlinger S. Review article: new insights into the mechanisms of hepatic transport and bile secretion. J. Gastroenterol. Hepatol. 11: 575-579 (1996).

• Erlinger S. Mechanisms of hepatic transport and bile secretion. Acta Gastroenterol. Belg. 59: 159-162 (1996).

• Faa G. The role of the pathologist in the diagnosis and monitoring of Wilson's disease. Pathologica 88: 102-110 (1996).

• Faist E, Schinkel C, Zimmer S. Update on the mechanisms of immune suppression of injury and immune modulation. World J. Surg. 20: 454-459 (1996). *

• Fallon MB, Abrams GA. Scenario number one: hepatopulmonary syndrome. Liver Transpl. Surg. 2: 313-319 (1996).

• Fan ST, Lo CM, Chan KL, Lo R, Saing H, Wei W, Lai CL, Tsoi NS, Ng I, Chan JK, Chau MT, Tso WK, Wong J. Liver transplantation - perspective from Hong Kong. Hepatogastroenterology 43: 893-897 (1996).

• Fan ST, Lo CM, Man K. Liver transplantation report of 23 cases. Zhonghua Yi Xue Za Zhi 76: 267-270 (1996).

• Fardel O, Lecureur V, Guillouzo A. The P-glycoprotein multidrug transporter. Gen. Pharmacol. 27: 1283-1291 (1996).

• Farges O, Saliba F, Farhamant H, Samuel D, Bismuth A, Reynes M, Bismuth H. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins. Hepatology 23: 240-248 (1996). *

• Farinati F, Cardin R, Naccarato R, Floreani A. Cysteine and glutathione in the liver of patients with primary biliary cirrhosis. J. Hepatol. 25: 123 (1996). *

• Farstad IN, Halstensen TS, Lien B, Kilshaw PJ, Lazarovits AI, Brandtzaeg P. Distribution of beta 7 integrins in human intestinal mucosa and organized gut-associated lymphoid tissue. Immunology 89: 227-237 (1996). *

• Feagan BG, McDonald JW, Koval JJ. Therapeutics and inflammatory bowel disease: a guide to the interpretation of randomized controlled trials. Gastroenterology 110: 275-283 (1996). *

• Fedyk ER, Phipps RP. Prostaglandin E2 receptors of the EP2 and EP4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. Proc. Natl. Acad. Sci. U.S.A. 93: 10978-10983 (1996). *

• Fell JM, Walker-Smith JA, Spencer J, MacDonald TT. The distribution of dividing T cells throughout the intestinal wall in inflammatory bowel disease (IBD). Clin. Exp. Immunol. 104: 280-285 (1996). *

• Feller AC, Lohler J, Reimann J, Merz H. Pathogenetic models ulcerative colitis and Crohn disease. Verh. Dtsch. Ges. Pathol. 80: 104-108 (1996).

• Feller RB, Waugh RC, Selby WS, Dolan PM, Sheil AG, McCaughan GW. Biliary strictures after liver transplantation: clinical picture, correlates and outcomes. J. Gastroenterol. Hepatol. 11: 21-25 (1996).

• Ferrari M, Cremonesi L. Genotype-phenotype correlation in cystic fibrosis patients. Ann. Biol. Clin. (Paris) 54: 235-241 (1996).

• Field LL, Tobias R, Thomson G, Plon S. Susceptibility to insulin-dependent diabetes mellitus maps to a locus (IDDM11) on human chromosome 14q24.3-q31. Genomics 33: 1-8 (1996). *

• Finch PW, Pricolo V, Wu A, Finkelstein SD. Increased expression of keratinocyte growth factor messenger RNA associated with inflammatory bowel disease. Gastroenterology 110: 441-451 (1996). *

• Fischer S, Beuers U, Spengler U, Zwiebel FM, Koebe HG. Hepatic levels of bile acids in end-stage chronic cholestatic liver disease. Clin. Chim. Acta 251: 173-186 (1996). *

• Fishback N, Koss M. Update on lymphoid interstitial pneumonitis. Curr. Opin. Pulm. Med. 2: 429-433 (1996).

• Fisher GJ, Voorhees JJ. Molecular mechanisms of retinoid actions in skin. FASEB J. 10: 1002-1013 (1996). *

• Floreani A, Paternoster D, Melis A, Grella PV. S-Adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial. Eur. J. Obstet. Gynecol. Reprod. Biol. 67: 109-113 (1996).

• Florquin S, Goldman M. Immunoregulatory mechanisms of T-cell-dependent shock induced by a bacterial superantigen in mice. Infect. Immun. 64: 3443-3445 (1996). *

• Fong KY, Boey ML, Yuen M, Nadarajah M, Feng PH. Absence of retroviral antibodies in the sera of patients with systemic lupus erythematosus. Singapore Med. J. 37: 479-481 (1996).

• Forbes A. Smoking and inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 8: 761-763 (1996).

• Forcione DG, Sands B, Isselbacher KJ, Rustgi A, Podolsky DK, Pillai S. An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3*0301 allele. Proc. Natl. Acad. Sci. U.S.A. 93: 5094-5098 (1996). *

• Forde AM, Feighery C, Jackson J. Anti-monocyte cytoplasmic antibodies in granulomatous disease. Clin. Immunol. Immunopathol. 81: 88-95 (1996). *

• Forestier M, Reichen J, Solioz M. Application of mRNA differential display to liver cirrhosis: reduced fetuin expression in biliary cirrhosis in the rat. Biochem. Biophys. Res. Commun. 225: 377-383 (1996). *

• Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, Pin JJ, Garrone P, Garcia E, Saeland S, Blanchard D, Gaillard C, Das Mahapatra B, Rouvier E, Golstein P, Banchereau J, Lebecque S. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183: 2593-2603 (1996). *

• Fox VL, Cohen MB, Whitington PF, Colletti RB. Outpatient liver biopsy in children: a medical position statement of the North American Society for Pediatric Gastroenterology and Nutrition. J. Pediatr. Gastroenterol. Nutr. 23: 213-216 (1996). *

• Fracassetti O, Delvecchio G, Tambini R, Lorenzi N, Gavazzeni G. Primary sclerosing cholangitis with celiac sprue: two cases. J. Clin. Gastroenterol. 22: 71-72 (1996).

• Fracchia M, Jazrawi RP, Galatola G. Determination of gallbladder bile lithogenicity in patients with primary biliary cirrhosis. Ital. J. Gastroenterol. 28: 255-260 (1996).

• Fracchia M, Setchell KD, Crosignani A, Podda M, O'Connell N, Ferraris R, Hofmann AF, Galatola G. Bile acid conjugation in early stage cholestatic liver disease before and during treatment with ursodeoxycholic acid. Clin. Chim. Acta 248: 175-185 (1996). *

• Frank TS, Cook SM. Analysis of paraffin sections of Crohn's disease for Mycobacterium paratuberculosis using polymerase chain reaction. Mod. Pathol. 9: 32-35 (1996).

• Franssen CF, Hoorntje SJ, Kallenberg CG, Gans RO. The role of perinuclear antineutrophil granulocytes cytoplasmic antibodies in the diagnosis of vasculitis and chronic inflammatory diseases. Ned. Tijdschr. Geneeskd. 140: 2076-2082 (1996).

• Freie BW, Dutt P, Clapp DW. Correction of Fanconi anemia type C phenotypic abnormalities using a clinically suitable retroviral vector infection protocol. Cell Transplant. 5: 385-393 (1996).

• Frijters CM, Ottenhoff R, Van Wijland MJ, Van Nieuwkerk C, Groen AK, Oude Elferink RP. Influence of bile salts on hepatic mdr2 P-glycoprotein expression. Adv. Enzyme Regul. 36: 351-363 (1996). *

• Friman V, Adlerberth I, Connell H, Svanborg C, Hanson LA, Wold AE. Decreased expression of mannose-specific adhesins by Escherichia coli in the colonic microflora of immunoglobulin A-deficient individuals. Infect. Immun. 64: 2794-2798 (1996). *

• Fu Z, Hu Y, Konishi K, Takata Y, Ogawa H, Gomi T, Fujioka M, Takusagawa F. Crystal structure of glycine N-methyltransferase from rat liver. Biochemistry 35: 11985-11993 (1996). *

• Fujimoto M, Sato S, Ihn H, Tamaki T, Kikuchi K, Soma Y, Tamaki K. Autoantibodies to mitochondrial 2-oxo-acid dehydrogenase complexes in localized scleroderma. Clin. Exp. Immunol. 105: 297-301 (1996). *

• Fujita S, Arii S, Monden K, Ishiguro S, Nakamura T, Mizumoto M, Imamura M. The preventive effects of OK432 on endotoxin-induced liver injury: liver protection by the modulation of hepatic macrophage function. Surg. Today 26: 29-35 (1996).

• Fukumoto Y, Okita K, Kodama T, Matsuda S, Kawamura S, Harima K, Harada Y, Kawaguchi K, Iida Y, Konishi T, Andoh K, Tanaka H, Hanta T, Sekitani T, Takenami T, Yamasaki T, Yamashita S, Fujimura H, Shimada M, Kohzu M, Shigeta K, Shirasawa H. Therapeutic effect of secretin in patients with jaundice; double-blind placebo-controlled multicentric trial. J. Gastroenterol. 31: 394-403 (1996).

• Fukuo Y, Kitami T, Nomoto T, Terashi A. A lipid lowering drug (bezafibrate) has a favorable effect on liver enzymes (Al-P and gamma-GTP). Nippon Ika Daigaku Zasshi 63: 424-430 (1996).

• Furukawa M, Sakamoto A, Kita Y, Ohishi Y, Matsumura R, Tsubata R, Tsubata T, Iwamoto I, Saito Y, Sumida T. T-cell receptor repertoire of infiltrating T cells in lachrymal glands, salivary glands and kidneys from alymphoplasia (aly) mutant mice: a new model for Sjogren's syndrome. Br. J. Rheumatol. 35: 1223-1230 (1996). *

• Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, Fiocchi C, Strober W. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 157: 1261-1270 (1996).

• Gaddipati K, Yang P. Hepatobiliary complications of parenteral nutrition. Gastroenterologist 4: 98-106 (1996).

• Galperin C, Gershwin ME. Immunopathology of primary biliary cirrhosis. Baillieres Clin. Gastroenterol. 10: 461-481 (1996).

• Ganea D. Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs. Adv. Neuroimmunol. 6: 61-74 (1996).

• Gangopadhyay NN, Moldoveanu Z, Stephensen CB. Vitamin A deficiency has different effects on immunoglobulin A production and transport during influenza A infection in BALB/c mice. J. Nutr. 126: 2960-2967 (1996). *

• Garrido MC, Hubscher SG. Accuracy of staging in primary biliary cirrhosis. J. Clin. Pathol. 49: 556-559 (1996). *

• Gartung C, Ananthanarayanan M, Rahman MA, Schuele S, Nundy S, Soroka CJ, Stolz A, Suchy FJ, Boyer JL. Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis. Gastroenterology 110: 199-209 (1996). *

• Gattei V, Aldinucci D, Quinn JM, Degan M, Cozzi M, Perin V, Iuliis AD, Juzbasic S, Improta S, Athanasou NA, Ashman LK, Pinto A. Human osteoclasts and preosteoclast cells (FLG 29.1) express functional c-kit receptors and interact with osteoblast and stromal cells via membrane-bound stem cell factor. Cell Growth Differ. 7: 753-763 (1996). *

• Gaudio E, Onori P, Pannarale L, Alvaro D. Hepatic microcirculation and peribiliary plexus in experimental biliary cirrhosis: a morphological study. Gastroenterology 111: 1118-1124 (1996). *

• Geissler K. Current status of clinical development of interleukin-10. Curr. Opin. Hematol. 3: 203-208 (1996).

• Genchi G, Wang W, Barua A, Bidlack WR, Olson JA. Formation of beta-glucuronides and of beta-galacturonides of various retinoids catalyzed by induced and noninduced microsomal UDP-glucuronosyltransferases of rat liver. Biochim. Biophys. Acta 1289: 284-290 (1996).

• Gieni RS, Yang X, Kelso A, Hayglass KT. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation. Immunology 87: 119-126 (1996). *

• Gimble JM, Robinson CE, Wu X, Kelly KA, Rodriguez BR, Kliewer SA, Lehmann JM, Morris DC. Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. Mol. Pharmacol. 50: 1087-1094 (1996). *

• Glauser MP. The inflammatory cytokines. New developments in the pathophysiology and treatment of septic shock. Drugs 52 Suppl. 2: 9-17 (1996).

• Gloria L, Cravo M, Pinto A, de Sousa LS, Chaves P, Leitao CN, Quina M, Mira FC, Soares J. DNA hypomethylation and proliferative activity are increased in the rectal mucosa of patients with long-standing ulcerative colitis. Cancer 78: 2300-2306 (1996).

• Goa KL, Barradell LB, Plosker GL. Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia. Drugs 52: 725-753 (1996).

• Gohlke F, Lohse AW, Dienes HP, Lohr H, Marker-Hermann E, Gerken G, Meyer zum Buschenfelde KH. Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J. Hepatol. 24: 699-705 (1996). *

• Goldstein R, Moulds JM, Smith CD, Sengar DP. MHC studies of the primary antiphospholipid antibody syndrome and of antiphospholipid antibodies in systemic lupus erythematosus. J. Rheumatol. 23: 1173-1179 (1996).

• Goronzy JJ, Gold KN, Weyand CM. T-cell derived lymphokines as regulators of chronic inflammation: potential targets for immunomodulation? Am. J. Ther. 3: 109-114 (1996).

• Goseki-Sone M, Oida S, Iimura T, Yamamoto A, Matsumoto HN, Omi N, Takeda K, Maruoka Y, Ezawa I, Sasaki S. Expression of mRNA encoding intestinal type alkaline phosphatase in rat liver and its increase by fat-feeding. Liver 16: 358-364 (1996).

• Gough A, Chapman S, Wagstaff K, Emery P, Elias E. Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. BMJ 312: 169-172 (1996). *

• Goyal RK, Hirano I. The enteric nervous system. N. Engl. J. Med. 334: 1106-1115 (1996). *

• Gradelet S, Leclerc J, Siess MH, Astorg PO. beta-Apo-8'-carotenal, but not beta-carotene, is a strong inducer of liver cytochromes P4501A1 and 1A2 in rat. Xenobiotica 26: 909-919 (1996).

• Graeve L, Korolenko TA, Hemmann U, Weiergraber O, Dittrich E, Heinrich PC. A complex of the soluble interleukin-6 receptor and interleukin-6 is internalized via the signal transducer gp130. FEBS Lett. 399: 131-134 (1996). *

• Greenberg GR, Feagan BG, Martin F, Sutherland LR, Thomson AB, Williams CN, Nilsson LG, Persson T. Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group. Gastroenterology 110: 45-51 (1996). *

• Greenberg PD, Cello JP. Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13: 348-354 (1996).

• Grewal IS, Flavell RA. The role of CD40 ligand in costimulation and T-cell activation. Immunol. Rev. 153: 85-106 (1996).

• Griffel LH, Das KM. Ulcerative colitis: pathogenesis, diagnosis, and current treatment. J. Assoc. Acad. Minor Phys. 7: 63-69 (1996).

• Grimbert S, Johanet C, Bendjaballah F, Homberg JC, Poupon R, Beaugrand M. Antimitochondrial antibodies in patients with chronic hepatitis C. Liver 16: 161-165 (1996).

• Grimm MC, Elsbury SK, Pavli P, Doe WF. Interleukin 8: cells of origin in inflammatory bowel disease. Gut 38: 90-98 (1996). *

• Grimm MC, Elsbury SK, Pavli P, Doe WF. Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa. J. Leukoc. Biol. 59: 804-812 (1996). *

• Grimminger F, Hattar K, Papavassilis C, Temmesfeld B, Csernok E, Gross WL, Seeger W, Sibelius U. Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generation. J. Exp. Med. 184: 1567-1572 (1996). *

• Groen AK, Oude Elferink RP, Tager JM. Control analysis of biliary lipid secretion. J. Theor. Biol. 182: 427-436 (1996). *

• Gronnesby JK, Borgan O. A method for checking regression models in survival analysis based on the risk score. Lifetime Data Anal. 2: 315-328 (1996).

• Grottrup-Wolfers E, Moeller J, Karbach U, Muller-Lissner S, Endres S. Elevated cell-associated levels of interleukin 1beta and interleukin 6 in inflamed mucosa of inflammatory bowel disease. Eur. J. Clin. Invest. 26: 115-122 (1996).

• Grotzinger T, Jensen K, Guldner HH, Sternsdorf T, Szostecki C, Schwab M, Savelyeva L, Reich B, Will H. A highly amplified mouse gene is homologous to the human interferon-responsive Sp100 gene encoding an autoantigen associated with nuclear dots. Mol. Cell Biol. 16: 1150-1156 (1996). *

• Gruenert DC. Cystic fibrosis therapy - where we are and how we got there. West. J. Med. 164: 361-362 (1996). *

• Guedes Barbosa LS, Gilbrut B, Shoenfeld Y, Scheinberg MA. Autoantibodies in leprosy sera. Clin. Rheumatol. 15: 26-28 (1996).

• Gumperz JE, Valiante NM, Parham P, Lanier LL, Tyan D. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex … J. Exp. Med. 183: 1817-1827 (1996). *

• Guy-Crotte O, Carrere J, Figarella C. Exocrine pancreatic function in cystic fibrosis. Eur. J. Gastroenterol. Hepatol. 8: 755-759 (1996).

• Gylling H, Vuoristo M, Farkkila M, Miettinen TA. The metabolism of cholestanol in primary biliary cirrhosis. J. Hepatol. 24: 444-451 (1996). *

• Haegert DG, Swift FV, Benedikz J. Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland. Neurology 46: 1107-1111 (1996).

• Hagenbuch B, Meier PJ. Sinusoidal (basolateral) bile salt uptake systems of hepatocytes. Semin. Liver Dis. 16: 129-136 (1996).

• Hagenbuch B, Scharschmidt BF, Meier PJ. Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes. Biochem. J. 316: 901-904 (1996). *

• Häggblom JO, Jokilammi-Siltanen AB, Peuravuori H, Nevalainen TJ. Time-resolved fluoroimmunoassay for bactericidal/permeability-increasing protein. Mediators Inflamm. 5: 47-50 (1996). *

• Hajeer AH, Worthington J, Silman AJ, Ollier WE. Association of tumor necrosis factor microsatellite polymorphisms with HLA-DRB1*04-bearing haplotypes in rheumatoid arthritis patients. Arthritis Rheum. 39: 1109-1114 (1996).

• Hall WC, Rojko JL. The use of immunohistochemistry for evaluating the liver. Toxicol. Pathol. 24: 4-12 (1996). *

• Halliwell B. Antioxidants in human health and disease. Annu. Rev. Nutr. 16: 33-50 (1996). *

• Hamid Q, Naseer T, Minshall EM, Song YL, Boguniewicz M, Leung DY. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J. Allergy Clin. Immunol. 98: 225-231 (1996). *

• Hammond BR Jr, Wooten BR, Snodderly DM. Cigarette smoking and retinal carotenoids: implications for age-related macular degeneration. Vision Res. 36: 3003-3009 (1996).

• Hanauer SB. Inflammatory bowel disease. N. Engl. J. Med. 334: 841-848 (1996). *

• Haneline LS, Marshall KP, Clapp DW. The highest concentration of primitive hematopoietic progenitor cells in cord blood is found in extremely premature infants. Pediatr. Res. 39: 820-825 (1996).

• Harant H, de Martin R, Andrew PJ, Foglar E, Dittrich C, Lindley IJ. Synergistic activation of interleukin-8 gene transcription by all-trans-retinoic acid and tumor necrosis factor-alpha involves the transcription factor NF-kappaB. J. Biol. Chem. 271: 26954-26961 (1996). *

• Harpaz N, Talbot IC. Colorectal cancer in idiopathic inflammatory bowel disease. Semin. Diagn. Pathol. 13: 339-357 (1996).

• Hartley MG, Hudson MJ, Swarbrick ET, Grace RH, Gent AE, Hellier MD. Sulphasalazine treatment and the colorectal mucosa-associated flora in ulcerative colitis. Aliment. Pharmacol. Ther. 10: 157-163 (1996).

• Hattori Y, Murakami Y, Hattori S, Kuroda H, Kasai K, Shimoda S. Ursodeoxycholic acid inhibits the induction of nitric oxide synthase. Eur. J. Pharmacol. 300: 147-150 (1996).

• Hayward PA, Satsangi J, Jewell DP. Inflammatory bowel disease and the X chromosome. QJM 89: 713-718 (1996).

• Heathcote J. Treatment of primary biliary cirrhosis. J. Gastroenterol. Hepatol. 11: 605-609 (1996).

• Hebuterne X, Wang XD, Smith DE, Tang G, Russell RM. In vivo biosynthesis of retinoic acid from beta-carotene involves and excentric cleavage pathway in ferret intestine. J. Lipid Res. 37: 482-492 (1996). *

• Heckmann JM, Morrison KE, Emeryk-Szajewska B, Strugalska H, Bergoffen J, Willcox N, Newsom-Davis J. Human muscle acetylcholine receptor alpha-subunit gene (CHRNA1) association with autoimmune myasthenia gravis in black, mixed-ancestry and Caucasian subjects. J. Autoimmun. 9: 175-180 (1996).

• Helmchen C, Boerner RJ, Meyendorf R, Hegerl U. Reversible hepatotoxicity of paroxetine in a patient with major depression. Pharmacopsychiatry 29: 223-226 (1996).

• Henderson B, Poole S, Wilson M. Microbial/host interactions in health and disease: who controls the cytokine network? Immunopharmacology 35: 1-21 (1996).

• Hendriks HF. Retinoid (vitamin A) metabolism. Eur. J. Clin. Nutr. 50 Suppl. 3: S2-S6 (1996).

• Henker J. Therapy with recombinant growth hormone in children with Crohn disease and growth failure. Eur. J. Pediatr. 155: 1066-1067 (1996).

• Heresbach D, Alizadeh M, Bretagne JF, Gautier A, Quillivic F, Lemarchand B, Gosselin M, Genetet B, Semana G. Investigation of the association of major histocompatibility complex genes, including HLA class I, class II and TAP genes, with clinical forms of Crohn's disease. Eur. J. Immunogenet. 23: 141-151 (1996).

• Heresbach D, Alizadeh M, Reumaux D, Colombel JF, Delamaire M, Danze PM, Gosselin M, Genetet B, Bretagne JF, Semana G. Are HLA-DR or TAP genes genetic markers of severity in ulcerative colitis? J. Autoimmun. 9: 777-784 (1996).

• Herr W, Lohse AW, Spahn TW, Dienes HP, Trautmann F, Meyer zum Buschenfelde KH, Marker-Hermann E. Nodular nonsuppurative panniculitis in association with primary biliary cirrhosis and Hashimoto's thyroiditis. Z. Rheumatol. 55: 122-126 (1996).

• Hertz R, Berman I, Keppler D, Bar-Tana J. Activation of gene transcription by prostacyclin analogues is mediated by the peroxisome-proliferators-activated receptor (PPAR). Eur. J. Biochem. 235: 242-247 (1996). *

• Herzog K, Goldblum JR. Gallbladder adenocarcinoma and acalculous chronic lymphoplasmacytic cholecystitis associated with ulcerative colitis. Mod. Pathol. 9: 194-198 (1996).

• Hinson RM, Williams JA, Shacter E. Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2. Proc. Natl. Acad. Sci. U.S.A. 93: 4885-4890 (1996). *

• Hirano F, Tanada H, Makino Y, Okamoto K, Hiramoto M, Handa H, Makino I. Induction of the transcription factor AP-1 in cultured human colon adenocarcinoma cells following exposure to bile acids. Carcinogenesis 17: 427-433 (1996). *

• Hirano F, Tanaka H, Makino Y, Okamoto K, Makino I. Effects of ursodeoxycholic acid and chenodeoxycholic acid on major histocompatibility complex class I gene expression. J. Gastroenterol. 31: 55-60 (1996).

• Hodin RA, Shei A, Morin M, Meng S. Thyroid hormone and the gut: selective transcriptional activation of a villus-enterocyte marker. Surgery 120: 138-143 (1996).

• Hoepelman AI. Current therapeutic approaches to cryptosporidiosis in immunocompromised patients. J. Antimicrob. Chemother. 37: 871-880 (1996). *

• Hohler T, Schneider PM, Rittner C, Hasenclever P, Meyer zum Buschenfelde KH, Marker-Hermann E. LMP polymorphisms do not influence disease expression in psoriatic arthritis. Clin. Exp. Rheumatol. 14: 661-664 (1996).

• Hohler T, Weinmann A, Schneider PM, Rittner C, Schopf RE, Knop J, Hasenclever P, Meyer zum Buschenfelde KH, Marker-Hermann E. TAP-polymorphisms in juvenile onset psoriasis and psoriatic arthritis. Hum. Immunol. 51: 49-54 (1996).

• Holland AJ, Ibach EG. Long-term review of coeliac axis compression syndrome. Ann. R. Coll. Surg. Engl. 78: 470-472 (1996).

• Hong GH, Park MH, Takeuchi F, Oh MD, Song YW, Nabeta H, Nakano K, Ito K, Park KS. Association of specific amino acid sequence of HLA-DR with rheumatoid arthritis in Koreans and its diagnostic value. J. Rheumatol. 23: 1699-1703 (1996).

• Horiuchi A, Kaneko T, Yamamura N, Nagata A, Nakamura T, Akamatsu T, Mukawa K, Kawa S, Kiyosawa K. Autoimmune chronic pancreatitis simulating pancreatic lymphoma. Am. J. Gastroenterol. 91: 2607-2609 (1996).

• Horsmans Y, Geubel AP. Pruritus associated with cholestatic liver disease. Ann. Intern. Med. 125: 701 (1996). *

• Houlston RS, Ford D. Genetics of coeliac disease. QJM 89: 737-743 (1996).

• Hrusovsky S, Danninger F, Kupcova V, Becker MC, Mantion G, Miguet JP. Indications and contraindications for liver transplantation. Bratisl. Lek. Listy. 97: 12-18 (1996).

• Hu W, Blazar BR, Manivel JC, Paradis K, Sharp HL. Phenotypical and functional characterization of intrahepatic bile duct cells from common duct ligated mice. J. Lab. Clin. Med. 128: 536-544 (1996).

• Huang W, Connor E, Rosa TD, Muir A, Schatz D, Silverstein J, Crockett S, She JX, Maclaren NK. Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in beta-cell autoimmunity. J. Clin. Endocrinol. Metab. 81: 2559-2563 (1996). *

• Huber BT, Hsu PN, Sutkowski N. Virus-encoded superantigens. Microbiol. Rev. 60: 473-482 (1996). *

• Hubert D, Bienvenu T, Desmazes-Dufeu N, Fajac I, Lacronique J, Matran R, Kaplan JC, Dusser DJ. Genotype-phenotype relationships in a cohort of adult cystic fibrosis patients. Eur. Respir. J. 9: 2207-2214 (1996). *

• Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, Bonaiti-Pellie C, Weissenbach J, Mathew CG, Lennard-Jones JE, Cortot A, Colombel JF, Thomas G. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379: 821-823 (1996). *

• Hultgardh-Nilsson A, Cercek B, Wang JW, Naito S, Lovdahl C, Sharifi B, Forrester JS, Fagin JA. Regulated expression of the ets-1 transcription factor in vascular smooth muscle cells in vivo and in vitro. Circ. Res. 78: 589-595 (1996).

• Hummel M, Durinovic-Bello I, Ziegler AG. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes. J. Autoimmun. 9: 427-430 (1996).

• Hunt CM, Tart JS, Dowdy E, Bute BP, Williams DM, Clavien PA. Effect of orthotopic liver transplantation on employment and health status. Liver Transpl. Surg. 2: 148-153 (1996).

• Hunter J, Kassam A, Winrow CJ, Rachubinski RA, Capone JP. Crosstalk between the thyroid hormone and peroxisome proliferator-activated receptors in regulating peroxisome proliferator-responsive genes. Mol. Cell. Endocrinol. 116: 213-221 (1996).

• Ide T, Sata M, Suzuki H, Uchimura Y, Murashima S, Shirachi M, Tanikawa K. An experimental animal model of primary biliary cirrhosis induced by lipopolysaccharide and pyruvate dehydrogenase. Kurume. Med. J. 43: 185-188 (1996).

• Iijima S, Iwata M, Otsuka F. Psoriatic arthritis and hypopyon-iridocyclitis. Possible mechanism of the association of psoriasis and anterior uveitis. Dermatology 193: 295-299 (1996).

• Iijima S, Iwata M, Otsuka F. Rheological analysis of peripheral blood neutrophils in a patient with cutaneous and arthropathic psoriasis accompanying hypopyon-iridocyclitis. Australas. J. Dermatol. 37 Suppl. 1: S40-S41 (1996).

• Ikaheimo I, Silvennoinen-Kassinen S, Karvonen J, Jarvinen T, Tiilikainen A. Immunogenetic profile of psoriasis vulgaris: association with haplotypes A2,B13,Cw6,DR7,DQA1*0201 and A1,B17,Cw6,DR7,DQA1*0201. Arch. Dermatol. Res. 288: 63-67 (1996). *

• Ikeda H, Inao M, Fujiwara K. Inhibitory effect of tranilast on activation and transforming growth factor beta 1 expression in cultured rat stellate cells. Biochem. Biophys. Res. Commun. 227: 322-327 (1996). *

• Ikeda T, Sato C, Noguchi O, Kobayashi F, Tozuka S, Sakamoto S, Marumo F. Improvement of peripheral blood lymphocyte subsets in primary biliary cirrhosis after ursodeoxycholic acid therapy. J. Gastroenterol. Hepatol. 11: 366-372 (1996).

• Ikeda T, Tozuka S, Noguchi O, Kobayashi F, Sakamoto S, Marumo F, Sato C. Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: a prospective randomized study. J. Hepatol. 24: 88-94 (1996). *

• Imada J, Hoshino H, Nishimura D, Morita K, Yoshida N, Katada N, Sano H, Kato K, Mori N. Case report: multiple cancers: hepatocellular carcinoma and adenocarcinomas of the common bile duct and the gall-bladder in a woman with primary biliary cirrhosis. J. Gastroenterol. Hepatol. 11: 546-550 (1996).

• Ishihara M, Ishida T, Inoko H, Ando H, Naruse T, Nose Y, Ohno S. HLA serological and class II genotyping in sarcoidosis patients in Japan. Jpn. J. Ophthalmol. 40: 86-94 (1996).

• Ishihara M, Ohno S, Mizuki N, Yamagata N, Ishida T, Naruse T, Ando A, Inoko H. LMP7 polymorphism in Japanese patients with sarcoidosis and Behcet's disease. Hum. Immunol. 51: 103-105 (1996).

• Ishihara M, Ohno S, Mizuki N, Yamagata N, Ishida T, Naruse T, Kuwata S, Inoko H. Genetic polymorphisms of the major histocompatibility complex-encoded antigen-processing genes TAP and LMP in sarcoidosis. Hum. Immunol. 45: 105-110 (1996).

• Ishihara M, Yamagata N, Ohno S, Naruse T, Ando A, Kawata H, Ozawa A, Ohkido M, Mizuki N, Shiina T, Ando H, Inoko H. Genetic polymorphisms in the keratin-like S gene within the human major histocompatibility complex and association analysis on the susceptibility to psoriasis vulgaris. Tissue Antigens 48: 182-186 (1996).

• Jalan R, Sargentoni J, Coutts GA, Bell JD, Rolles K, Burroughs AK, Taylor Robinson SD. Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models. Gut 39: 141-146 (1996). *

• Janczewska I, Olsson R, Hultcrantz R, Broome U. Pregnancy in patients with primary sclerosing cholangitis. Liver 16: 326-330 (1996).

• Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383: 728-731 (1996). *

• Jaskiewicz K, Voigt H, Blakolmer K. Increased matrix proteins, collagen and transforming growth factor are early markers of hepatotoxicity in patients on long-term methotrexate therapy. J. Toxicol. Clin. Toxicol. 34: 301-305 (1996).

• Jaspan JB, Sullivan K, Garry RF, Lopez M, Wolfe M, Clejan S, Yan C, Tenenbaum S, Sander DM, Ahmed B, Bryer-Ash M. The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves' disease. J. Clin. Endocrinol. Metab. 81: 2271-2279 (1996). *

• Jin CH, Pike JW. Human vitamin D receptor-dependent transactivation in Saccharomyces cerevisiae requires retinoid X receptor. Mol. Endocrinol. 10: 196-205 (1996). *

• Johansen BH, Gjertsen HA, Vartdal F, Buus S, Thorsby E, Lundin KE, Sollid LM. Binding of peptides from the N-terminal region of alpha-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T cell assays. Clin. Immunol. Immunopathol. 79: 288-293 (1996).

• Johansen BH, Jensen T, Thorpe CJ, Vartdal F, Thorsby E, Sollid LM. Both alpha and beta chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with beta chain residues being most influential. Immunogenetics 45: 142-150 (1996).

• Johansen HK. Potential of preventing Pseudomonas aeruginosa lung infections in cystic fibrosis patients: experimental studies in animals. APMIS Suppl. 63: 5-42 (1996).

• Johnson EF, Palmer CN, Griffin KJ, Hsu MH. Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation. FASEB J. 10: 1241-1248 (1996). *

• Johnson HM, Torres BA, Soos JM. Superantigens: structure and relevance to human disease. Proc. Soc. Exp. Biol. Med. 212: 99-109 (1996).

• Jones DE. T-cell autoimmunity in primary biliary cirrhosis. Clin. Sci. (Lond.) 91: 551-558 (1996).

• Jones EA, Bergasa NV. Why do cholestatic patients itch? Gut 38: 644-645 (1996). *

• Jones JW, Ansari A. Case in point. Primary biliary cirrhosis. Hosp. Pract. (Off. Ed.) 31: 173 (1996).

• Jones MD PH. Treatment of dyslipidemias. Endocr. Pract. 2: 30-36 (1996).

• Jones RH. Clinical economics review: gastrointestinal disease in primary care. Aliment. Pharmacol. Ther. 10: 233-239 (1996). *

• Jones SA, Black MM, Thompson RP. Pustular vasculitis and sclerosing cholangitis. Br. J. Dermatol. 135: 662-663 (1996).

• Jonville-Bera AP, Autret E, Galy-Eyraud C, Hessel L. Thrombocytopenic purpura after measles, mumps and rubella vaccination: a retrospective survey by the French Regional Pharmacovigilance Centres and Pasteur-Merieux Serums et Vaccins. Pediatr. Infect. Dis. J. 15: 44-48 (1996).

• Kahlem P, Terre C, Green H, Djian P. Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system. Proc. Natl. Acad. Sci. U.S.A. 93: 14580-14585 (1996). *

• Kaipiainen-Seppanen O, Savolainen A. Incidence of chronic juvenile rheumatic diseases in Finland during 1980-1990. Clin. Exp. Rheumatol. 14: 441-444 (1996).

• Kalaria RN, Harshbarger-Kelly M, Cohen DL, Premkumar DR. Molecular aspects of inflammatory and immune responses in Alzheimer's disease. Neurobiol. Aging 17: 687-693 (1996).

• Kalil J, Cunha-Neto E. Autoimmunity in Chagas disease cardiomyopathy: fulfilling the criteria at last? Parasitol. Today 12: 396-399 (1996). *

• Kaplan MM. Primary biliary cirrhosis. N. Engl. J. Med. 335: 1570-1580 (1996). *

• Karan B, Kama NA, Hascelik G, Ercan M. Effects of vitamin A on immunological deficiencies in rats with obstructive jaundice. Eur. J. Surg. 162: 217-222 (1996).

• Karandikar NJ, Vanderlugt CL, Walunas TL, Miller SD, Bluestone JA. CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med. 184: 783-788 (1996). *

• Kardorff R, Melter M, Rodeck B, Brodehl J. Long-term ursodeoxycholic acid treatment of cholestatic liver diseases in childhood - clinical and biochemical effects. Klin. Padiatr. 208: 118-122 (1996).

• Kartheuser AH, Dozois RR, LaRusso NF, Wiesner RH, Ilstrup DM, Schleck CD. Comparison of surgical treatment of ulcerative colitis associated with primary sclerosing cholangitis: ileal pouch-anal anastomosis versus Brooke ileostomy. Mayo Clin. Proc. 71: 748-756 (1996). *

• Kataoka S, Tsuruo T. Physician education: apoptosis. Oncologist 1: 399-401 (1996). *

• Katz DP, Manner T, Furst P, Askanazi J. The use of an intravenous fish oil emulsion enriched with omega-3 fatty acids in patients with cystic fibrosis. Nutrition 12: 334-339 (1996).

• Kelley DS, Bendich A. Essential nutrients and immunologic functions. Am. J. Clin. Nutr. 63: 994S-996S (1996). *

• Kelloff GJ, Boone CW, Crowell JA, Steele VE, Lubet RA, Doody LA, Malone WF, Hawk ET, Sigman CC. New agents for cancer chemoprevention. J. Cell. Biochem. Suppl. 26: 1-28 (1996).

• Kelsall BL, Stuber E, Neurath M, Strober W. Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses. Ann. N. Y. Acad. Sci. 795: 116-126 (1996). *

• Kennedy J, Rossi DL, Zurawski SM, Vega F Jr, Kastelein RA, Wagner JL, Hannum CH, Zlotnik A. Mouse IL-17: a cytokine preferentially expressed by alpha beta TCR + CD4-CD8-T cells. J. Interferon Cytokine Res. 16: 611-617 (1996).

• Kennedy LD. Nicotine therapy for ulcerative colitis. Ann. Pharmacother. 30: 1022-1023 (1996).

• Keppler D, Leier I, Jedlitschky G, Mayer R, Buchler M. The function of the multidrug resistance proteins (MRP and cMRP) in drug conjugate transport and hepatobiliary excretion. Adv. Enzyme Regul. 36: 17-29 (1996). *

• Keranen U, Jarvinen H, Kiviluoto T, Kivilaakso E, Soinila S. Substance P- and vasoactive intestinal polypeptide-immunoreactive innervation in normal and inflamed pouches after restorative proctocolectomy for ulcerative colitis. Dig. Dis. Sci. 41: 1658-1664 (1996).

• Kerem B, Kerem E. The molecular basis for disease variability in cystic fibrosis. Eur. J. Hum. Genet. 4: 65-73 (1996).

• Kerem E, Kerem B. Genotype-phenotype correlations in cystic fibrosis. Pediatr. Pulmonol. 22: 387-395 (1996).

• Kersten S, Dawson MI, Lewis BA, Noy N. Individual subunits of heterodimers comprised of retinoic acid and retinoid X receptors interact with their ligands independently. Biochemistry 35: 3816-3824 (1996). *

• Kettering JM, Towers JD, Rubin DA. The seronegative spondyloarthropathies. Semin. Roentgenol. 31: 220-228 (1996).

• Khair-El-Din T, Sicher SC, Vazquez MA, Chung GW, Stallworth KA, Kitamura K, Miller RT, Lu CY. Transcription of the murine iNOS gene is inhibited by docosahexaenoic acid, a major constituent of fetal and neonatal sera as well as fish oils. J. Exp. Med. 183: 1241-1246 (1996). *

• Khalfoun B, Thibault G, Bardos P, Lebranchu Y. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human lymphocyte-endothelial cell adhesion. Transplantation 62: 1649-1657 (1996).

• Kiechl S, Kohlendorfer U, Willeit J, Pohl P, Vogel W. Myasthenia gravis and primary biliary cirrhosis. Common immunological features and rare coincidence. Acta Neurol. Scand. 93: 263-265 (1996).

• Kilmurry MR, Heathcote EJ, Cauch-Dudek K, O'Rourke K, Bailey RJ, Blendis LM, Ghent CN, Minuk GY, Pappas SC, Scully LJ, Steinbrecher UP, Sutherland LR, Williams CN, Worobetz LJ. Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis? Hepatology 23: 1148-1153 (1996). *

• Kimura I, Nagahama S, Kawasaki M, Kataoka M, Sato M. Study on the experimental ulcerative colitis (UC) model induced by dextran sulfate sodium (DSS) in rats (3). Nippon Yakurigaku Zasshi 108: 259-266 (1996).

• Kimura T, Suzuki K, Inada S, Hayashi A, Isobe M, Matsuzaki Y, Tanaka N, Osuga T, Fujiwara M. Monoclonal antibody against lymphocyte function-associated antigen 1 inhibits the formation of primary biliary cirrhosis-like lesions induced by murine graft-versus-host reaction. Hepatology 24: 888-894 (1996). *

• King PD, Rumbaut R, Sanchez C. Pulmonary manifestations of chronic liver disease. Dig. Dis. 14: 73-82 (1996).

• Kino-Ohsaki J, Nishimori I, Morita M, Okazaki K, Yamamoto Y, Onishi S, Hollingsworth MA. Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjogren's syndrome. Gastroenterology 110: 1579-1586 (1996). *

• Kirman I, Nielsen OH. Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. Am. J. Gastroenterol. 91: 1789-1794 (1996).

• Kisand KE, Karvonen AL, Vuoristo M, Farkkila M, Lehtola J, Inkovaara J, Kisand KV, Miettinen T, Krohn K, Uibo R. Ursodeoxycholic acid treatment lowers the serum level of antibodies against pyruvate dehydrogenase and influences their inhibitory capacity for the enzyme complex in patients with primary biliary cirrhosis. J. Mol. Med. 74: 269-272 (1996).

• Kitareewan S, Burka LT, Tomer KB, Parker CE, Deterding LJ, Stevens RD, Forman BM, Mais DE, Heyman RA, McMorris T, Weinberger C. Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR. Mol. Biol. Cell 7: 1153-1166 (1996). *

• Klompmaker IJ, Haagsma EB, Verwer R, Jansen PL, Sloofe MJ. Primary sclerosing cholangitis and liver transplantation. Scand. J. Gastroenterol. Suppl. 218: 98-102 (1996).

• Knoop M, Bechstein WO, Schrem H, Lobeck H, Hopf U, Neuhaus P. Clinical significance of recurrent primary biliary cirrhosis after liver transplantation. Transpl. Int. 9 Suppl. 1: S115-S119 (1996).

• Knox TA, Olans LB. Liver disease in pregnancy. N. Engl. J. Med. 335: 569-576 (1996). *

• Ko GT, Szeto CC, Yeung VT, Chow CC, Chan H, Cockram CS. Autoimmune polyglandular syndrome and primary biliary cirrhosis. Br. J. Clin. Pract. 50: 344-346 (1996).

• Kobayashi E, Motoki K, Yamaguchi Y, Uchida T, Fukushima H, Koezuka Y. Enhancing effects of alpha-,beta-monoglycosylceramides on natural killer cell activity. Bioorg. Med. Chem. 4: 615-619 (1996). *

• Kochhar R, Goenka MK, Das K, Nagi B, Bhasin DK, Chawla YK, Vaiphei K, Singh K, Dilawari JB. Primary sclerosing cholangitis: an experience from India. J. Gastroenterol. Hepatol. 11: 429-433 (1996).

• Kodama T, Imai H, Wakui H, Ohtani H, Komatsuda A, Miura AB. Tubulointerstitial nephritis with renal tubular acidosis and asymptomatic primary biliary cirrhosis accompanied by antibody to a 52-kDa mitochondrial protein alone. Clin. Nephrol. 45: 401-405 (1996).

• Kohne G, Schneider T, Zeitz M. Special features of the intestinal lymphocytic system. Baillieres Clin. Gastroenterol. 10: 427-442 (1996).

• Kolbus N, Beuche W, Felgenhauer K, Mader M. Definition of a discontinuous immunodominant epitope of intestinal alkaline phosphatase, an autoantigen in acute bacterial infections. Clin. Immunol. Immunopathol. 80: 298-306 (1996). *

• Kolodny L, Horstman LL, Sevin BU, Brown H, Ahn YS. Danazol relieves refractory pruritus associated with myeloproliferative disorders and other diseases. Am. J. Hematol. 51: 112-116 (1996).

• Kong YC, Lomo LC, Motte RW, Giraldo AA, Baisch J, Strauss G, Hammerling GJ, David CS. HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene. J. Exp. Med. 184: 1167-1172 (1996). *

• Kooy A, de Heide LJ, Engelkens HJ, Mulder AH, van Hagen M, Schalm SW. Hepatitis in a patient with SLE: is it autoimmune hepatitis? Neth. J. Med. 48: 128-132 (1996).

• Koskinen S. Long-term follow-up of health in blood donors with primary selective IgA deficiency. J. Clin. Immunol. 16: 165-170 (1996).

• Koszewski NJ, Reinhardt TA, Horst RL. Vitamin D receptor interactions with the murine osteopontin response element. J. Steroid Biochem. Mol. Biol. 59: 377-388 (1996).

• Kotake M, Nakai A, Mokuno T, Oda N, Sawai Y, Itoh Y, Shimazaki K, Kato R, Hayakawa N, Uchikawa A, Oiso Y, Hirooka Y, Mitsuma T, Itoh M, Nagasaka A. Short stature due to growth hormone deficiency associated with Cushing's disease and ulcerative colitis. Horm. Metab. Res. 28: 565-569 (1996).

• Kotilainen P, Merilahti-Palo R, Lehtonen OP, Manner I, Helander I, Mottonen T, Rintala E. Propionibacterium acnes isolated from sternal osteitis in a patient with SAPHO syndrome. J. Rheumatol. 23: 1302-1304 (1996).

• Kotilainen PM, Laxen FO, Manner IK, Gullichsen RE, Saario RM. An aseptic inflammation of the clavicle in a patient with Crohn's disease. A potential manifestation of the SAPHO syndrome. Scand. J. Rheumatol. 25: 112-114 (1996).

• Koutroubakis I, Manousos ON, Meuwissen SG, Pena AS. Environmental risk factors in inflammatory bowel disease. Hepatogastroenterology 43: 381-393 (1996).

• Kowdley KV. Update on therapy for hepatobiliary diseases. Nurse Pract. 21: 78, 81-4, 86 (1996).

• Krahenbuhl S. Carnitine metabolism in chronic liver disease. Life Sci. 59: 1579-1599 (1996). *

• Krams SM, Cao S, Hayashi M, Villanueva JC, Martinez OM. Elevations in IFN-gamma, IL-5, and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: association with autoantibodies and soluble CD30. Clin. Immunol. Immunopathol. 80: 311-320 (1996). *

• Krawitt EL. Autoimmune hepatitis. N. Engl. J. Med. 334: 897-903 (1996). *

• Kremer JM. Effects of modulation of inflammatory and immune parameters in patients with rheumatic and inflammatory disease receiving dietary supplementation of n-3 and n-6 fatty acids. Lipids 31: S243-S247 (1996).

• Krezel W, Dupe V, Mark M, Dierich A, Kastner P, Chambon P. RXR gamma null mice are apparently normal and compound RXR alpha +/-/RXR beta -/-/RXR gamma -/- mutant mice are viable. Proc. Natl. Acad. Sci. U.S.A. 93: 9010-9014 (1996). *

• Krishnan K, Brenner DE. Chemoprevention of colorectal cancer. Gastroenterol. Clin. North Am. 25: 821-858 (1996).

• Kroese FG, de Waard R, Bos NA. B-1 cells and their reactivity with the murine intestinal microflora. Semin. Immunol. 8: 11-18 (1996). *

• Krogh Jensen M, Ekelund S, Svendsen L. Folate and homocysteine status and haemolysis in patients treated with sulphasalazine for arthritis. Scand. J. Clin. Lab. Invest. 56: 421-429 (1996).

• Krowka MJ. Recent pulmonary observations in alpha 1-antitrypsin deficiency, primary biliary cirrhosis, chronic hepatitis C, and other hepatic problems. Clin. Chest Med. 17: 67-82 (1996).

• Kucharzik T, Lugering N, Weigelt H, Adolf M, Domschke W, Stoll R. Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10. Clin. Exp. Immunol. 104: 483-490 (1996). *

• Kullak-Ublick GA, Beuers U, Meier PJ, Domdey H, Paumgartner G. Assignment of the human organic anion transporting polypeptide (OATP) gene to chromosome 12p12 by fluorescence in situ hybridization. J. Hepatol. 25: 985-987 (1996). *

• Kullak-Ublick GA, Beuers U, Paumgartner G. Molecular and functional characterization of bile acid transport in human hepatoblastoma HepG2 cells. Hepatology 23: 1053-1060 (1996). *

• Kumar A, Edward N, White MI, Johnston PW, Catto GR. Allopurinol, erythema multiforme, and renal insufficiency. BMJ 312: 173-174 (1996). *

• Kuo K, Ker CG, Sheen PC, Wang HJ. Changes of bile duct mucosa after choledochoduodenostomy in rats. Eur. Surg. Res. 28: 63-69 (1996).

• Kuokkanen S, Sundvall M, Terwilliger JD, Tienari PJ, Wikstrom J, Holmdahl R, Pettersson U, Peltonen L. A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus Eae2. Nat. Genet. 13: 477-480 (1996). *

• Kuroda M, Morito T, Takagi T, Ohira H, Kokubun M, Kojima T, Ono K, Kochi H, Kasukawa R. Antibodies to E1 and E2/Protein X components of pyruvate dehydrogenase complex in sera of patients with primary biliary cirrhosis. J. Hepatol. 25: 867-876 (1996). *

• Kuroki T, Seki S, Kawakita N, Nakatani K, Hisa T, Kitada T, Sakaguchi H. Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis. Virchows Arch. 429: 119-129 (1996).

• Kuwabara K, Shudo K, Hori Y. Novel synthetic retinoic acid inhibits rat collagen arthritis and differentially affects serum immunoglobulin subclass levels. FEBS Lett. 378: 153-156 (1996). *

• Kuwahara M, Marumo F. Diseases caused by disorders of membrane transport: an overview. Nippon Rinsho 54: 581-585 (1996).

• Laliberte L, Villeneuve JP. Hepatitis after the use of germander, a herbal remedy. CMAJ 154: 1689-1692 (1996). *

• Lang CC, Brown RM, Kinirons MT, Deathridge MA, Guengerich FP, Kelleher D, O'Briain DS, Ghishan FK, Wood AJ. Decreased intestinal CYP3A in celiac disease: reversal after successful gluten-free diet: a potential source of interindividual variability in first-pass drug metabolism. Clin. Pharmacol. Ther. 59: 41-46 (1996).

• Lange S, Delbro DS, Jennische E, Mattsby-Baltzer I. The role of the Lps gene in experimental ulcerative colitis in mice. APMIS 104: 823-833 (1996).

• Langlois M, Delanghe J, De Buyzere M. Relation between serum IgA concentration and haptoglobin type. Clin. Chem. 42: 1722-1723 (1996).

• Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin. Chem. 42: 1589-1600 (1996). *

• Lanier LL, Phillips JH. Inhibitory MHC class I receptors on NK cells and T cells. Immunol. Today 17: 86-91 (1996). *

• Laprise C, Boulet LP. Airway responsiveness and atopy in families of patients with asthma. Clin. Invest. Med. 19: 461-469 (1996).

• Launois B, Meunier B, Foglia M, Khelif D, Spiliopoulos Y, Stasik C, Lakehal M, Guezennec L, Camus C, Messner M. 200 first hepatic transplantation at the Rennes University Hospital. Chirurgie 121: 207-214 (1996).

• Laurin J, Lindor KD, Crippin JS, Gossard A, Gores GJ, Ludwig J, Rakela J, McGill DB. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology 23: 1464-1467 (1996). *

• Lavaissiere L, Jia S, Nishiyama M, de la Monte S, Stern AM, Wands JR, Friedman PA. Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma. J. Clin. Invest. 98: 1313-1323 (1996). *

• Lawrence BP, Leid M, Kerkvliet NI. Distribution and behavior of the Ah receptor in murine T lymphocytes. Toxicol. Appl. Pharmacol. 138: 275-284 (1996). *

• Leclerc KM, Landry FJ. Benign nocturnal leg cramps. Current controversies over use of quinine. Postgrad. Med. 99: 177-178, 181-184 (1996).

• Lee C, Martin KO, Javitt NB. Bile acid synthesis: 7 alpha-hydroxylation of intermediates in the sterol 27-hydroxylase metabolic pathway. J. Lipid Res. 37: 1356-1362 (1996). *

• Lee HC, Ikegami H, Fujisawa T, Ogihara T, Park SW, Chung YS, Park JO, Lee EJ, Lim SK, Kim KR, Huh KB, Kim YS, Lee DS, Kim DH. Role of HLA class II alleles in Korean patients with IDDM. Diabetes Res. Clin. Pract. 31: 9-15 (1996).

• Lee JC, Lennard-Jones JE. Inflammatory bowel disease in 67 families each with three or more affected first-degree relatives. Gastroenterology 111: 587-596 (1996). *

• Lee M, Hodges WG, Huggins TL, Lee EL. Eosinophilic gastroenteritis. South. Med. J. 89: 189-194 (1996).

• Lemann M, Chamiot-Prieur C, Mesnard B, Halphen M, Messing B, Rambaud JC, Gendre JP, Colombel JF, Modigliani R. Methotrexate for the treatment of refractory Crohn's disease. Aliment. Pharmacol. Ther. 10: 309-314 (1996). *

• Lemberger T, Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu. Rev. Cell. Dev. Biol. 12: 335-363 (1996).

• Lemberger T, Saladin R, Vazquez M, Assimacopoulos F, Staels B, Desvergne B, Wahli W, Auwerx J. Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm. J. Biol. Chem. 271: 1764-1769 (1996). *

• Lemon BD, Freedman LP. Selective effects of ligands on vitamin D3 receptor- and retinoid X receptor-mediated gene activation in vivo. Mol. Cell Biol. 16: 1006-1016 (1996). *

• Lemotte PK, Keidel S, Apfel CM. Phytanic acid is a retinoid X receptor ligand. Eur. J. Biochem. 236: 328-333 (1996). *

• Leon MP, Bassendine MF, Wilson JL, Ali S, Thick M, Kirby JA. Immunogenicity of biliary epithelium: investigation of antigen presentation to CD4+ T cells. Hepatology 24: 561-567 (1996).

• Lesavre P. The diagnostic and prognostic significance of ANCA. Ren. Fail. 18: 803-812 (1996).

• Leung AK, Robson WL. Evaluating the child with chronic diarrhea. Am. Fam. Physician 53: 635-643 (1996).

• Leung PS, Cha S, Joplin RE, Galperin C, Van de Water J, Ansari AA, Coppel RL, Schatz PJ, Cwirla S, Fabris LE, Neuberger JM, Gershwin ME. Inhibition of PDC-E2 human combinatorial autoantibodies by peptide mimotopes. J. Autoimmun. 9: 785-793 (1996). *

• Leung PS, Van de Water J, Coppel RL, Nakanuma Y, Munoz S, Gershwin ME. Molecular aspects and the pathological basis of primary biliary cirrhosis. J. Autoimmun. 9: 119-128 (1996). *

• Leuschner M, Guldutuna S, You T, Hubner K, Bhatti S, Leuschner U. Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis. J. Hepatol. 25: 49-57 (1996). *

• Levin ED, Conners CK, Sparrow E, Hinton SC, Erhardt D, Meck WH, Rose JE, March J. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl.) 123: 55-63 (1996).

• Levine J, Furne JK, Levitt MD. Ashkenazi Jews, sulfur gases, and ulcerative colitis. J. Clin. Gastroenterol. 22: 288-291 (1996).

• Levy MT, Torzillo P, Bookallil M, Sheil AG, McCaughan GW. Case report: delayed resolution of severe pulmonary hypertension after isolated liver transplantation in a patient with cirrhosis. J. Gastroenterol. Hepatol. 11: 734-737 (1996).

• Levy R, Shriker O, Porath A, Riesenberg K, Schlaeffer F. Vitamin C for the treatment of recurrent furunculosis in patients with imparied neutrophil functions. J. Infect. Dis. 173: 1502-1505 (1996).

• Lichtman SN, Wang J, Zhang C, Lemasters JJ. Endocytosis and Ca2+ are required for endotoxin-stimulated TNF-alpha release by rat Kupffer cells. Am. J. Physiol. 271: G920-G928 (1996).

• Likhoded VG, Iushchuk ND, Iakovlev MIu. Role of Gram-negative bacterial endotoxins in infectious and non-infectious diseases. Arkh. Patol. 58: 8-13 (1996).

• Lin F, Noyer CM, Ye Q, Courvalin JC, Worman HJ. Autoantibodies from patients with primary biliary cirrhosis recognize a region within the nucleoplasmic domain of inner nuclear membrane protein LBR. Hepatology 23: 57-61 (1996). *

• Lin Y, Havinga R, Schippers IJ, Verkade HJ, Vonk RJ, Kuipers F. Characterization of the inhibitory effects of bile acids on very-low-density lipoprotein secretion by rat hepatocytes in primary culture. Biochem. J. 316: 531-538 (1996). *

• Lindor KD, Bru C, Jorgensen RA, Rakela J, Bordas JM, Gross JB, Rodes J, McGill DB, Reading CC, James EM, Charboneau JW, Ludwig J, Batts KP, Zinsmeister AR. The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy. Hepatology 23: 1079-1083 (1996). *

• Lindor KD, Hoofnagle J, Maddrey WC, Mackay IE, Dickson ER. Primary biliary cirrhosis clinical research single-topic conference. Hepatology 23: 639-644 (1996). *

• Lindor KD, Jorgensen RA, Anderson ML, Gores GJ, Hofmann AF, LaRusso NF. Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: a pilot study. Am. J. Gastroenterol. 91: 511-515 (1996).

• Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Dickson ER. Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology 110: 1515-1518 (1996). *

• Lipscombe RJ, Beatty DW, Ganczakowski M, Goddard EA, Jenkins T, Lau YL, Spurdle AB, Sumiya M, Summerfield JA, Turner MW. Mutations in the human mannose-binding protein gene: frequencies in several population groups. Eur. J. Hum. Genet. 4: 13-19 (1996).

• Litzman J, Burianova M, Thon V, Lokaj J. Progression of selective IgA deficiency to common variable immunodeficiency in a 16 year old boy. Allergol. Immunopathol. (Madr.) 24: 174-176 (1996).

• Liu W, Hellman P, Li Q, Yu WR, Juhlin C, Nordlinder H, Rollman O, Akerstrom G, Torma H, Melhus H. Biosynthesis and function of all-trans- and 9-cis-retinoic acid in parathyroid cells. Biochem. Biophys. Res. Commun. 229: 922-929 (1996). *

• Ljubuncic P, Fuhrman B, Oiknine J, Aviram M, Bomzon A. Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages. Gut 39: 475-478 (1996). *

• Lobeck H, Hopf U, Gill C, Pohl C, Neuhaus P. Primary biliary cirrhosis - cellular mechanisms and role of enterobacterial antigens. Verh. Dtsch. Ges. Pathol. 80: 267-271 (1996).

• Locke GR 3rd, Therneau TM, Ludwig J, Dickson ER, Lindor KD. Time course of histological progression in primary biliary cirrhosis. Hepatology 23: 52-56 (1996). *

• Locke IC, Cambridge G. Autoantibodies to neutrophil granule proteins: pathogenic potential in vasculitis? Br. J. Biomed. Sci. 53: 302-316 (1996).

• Loehrer FM, Haefeli WE, Angst CP, Browne G, Frick G, Fowler B. Effect of methionine loading on 5-methyltetrahydrofolate, S-adenosylmethionine and S-adenosylhomocysteine in plasma of healthy humans. Clin. Sci. (Lond.) 91: 79-86 (1996).

• Loeschke K, Ueberschaer B, Pietsch A, Gruber E, Ewe K, Wiebecke B, Heldwein W, Lorenz R. n-3 Fatty acids only delay early relapse of ulcerative colitis in remission. Dig. Dis. Sci. 41: 2087-2094 (1996).

• Lofberg R, Rutgeerts P, Malchow H, Lamers C, Danielsson A, Olaison G, Jewell D, Ostergaard Thomsen O, Lorenz-Meyer H, Goebell H, Hodgson H, Persson T, Seidegard C. Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study. Gut 39: 82-86 (1996). *

• Loftus EV Jr, Sandborn WJ, Tremaine WJ, Mahoney DW, Zinsmeister AR, Offord KP, Melton LJ 3rd. Primary sclerosing cholangitis is associated with nonsmoking: a case-control study. Gastroenterology 110: 1496-1502 (1996). *

• Loftus EV Jr, Sandborn WJ, Tremaine WJ, Mahoney DW, Zinsmeister AR, Offord KP, Melton LJ 3rd. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology 110: 432-440 (1996). *

• Logan SK, Garabedian MJ, Campbell CE, Werb Z. Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors. J. Biol. Chem. 271: 774-782 (1996). *

• Loginov AS, Reshetniak VI, Chebanov SM, Matiushin BN. Clinical significance of gel electrophoresis of blood lipoproteins in primary biliary cirrhosis. Klin. Lab. Diagn. 2: 33-35 (1996).

• Lohler J, Sadlack B, Schorle H, Klebb G, Haber H, Horak I. Generalized autoimmune diseases in BALB/c mice with a genetically dependent interleukin-2 deficiency. Verh. Dtsch. Ges. Pathol. 80: 293-296 (1996).

• Lohr HF, Schlaak JF, Lohse AW, Bocher WO, Arenz M, Gerken G, Meyer Zum Buschenfelde KH. Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis. Hepatology 24: 1416-1421 (1996). *

• Lohse AW, Dinkelmann M, Kimmig M, Herkel J, Meyer zum Buschenfelde KH. Estimation of the frequency of self-reactive T cells in health and inflammatory diseases by limiting dilution analysis and single cell cloning. J. Autoimmun. 9: 667-675 (1996).

• Lomri N, Fitz JG, Scharschmidt BF. Hepatocellular transport: role of ATP-binding cassette proteins. Semin. Liver Dis. 16: 201-210 (1996).

• Long EO, Colonna M, Lanier LL. Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature. Immunol. Today 17: 100 (1996). *

• Lopez H, Sandoval GF, Vera JG, Solano MO. Superantigens and their behavior in the immune response. Rev. Alerg. Mex. 43: 13-17 (1996).

• Lopez-Botet M, Moretta L, Strominger J. NK-cell receptors and recognition of MHC class I molecules. Immunol. Today 17: 212-214 (1996). *

• Lopez-Larrea C, Gonzalez-Roces S, Alvarez V. HLA-B27 structure, function, and disease association. Curr. Opin. Rheumatol. 8: 296-308 (1996).

• Lopez-Moratalla N, Ruiz E, Lopez-Zabalza MJ, Santiago E. A common structural motif in immunopotentiating peptides with sequences present in human autoantigens. Elicitation of a response mediated by monocytes and Th1 cells. Biochim. Biophys. Acta 1317: 183-191 (1996).

• Lotan R. Retinoids in cancer chemoprevention. FASEB J. 10: 1031-1039 (1996). *

• Louagie HK, Brouwer JT, Delanghe JR, De Buyzere ML, Leroux-Roels GG. Haptoglobin polymorphism and chronic hepatitis C. J. Hepatol. 25: 10-14 (1996).

• Louis E, Satsangi J, Roussomoustakaki M, Parkes M, Fanning G, Welsh K, Jewell D. Cytokine gene polymorphisms in inflammatory bowel disease. Gut 39: 705-710 (1996). *

• Lucidarme D, Vandermolen P, Khattab H, Catala P, Le Capon JB, Creusy C, Filoche B. Hepatocellular carcinoma in asymptomatic primary biliary cirrhosis. Rev. Med. Interne. 17: 568-570 (1996).

• Ludwig J, Hashimoto E, Porayko MK, Therneau TM. Failed allografts and causes of death after orthotopic liver transplantation from 1985 to 1995: decreasing prevalence of irreversible hepatic allograft rejection. Liver Transpl. Surg. 2: 185-191 (1996).

• Lykavieris P, Bernard O, Hadchouel M. Neonatal cholestasis as the presenting feature in cystic fibrosis. Arch. Dis. Child. 75: 67-70 (1996). *

• MacDermott RP. Alterations of the mucosal immune system in inflammatory bowel disease. J. Gastroenterol. 31: 907-916 (1996).

• Mach B, Steimle V, Martinez-Soria E, Reith W. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14: 301-331 (1996). *

• Macpherson A, Khoo UY, Forgacs I, Philpott-Howard J, Bjarnason I. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 38: 365-375 (1996). *

• Madersbacher S, Ludvik G, Stulnig T, Grunberger T, Maier U. The impact of liver transplantation on endocrine status in men. Clin. Endocrinol. (Oxf.) 44: 461-466 (1996).

• Madretsma GS, Donze GJ, van Dijk AP, Tak CJ, Wilson JH, Zijlstra FJ. Nicotine inhibits the in vitro production of interleukin 2 and tumour necrosis factor-alpha by human mononuclear cells. Immunopharmacology 35: 47-51 (1996).

• Madretsma S, Wolters LM, van Dijk JP, Tak CJ, Feyerabend C, Wilson JH, Zijlstra FJ. In-vivo effect of nicotine on cytokine production by human non-adherent mononuclear cells. Eur. J. Gastroenterol. Hepatol. 8: 1017-1020 (1996).

• Mahl MA, von Schonfeld J, Uppenkamp M, Breuer N. Hemolytic anemia as cause of a marked bilirubin increase in primary biliary cirrhosis. Dtsch. Med. Wochenschr. 121: 1226-1228 (1996).

• Maier KP. Current diagnosis of chronic nonviral hepatitis. Schweiz. Rundsch. Med. Prax. 85: 1507-1512 (1996).

• Makino I. Primary biliary cirrhosis and ursodeoxycholic acid therapy. Nippon Naika Gakkai Zasshi 85: 399-403 (1996).

• Mallard K, Jones DB, Richmond J, McGill M, Foulis AK. Expression of the human heat shock protein 60 in thyroid, pancreatic, hepatic and adrenal autoimmunity. J. Autoimmun. 9: 89-96 (1996).

• Mallow EB, Harris A, Salzman N, Russell JP, DeBerardinis RJ, Ruchelli E, Bevins CL. Human enteric defensins. Gene structure and developmental expression. J. Biol. Chem. 271: 4038-4045 (1996). *

• Marchesini G, Fabbri A, Bianchi G, Brizi M, Zoli M. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Hepatology 23: 1084-1092 (1996). *

• Marsh CB, Wewers MD. The pathogenesis of sepsis. Factors that modulate the response to Gram-negative bacterial infection. Clin. Chest Med. 17: 183-197 (1996).

• Marteau P, Nelet F, Le Lu M, Devaux C. Adverse events in patients treated with 5-aminosalicyclic acid: 1993-1994 pharmacovigilance report for Pentasa in France. Aliment. Pharmacol. Ther. 10: 949-956 (1996).

• Martin KR, Failla ML, Smith JC Jr. Beta-carotene and lutein protect HepG2 human liver cells against oxidant-induced damage. J. Nutr. 126: 2098-2106 (1996). *

• Martinez S, Berrios S, Fernandez-Donoso R, Brahm J, Cuchacovich M. Antimitochondrial antibody detection by indirect immunofluorescence on mouse sperms. Eur. J. Histochem. 40: 315-322 (1996).

• Martinez-Laso J, Gazit E, Gomez-Casado E, Morales P, Martinez-Quiles N, Alvarez M, Martin-Villa JM, Fernandez V, Arnaiz-Villena A. HLA DR and DQ polymorphism in Ashkenazi and non-Ashkenazi Jews: comparison with other Mediterraneans. Tissue Antigens 47: 63-71 (1996).

• Martins EB, Chapman RW, Marron K, Fleming KA. Biliary expression of heat shock protein: a non-specific feature of chronic cholestatic liver diseases. J. Clin. Pathol. 49: 53-56 (1996). *

• Martins EB, Graham AK, Chapman RW, Fleming KA. Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases. Hepatology 23: 988-993 (1996). *

• Maruya E, Saji H, Yokoyama S. PCR-LIS-SSCP (low ionic strength single-stranded conformation polymorphism) - a simple method for high-resolution allele typing of HLA-DRB1, -DQB1, and -DPB1. Genome Res. 6: 51-57 (1996). *

• Mashimo H, Wu DC, Podolsky DK, Fishman MC. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 274: 262-265 (1996). *

• Mason JB, Levesque T. Folate: effects on carcinogenesis and the potential for cancer chemoprevention. Oncology (Williston Park) 10: 1727-1736, 1742-1743 (1996).

• Masters C. Omega-3 fatty acids and the peroxisome. Mol. Cell. Biochem. 165: 83-93 (1996).

• Mastroianni A, Coronado O, Scarani P, Manfredi R, Chiodo F. Liver toxoplasmosis and acquired immunodeficiency syndrome. Recenti Prog. Med. 87: 353-355 (1996).

• Mastronardi FG, Mak B, Ackerley CA, Roots BI, Moscarello MA. Modifications of myelin basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis. J. Clin. Invest. 97: 349-358 (1996). *

• Matamoros N, Mila J, Ciria L, Rosell A. Hyper-IgM syndrome linked to X chromosome and hepatopathy: a frequent association. Med. Clin. (Barc.) 107: 199 (1996).

• Mate-Jimenez J, Correa-Estan JA, Perez-Miranda M, Gomez-Cedenilla A, Pajares JM, Moreno-Otero R. Tonsillectomy and inflammatory bowel disease location. Eur. J. Gastroenterol. Hepatol. 8: 1185-1188 (1996).

• Mathew CG, Easton DF, Lennard-Jones JE. HLA and inflammatory bowel disease. Lancet 348: 68 (1996).

• Matsumoto I, Tsubota K, Satake Y, Kita Y, Matsumura R, Murata H, Namekawa T, Nishioka K, Iwamoto I, Saitoh Y, Sumida T. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjogren's syndrome. J. Clin. Invest. 97: 1969-1977 (1996). *

• Matsushima-Nishiwaki R, Shidoji Y, Nishiwaki S, Yamada T, Moriwaki H, Muto Y. Aberrant metabolism of retinoid X receptor proteins in human hepatocellular carcinoma. Mol. Cell. Endocrinol. 121: 179-190 (1996).

• Matsushita S, Fujisao S, Nishimura Y. Molecular mechanisms underlying HLA-DR-associated susceptibility to autoimmunity. Int. J. Cardiol. 54 Suppl.: S81-S90 (1996).

• Mayo MJ, Combes B, Jenkins RN. T-cell receptor Vbeta gene utilization in primary biliary cirrhosis. Hepatology 24: 1148-1155 (1996). *

• McCoy H, Kenney MA. Interactions between magnesium and vitamin D: possible implications in the immune system. Magnes. Res. 9: 185-203 (1996).

• McGill JM, Williams DM, Hunt CM. Survey of cystic fibrosis transmembrane conductance regulator genotypes in primary sclerosing cholangitis. Dig. Dis. Sci. 41: 540-542 (1996).

• McManus R, Moloney M, Borton M, Finch A, Chuan YT, Lawlor E, Weir DG, Kelleher D. Association of celiac disease with microsatellite polymorphisms close to the tumor necrosis factor genes. Hum. Immunol. 45: 24-31 (1996).

• McManus R, Wilson AG, Mansfield J, Weir DG, Duff GW, Kelleher D. TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype. Eur. J. Immunol. 26: 2113-2118 (1996).

• McMichael J, Lieberman R, McCauley J, Irish W, Marino I, Doyle H. Computer-guided randomized concentration-controlled trials of tacrolimus in autoimmunity: multiple sclerosis and primary biliary cirrhosis. Ther. Drug Monit. 18: 435-437 (1996).

• McMurray RW. Adhesion molecules in autoimmune disease. Semin. Arthritis Rheum. 25: 215-233 (1996). *

• McNab G, Reeves JL, Salmi M, Hubscher S, Jalkanen S, Adams DH. Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium. Gastroenterology 110: 522-528 (1996). *

• Meenan J, Rauws EA, Huibregtse K. Benign biliary strictures and sclerosing cholangitis. Gastrointest. Endosc. Clin. N. Am. 6: 127-138 (1996).

• Mehlman MA. Dangerous and cancer-causing properties of products and chemicals in the oil-refining and petrochemical industry. Part XXII: Health hazards from exposure to gasoline containing methyl tertiary butyl ether: study of New Jersey residents. Toxicol. Ind. Health 12: 613-627 (1996).

• Mehta YS, Jijina FF, Badakere SS, Pathare AV, Mohanty D. Rifampicin-induced immune thrombocytopenia. Tuber. Lung Dis. 77: 558-562 (1996).

• Mentes BB, Tatlicioglu E, Akyol G, Uluoglu O, Sultan N, Yilmaz E, Celebi M, Taneri F, Ferahkose Z. Intestinal endotoxins as co-factors of liver injury in obstructive jaundice. HPB Surg. 9: 61-69 (1996). *

• Mentha G, Giostra E, Rubbia L, Huber O, Grossholz M, Romand J, Hadengue A, Morel P. Follow-up and results of liver transplantation for primary biliary cirrhosis. Swiss Surg. 3: 116-122 (1996).

• Mestecky J, Husby S, Moldoveanu Z, Waldo FB, van den Wall Bake AW, Elson CO. Induction of tolerance in humans: effectiveness of oral and nasal immunization routes. Ann. N. Y. Acad. Sci. 778: 194-201 (1996). *

• Metcalf JV, Howel D, James OF, Bhopal R. Primary biliary cirrhosis: epidemiology helping the clinician. BMJ 312: 1181-1182 (1996). *

• Metcalf JV, Mitchison HC, Palmer JM, Jones DE, Bassendine MF, James OF. Natural history of early primary biliary cirrhosis. Lancet 348: 1399-1402 (1996). *

• Meydani SN. Effect of (n-3) polyunsaturated fatty acids on cytokine production and their biologic function. Nutrition 12: S8-S14 (1996).

• Meyer JM, Han J, Singh R, Moxley G. Sex influences on the penetrance of HLA shared-epitope genotypes for rheumatoid arthritis. Am. J. Hum. Genet. 58: 371-383 (1996). *

• Meyer UA. Overview of enzymes of drug metabolism. J. Pharmacokinet. Biopharm. 24: 449-459 (1996).

• Michalski JP, McCombs CC, Arai T, Elston RC, Cao T, McCarthy CF, Stevens FM. HLA-DR, DQ genotypes of celiac disease patients and healthy subjects from the West of Ireland. Tissue Antigens 47: 127-133 (1996).

• Mielants H, Veys EM, Cuvelier C, De Vos M. Course of gut inflammation in spondylarthropathies and therapeutic consequences. Baillieres Clin. Rheumatol. 10: 147-164 (1996).

• Miller NH, Mims B, Child A, Milewicz DM, Sponseller P, Blanton SH. Genetic analysis of structural elastic fiber and collagen genes in familial adolescent idiopathic scoliosis. J. Orthop. Res. 14: 994-999 (1996).

• Miller PW, Hamosh A, Macek M Jr, Greenberger PA, MacLean J, Walden SM, Slavin RG, Cutting GR. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am. J. Hum. Genet. 59: 45-51 (1996). *

• Miller VA, Rigas JR, Benedetti FM, Verret AL, Tong WP, Kris MG, Gill GM, Loewen GR, Truglia JA, Ulm EH, Warrell RP Jr. Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid. Clin. Cancer Res. 2: 471-475 (1996). *

• Mingari MC, Vitale C, Schiavetti F, Cambiaggi A, Bertone S, Zunino A, Ponte M. HLA-class I-specific inhibitory receptors of NK type on a subset of human T cells. Chem. Immunol. 64: 135-145 (1996).

• Mishina D, Katsel P, Brown ST, Gilberts EC, Greenstein RJ. On the etiology of Crohn disease. Proc. Natl. Acad. Sci. U.S.A. 93: 9816-9820 (1996). *

• Mithofer K, Fernandez-del Castillo C, Ferraro MJ, Lewandrowski K, Rattner DW, Warshaw AL. Antibiotic treatment improves survival in experimental acute necrotizing pancreatitis. Gastroenterology 110: 232-240 (1996). *

• Miyachi K, Shibata M, Onozuka Y, Kikuchi F, Imai N, Horigome T. Primary biliary cirrhosis sera recognize not only gp210 but also proteins of the p62 complex bearing N-acetylglucosamine residues from rat liver nuclear envelope. Anti-p62 complex antibody in PBC. Mol. Biol. Rep. 23: 227-234 (1996).

• Miyakawa H, Izumi N, Marumo F, Sato C. Roles of alcohol, hepatitis virus infection, and gender in the development of hepatocellular carcinoma in patients with liver cirrhosis. Alcohol Clin. Exp. Res. 20: 91A-94A (1996).

• Miyata KS, McCaw SE, Patel HV, Rachubinski RA, Capone JP. The orphan nuclear hormone receptor LXR alpha interacts with the peroxisome proliferator-activated receptor and inhibits peroxisome proliferator signaling. J. Biol. Chem. 271: 9189-9192 (1996). *

• Mizoguchi A, Mizoguchi E, Chiba C, Bhan AK. Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice. J. Exp. Med. 184: 707-715 (1996). *

• Mizoguchi A, Mizoguchi E, Chiba C, Spiekermann GM, Tonegawa S, Nagler-Anderson C, Bhan AK. Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease. J. Exp. Med. 183: 847-856 (1996). *

• Mizoguchi A, Mizoguchi E, Tonegawa S, Bhan AK. Alteration of a polyclonal to an oligoclonal immune response to cecal aerobic bacterial antigens in TCR alpha mutant mice with inflammatory bowel disease. Int. Immunol. 8: 1387-1394 (1996).

• Mizuhara H, Uno M, Seki N, Yamashita M, Yamaoka M, Ogawa T, Kaneda K, Fujii T, Senoh H, Fujiwara H. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology 23: 1608-1615 (1996).

• Mizukami Y, Ohhira M, Matsumoto A, Murazumi Y, Murazumi K, Ohta H, Ohhira M, Ono M, Miyake T, Maekawa I, Kohgo Y. Primary biliary cirrhosis associated with idiopathic thrombocytopenic purpura. J. Gastroenterol. 31: 284-288 (1996).

• Mizuki N, Ohno S. Immunogenetic studies of Behcet's disease. Rev. Rhum. Engl. Ed. 63: 520-527 (1996).

• Mizuki N, Ohno S, Ando H, Kimura M, Ishihara M, Miyata S, Nakamura S, Mizuki N, Inoko H. HLA-C genotyping of patient with Behcet's disease in the Japanese population. Hum. Immunol. 50: 47-53 (1996).

• Mizuno K, Hoshino M, Hayakawa T, Yamada H, Nakazawa T, Inagaki T, Takeuchi T, Kunimatsu M. Uncoupling of biliary lipid from bile acid secretion by formyl-methionyl-leucyl-phenylalanine in the rat. Hepatology 24: 1224-1229 (1996). *

• Mockenhaupt M, Schopf E. Epidemiology of drug-induced severe skin reactions. Semin. Cutan. Med. Surg. 15: 236-243 (1996).

• Mohammed R, Goh KL, Wong NW. Primary biliary cirrhosis - experience in University Hospital, Kuala Lumpur. Med. J. Malaysia 51: 99-102 (1996).

• Mollers M, Gladisch R, Heine M, Georgi M, Heene DL. 27-year-old patient with asymptomatic cholestasis and liver tumor. Internist (Berl.) 37: 931-935 (1996).

• Molleston JP, Alevy YG, SivaSai KS, Mohanakumar T, Howard TK. Evidence that pediatric liver transplant recipients may undergo late rejection episodes in spite of donor-specific microchimerism. Transplantation 61: 656-657 (1996).

• Monajemi H, Meenan J, Lamping R, Obradov DO, Radema SA, Trown PW, Tytgat GN, Van Deventer SJ. Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing protein. Gastroenterology 110: 733-739 (1996). *

• Moody GA, Jayanthi V, Probert CS, Mac Kay H, Mayberry JF. Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur. J. Gastroenterol. Hepatol. 8: 1179-1183 (1996).

• Moraillon I, Hayem F, Bourrillon A, Morel P, Rybojad M. Blau syndrome or familial form of sarcoidosis with onset during infancy. Ann. Dermatol. Venereol. 123: 29-30 (1996).

• Moran AP. Helicobacter pylori expresses Lewis X. Helicobacter 1: 190-191 (1996).

• Moran AP, Prendergast MM, Appelmelk BJ. Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. FEMS Immunol. Med. Microbiol. 16: 105-115 (1996). *

• Moran S, Rodriguez-Leal G, Marin-Lopez E, Arista J, Poo JL, Vargas-Vorackova F, Kershenobich D, Uribe M. Primary biliary cirrhosis: clinical features and survival of a Mexican population. Rev. Gastroenterol. Mex. 61: 212-219 (1996).

• Moreno I, Valenzuela A, Garcia A, Yelamos J, Sanchez B, Hernanz W. Association of the shared epitope with radiological severity of rheumatoid arthritis. J. Rheumatol. 23: 6-9 (1996).

• Mori A, Suko M, Kaminuma O, Inoue S, Ohmura T, Nishizaki Y, Nagahori T, Asakura Y, Hoshino A, Okumura Y, Sato G, Ito K, Okudaira H. IL-15 promotes cytokine production of human T helper cells. J. Immunol. 156: 2400-2405 (1996).

• Morita Y, Yamamura M, Suwaki K, Mima A, Ishizu T, Hirohata M, Kashihara N, Makino H, Ota Z. Takayasu's arteritis associated with ulcerative colitis; genetic factors in this association. Intern. Med. 35: 574-578 (1996). *

• Morse JH, Barst RJ, Fotino M, Zhang Y, Flaster E, Fritzler MJ. Primary pulmonary hypertension: immunogenetic response to high-mobility group (HMG) proteins and histone. Clin. Exp. Immunol. 106: 389-395 (1996). *

• Moss RB, Bocian RC, Hsu YP, Dong YJ, Kemna M, Wei T, Gardner P. Reduced IL-10 secretion by CD4+ T lymphocytes expressing mutant cystic fibrosis transmembrane conductance regulator (CFTR). Clin. Exp. Immunol. 106: 374-388 (1996). *

• Moteki S, Leung PS, Coppel RL, Dickson ER, Kaplan MM, Munoz S, Gershwin ME. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology 24: 97-103 (1996). *

• Moteki S, Leung PS, Dickson ER, Van Thiel DH, Galperin C, Buch T, Alarcon-Segovia D, Kershenobich D, Kawano K, Coppel RL, et al. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex. Hepatology 23: 436-444 (1996). *

• Mu H, Charmley P, King MC, Criswell LA. Synergy between T cell receptor beta gene polymorphism and HLA-DR4 in susceptibility to rheumatoid arthritis. Arthritis Rheum. 39: 931-937 (1996).

• Muller M, de Vries EG, Jansen PL. Role of multidrug resistance protein (MRP) in glutathione S-conjugate transport in mammalian cells. J. Hepatol. 24 Suppl. 1: 100-108 (1996).

• Muller M, Roelofsen H, Jansen PL. Secretion of organic anions by hepatocytes: involvement of homologues of the multidrug resistance protein. Semin. Liver Dis. 16: 211-220 (1996).

• Muller-Ladner U, Gross V, Andus T, Gschwendtner H, Roth M, Caesar I, Scholmerich J, Lang B. Distinct patterns of immunoglobulin classes and IgG subclasses of autoantibodies in patients with inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 8: 579-584 (1996).

• Munoz Espinosa LE. Primary biliary cirrhosis. Rev. Gastroenterol. Mex. 61: 274-275 (1996).

• Murakami-Mori K, Taga T, Kishimoto T, Nakamura S. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth. Int. Immunol. 8: 595-602 (1996). *

• Nabozny GH, Baisch JM, Cheng S, Cosgrove D, Griffiths MM, Luthra HS, David CS. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J. Exp. Med. 183: 27-37 (1996). *

• Nachman PH, Reisner HM, Yang JJ, Jennette JC, Falk RJ. Shared idiotypy among patients with myeloperoxidase-anti-neutrophil cytoplasmic autoantibody associated glomerulonephritis and vasculitis. Lab. Invest. 74: 519-527 (1996).

• Nadel S, Newport MJ, Booy R, Levin M. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J. Infect. Dis. 174: 878-880 (1996).

• Nadin L, Murray M. All-trans-retinoic acid 4-hydroxylation in human liver microsomes: in vitro modulation by therapeutic retinoids. Br. J. Clin. Pharmacol. 41: 609-612 (1996). *

• Nagy L, Saydak M, Shipley N, Lu S, Basilion JP, Yan ZH, Syka P, Chandraratna RA, Stein JP, Heyman RA, Davies PJ. Identification and characterization of a versatile retinoid response element (retinoic acid receptor response element-retinoid X receptor response element) in the mouse tissue transglutaminase gene promoter. J. Biol. Chem. 271: 4355-4365 (1996). *

• Nakamaru Y, Maguchi S, Takizawa M, Fukuda S, Inuyama Y. The association between human leukocyte antigens (HLA) and cytoplasmic-antineutrophil cytoplasmic antibody (cANCA)-positive Wegener's granulomatosis in a Japanese population. Rhinology 34: 163-165 (1996).

• Nakamura K, Yoneda M, Kimura A, Tamori K, Yokohama S, Sato Y, Kato T, Hasegawa T, Saito H, Aoshima M, Fujita M, Makino I. Increase of sulfated ursodeoxycholic acid in the serum and urine of patients with chronic liver disease after ursodeoxycholic acid therapy. J. Gastroenterol. Hepatol. 11: 385-390 (1996).

• Nakao M, Tanioka H, Sato S, Yano Y, Haraguchi M, Asai S, Iwasaki K, Matsuo I, Ikuno N, Omagari K, Hara K. A case of primary biliary cirrhosis complicated with autoimmune hepatitis. Nippon Shokakibyo Gakkai Zasshi 93: 49-53 (1996).

• Nakeeb A, Lipsett PA, Lillemoe KD, Fox-Talbot MK, Coleman J, Cameron JL, Pitt HA. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma. Am. J. Surg. 171: 147-152 (1996).

• Nalabolu SR, Shukla H, Nallur G, Parimoo S, Weissman SM. Genes in a 220-kb region spanning the TNF cluster in human MHC. Genomics 31: 215-222 (1996).

• Naom I, Lee J, Ford D, Bowman SJ, Lanchbury JS, Haris I, Hodgson SV, Easton D, Lennard-Jones J, Mathew CG. Analysis of the contribution of HLA genes to genetic predisposition in inflammatory bowel disease. Am. J. Hum. Genet. 59: 226-233 (1996). *

• Napoli JL. Biochemical pathways of retinoid transport, metabolism, and signal transduction. Clin. Immunol. Immunopathol. 80: S52-S62 (1996).

• Napoli JL. Retinoic acid biosynthesis and metabolism. FASEB J. 10: 993-1001 (1996). *

• Narimatsu H, Iwasaki H, Nishihara S, Kimura H, Kudo T, Yamauchi Y, Hirohashi S. Genetic evidence for the Lewis enzyme, which synthesizes type-1 Lewis antigens in colon tissue, and intracellular localization of the enzyme. Cancer Res. 56: 330-338 (1996). *

• Nashan B, Schlitt HJ, Tusch G, Oldhafer KJ, Ringe B, Wagner S, Pichlmayr R. Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation. Hepatology 23: 1105-1111 (1996). *

• Nashan B, Tusch G, Schlitt HJ, Pichlmayr R. Liver transplantation in patients with primary sclerosing cholangitis. Determining timing with reference to risk of malignancy. Langenbecks Arch. Chir. Suppl. Kongressbd. 113: 410-412 (1996).

• Nasr SZ, Strong TV, Mansoura MK, Dawson DC, Collins FS. Novel missense mutation (G314R) in a cystic fibrosis patient with hepatic failure. Hum. Mutat. 7: 151-154 (1996).

• Nassif A, Longo WE, Mazuski JE, Vernava AM, Kaminski DL. Role of cytokines and platelet-activating factor in inflammatory bowel disease. Implications for therapy. Dis. Colon Rectum 39: 217-223 (1996).

• Nataraj AJ, Black HS, Ananthaswamy HN. Signature p53 mutation at DNA cross-linking sites in 8-methoxypsoralen and ultraviolet A (PUVA)-induced murine skin cancers. Proc. Natl. Acad. Sci. U.S.A. 93: 7961-7965 (1996). *

• Navasa M, Forns X, Sanchez V, Andreu H, Marcos V, Borras JM, Rimola A, Grande L, Garcia-Valdecasas JC, Granados A, Rodes J. Quality of life, major medical complications and hospital service utilization in patients with primary biliary cirrhosis after liver transplantation. J. Hepatol. 25: 129-134 (1996). *

• Nepom BS, Nepom GT, Coleman M, Kwok WW. Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules. Proc. Natl. Acad. Sci. U.S.A. 93: 7202-7206 (1996). *

• Neurath MF, Fuss I, Kelsall BL, Presky DH, Waegell W, Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J. Exp. Med. 183: 2605-2616 (1996). *

• Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat. Med. 2: 998-1004 (1996).

• Neuschwander-Tetri BA, Nicholson C, Wells LD, Tracy TF Jr. Cholestatic liver injury down-regulates hepatic glutathione synthesis. J. Surg. Res. 63: 447-451 (1996).

• Newsholme EA, Blomstrand E. The plasma level of some amino acids and physical and mental fatigue. Experientia 52: 413-415 (1996).

• Nielsen OH, Brynskov J, Vainer B. Increased mucosal concentrations of soluble intercellular adhesion molecule-1 (sICAM-1), sE-selectin, and interleukin-8 in active ulcerative colitis. Dig. Dis. Sci. 41: 1780-1785 (1996).

• Nielsen OH, Koppen T, Rudiger N, Horn T, Eriksen J, Kirman I. Involvement of interleukin-4 and -10 in inflammatory bowel disease. Dig. Dis. Sci. 41: 1786-1793 (1996).

• Nishigaki Y, Ohnishi H, Moriwaki H, Muto Y. Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis. Dig. Dis. Sci. 41: 1487-1493 (1996).

• Nishimaki-Mogami T, Suzuki K, Okochi E, Takahashi A. Bezafibrate and clofibric acid are novel inhibitors of phosphatidylcholine synthesis via the methylation of phosphatidylethanolamine. Biochim. Biophys. Acta 1304: 11-20 (1996).

• Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, Larrad MT, Rios MS, Chow CC, Cockram CS, Jacobs K, Mijovic C, Bain SC, Barnett AH, Vandewalle CL, Schuit F, Gorus FK, Tosi R, Pozzilli P, Todd JA. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum. Mol. Genet. 5: 1075-1080 (1996). *

• Niu MT, Davis DM, Ellenberg S. Recombinant hepatitis B vaccination of neonates and infants: emerging safety data from the Vaccine Adverse Event Reporting System. Pediatr. Infect. Dis. J. 15: 771-776 (1996).

• No authors listed. Tretinoin: retinoic acid syndrome and first report of primary sclerosing cholangitis: case report. Reactions 1 (614): 12 (1996).

• Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am. J. Hum. Genet. 59: 1134-1148 (1996). *

• Noel PJ, Boise LH, Thompson CB. Regulation of T cell activation by CD28 and CTLA4. Adv. Exp. Med. Biol. 406: 209-217 (1996).

• Norheim OF, Bjooro K, Schrumpf E, Soreide O. Is liver transplantation a therapeutic possibility of low priority in Norway? Tidsskr. Nor. Laegeforen. 116: 72-76 (1996).

• Nos P, Arguello L, Hoyos M, Ramirez JJ, Hinojosa J, Moles JR, Garcia A, Berenguer M, Berenguer J. Familial prevalence in chronic intestinal inflammatory disease. Differences among groups of patients with and without a familial history. Rev. Esp. Enferm. Dig. 88: 470-474 (1996).

• Novo E, Viera N. Antineutrophil cytoplasmic antibodies: a missing link in the pathogenesis of periodontal disease? J. Periodontal Res. 31: 365-368 (1996).

• Numano F, Miyata T, Nakajima T. Ulcerative colitis, Takayasu arteritis and HLA. Intern. Med. 35: 521-522 (1996). *

• O'Brien CB, Shields DS, Saul SH, Reddy KR. Drug-induced vanishing bile duct syndrome: response to ursodiol. Am. J. Gastroenterol. 91: 1456-1457 (1996).

• O'Brien SM, Campbell GR, Burke AF, Maguire OC, Rowlands BJ, FitzGerald MX, Hegarty JE. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease. Eur. J. Gastroenterol. Hepatol. 8: 477-483 (1996).

• O'Donohue J, Williams R. Primary biliary cirrhosis. QJM 89: 5-13 (1996). *

• O'Donohue J, Williams R. Antimitochondrial antibody and primary biliary cirrhosis: can there be one without the other? J. Hepatol. 25: 574-577 (1996). *

• O'Donohue J, Williams R. Immunological control in primary biliary cirrhosis: the cytokine story. Clin. Exp. Immunol. 105: 199-201 (1996). *

• O'Hehir RE, Lake RA, Schall TJ, Yssel H, Panagiotopoulou E, Lamb JR. Regulation of cytokine and chemokine transcription in a human TH2 type T-cell clone during the induction phase of anergy. Clin. Exp. Allergy 26: 20-27 (1996).

• Obermayer-Straub P, Manns MP. Cytochrome P450 enzymes and UDP-glucuronosyltransferases as hepatocellular autoantigens. Mol. Biol. Rep. 23: 235-242 (1996).

• Ohmen JD, Yang HY, Yamamoto KK, Zhao HY, Ma Y, Bentley LG, Huang Z, Gerwehr S, Pressman S, McElree C, Targan S, Rotter JI, Fischel-Ghodsian N. Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis. Hum. Mol. Genet. 5: 1679-1683 (1996). *

• Okada H, Mizuno M, Yamamoto K, Tsuji T. Primary sclerosing cholangitis in Japanese patients: association with inflammatory bowel disease. Acta Med. Okayama 50: 227-235 (1996).

• Okolicsanyi L, Fabris L, Viaggi S, Carulli N, Podda M, Ricci G. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group. Eur. J. Gastroenterol. Hepatol. 8: 685-691 (1996).

• Oldstone MB, von Herrath M. Virus-induced autoimmune disease: transgenic approach to mimic insulin-dependent diabetes mellitus and other autoimmune diseases. APMIS 104: 689-697 (1996).

• Oliva MM, Lake AM. Nutritional considerations and management of the child with inflammatory bowel disease. Nutrition 12: 151-158 (1996).

• Olsen BS, Helin P, Mortensen HB. Recurrent arthritis in a child. A rare manifestation of Wilson's disease. Ugeskr. Laeger. 158: 4305-4306 (1996).

• Omagari K, Ikuno N, Matsuo I, Shirono K, Hara K, Feeney SJ, Whittingham S, Mackay IR. Autoimmune cholangitis syndrome with a bias towards primary biliary cirrhosis. Pathology 28: 255-258 (1996).

• Omagari K, Rowley MJ, Jois JA, Feeney SJ, Komatsu K, Maeda T, Onishi S, Yamazaki K, Suzuki K, Galperin C, Mackay IR. Immunoreactivity of antimitochondrial autoantibodies in Japanese patients with primary biliary cirrhosis. J. Gastroenterol. 31: 61-68 (1996).

• Omagari K, Rowley MJ, Whittingham S, Jois JA, Byron SL, Mackay IR. Autoantibodies to M2 mitochondrial autoantigens in normal human sera by immunofluorescence and novel assays. J. Gastroenterol. Hepatol. 11: 610-616 (1996).

• Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 334: 1150-1155 (1996).

• Ono M, Niinobu T, Yamanaka Y, Yasuda O, Rakugi H, Ikegami H, Miki T, Ogihara T. Primary biliary cirrhosis with polymyositis successfully treated with prednisolone and ursodeoxycholic acid. Nippon Ronen Igakkai Zasshi 33: 779-782 (1996).

• Onozuka Y, Shibata M, Yonezawa H, Terauti K, Miyachi K, Ueno Y. Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis. Rinsho Byori 44: 877-882 (1996).

• Orazi A, Du X, Yang Z, Kashai M, Williams DA. Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab. Invest. 75: 33-42 (1996).

• Ott F, Bollag W, Geiger JM. Oral 9-cis-retinoic acid versus 13-cis-retinoic acid in acne therapy. Dermatology 193: 124-126 (1996).

• Ott F, Bollag W, Geiger JM. Efficacy of oral low-dose tretinoin (all-trans-retinoic acid) in lichen planus. Dermatology 192: 334-336 (1996).

• Ott J. Complex traits on the map. Nature 379: 772-773 (1996). *

• Oude Elferink RP, Ottenhoff R, van Wijland M, Frijters CM, van Nieuwkerk C, Groen AK. Uncoupling of biliary phospholipid and cholesterol secretion in mice with reduced expression of mdr2 P-glycoprotein. J. Lipid Res. 37: 1065-1075 (1996). *

• Pallone F, Monteleone G. Regulatory cytokines in inflammatory bowel disease. Aliment. Pharmacol. Ther. 10 Suppl. 2: 75-79 (1996).

• Papadopoulos KI, Hornblad Y, Liljebladh H, Hallengren B. High frequency of endocrine autoimmunity in patients with sarcoidosis. Eur. J. Endocrinol. 134: 331-336 (1996).

• Papo M, Quer JC, Pastor RM, Garcia-Pardo G, Prats E, Mirapeix E, Rodriguez R, Richart C. Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease. Am. J. Gastroenterol. 91: 1512-1515 (1996).

• Pares A, Rodes J. Ursodeoxycholic acid: an alternative in the treatment of chronic cholestasis. Gastroenterol. Hepatol. 19: 58-67 (1996).

• Parham P. Presentation of HLA class I-derived peptides: potential involvement in allorecognition and HLA-B27-associated arthritis. Immunol. Rev. 154: 137-154 (1996).

• Park GR, Miller E. What changes drug metabolism in critically ill patients?: III. Effect of pre-existing disease on the metabolism of midazolam. Anaesthesia 51: 431-434 (1996).

• Park MH, Oh MD, Song YW, Pai HJ, Takeuchi F, Tokunaga K, Hong GH, Park KS. Association of complement alleles C4AQ0 and C4B5 with rheumatoid arthritis in Koreans. Ann. Rheum. Dis. 55: 776-778 (1996). *

• Parker RS. Absorption, metabolism, and transport of carotenoids. FASEB J. 10: 542-551 (1996). *

• Parkes AB, Darke C, Othman S, Thomas M, Young N, Richards CJ, Hall R, Lazarus JH. Major histocompatibility complex class II and complement polymorphisms in postpartum thyroiditis. Eur. J. Endocrinol. 134: 449-453 (1996).

• Parkes M, Satsangi J, Lathrop GM, Bell JI, Jewell DP. Susceptibility loci in inflammatory bowel disease. Lancet 348: 1588 (1996).

• Parra-Campos V, Escobar-Gutierrez A, Dominguez-Lopez ML, Cancino-Diaz M, Burgos-Vargas R, Granados-Arreola J, Jimenez-Zamudio L, Garcia-Latorre E. Antibody response to nitrogenase-positive and -negative Klebsiella pneumoniae strains in juvenile-onset ankylosing spondylitis patients and their first degree relatives: lack of differential recognition of the bacterial nitrogenase. Rev. Latinoam. Microbiol. 38: 121-127 (1996).

• Pasha TM, Lindor KD. Diagnosis and therapy of cholestatic liver disease. Med. Clin. North Am. 80: 995-1019 (1996).

• Pastor A, Collado PS, Almar M, Gonzalez-Gallego J. Microsomal function in biliary obstructed rats: effects of S-adenosylmethionine. J. Hepatol. 24: 353-359 (1996). *

• Paulusma CC, Bosma PJ, Zaman GJ, Bakker CT, Otter M, Scheffer GL, Scheper RJ, Borst P, Oude Elferink RP. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 271: 1126-1128 (1996). *

• Pavone P, Suma G, Laghi A, Catalano C, Russo F, Grasso RF, Corsetti A, Passariello R. Magnetic resonance angiography of the portal vein in liver transplant recipients. Radiol. Med. (Torino) 91: 760-763 (1996).

• Peck LW, Monsen ER, Ahmad S. Effect of three sources of long-chain fatty acids on the plasma fatty acid profile, plasma prostaglandin E2 concentrations, and pruritus symptoms in hemodialysis patients. Am. J. Clin. Nutr. 64: 210-214 (1996). *

• Pedersen JL, Kehlet H. The acute inflammatory response. Mechanisms and therapeutic possibilities. Ugeskr. Laeger. 158: 5754-5761 (1996).

• Peelman LJ, Chardon P, Vaiman M, Mattheeuws M, Van Zeveren A, Van de Weghe A, Bouquet Y, Campbell RD. A detailed physical map of the porcine major histocompatibility complex (MHC) class III region: comparison with human and mouse MHC class III regions. Mamm. Genome 7: 363-367 (1996). *

• Peen E, Enestrom S, Skogh T. Distribution of lactoferrin and 60/65 kDa heat shock protein in normal and inflamed human intestine and liver. Gut 38: 135-140 (1996). *

• Peen E, Sundqvist T, Skogh T. Leucocyte activation by anti-lactoferrin antibodies bound to vascular endothelium. Clin. Exp. Immunol. 103: 403-407 (1996). *

• Peer G, Kivity S, Agami O, Fireman E, Silverberg D, Blum M, laina A. Randomised crossover trial of naltrexone in uraemic pruritus. Lancet 348: 1552-1554 (1996). *

• Peeters M, Nevens H, Baert F, Hiele M, de Meyer AM, Vlietinck R, Rutgeerts P. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 111: 597-603 (1996). *

• Penna C, Dozois R, Tremaine W, Sandborn W, LaRusso N, Schleck C, Ilstrup D. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 38: 234-239 (1996). *

• Penzotti JE, Doherty D, Lybrand TP, Nepom GT. A structural model for TCR recognition of the HLA class II shared epitope sequence implicated in susceptibility to rheumatoid arthritis. J. Autoimmun. 9: 287-293 (1996).

• Perdriger A, Guggenbuhl P, Chales G, Le Dantec P, Yaouanq J, Genetet B, Pawlotsky Y, Semana G. The role of HLA-DR-DR and HLA-DR-DP interactions in genetic susceptibility to rheumatoid arthritis. Hum. Immunol. 46: 42-48 (1996).

• Perez-Aguilar F, Berenguer M, Ramirez-Palanca JJ, Paya A, Vera-Sempere FJ, Sanchez-Cuenca JM, Berenguer J. Chronic autoimmune hepatitis following cholestatic hepatitis caused by droxicam. Med. Clin. (Barc.) 106: 460-462 (1996).

• Peters JM, Zhou YC, Ram PA, Lee SS, Gonzalez FJ, Waxman DJ. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate. Mol. Pharmacol. 50: 67-74 (1996).

• Peters RH, French PJ, van Doorninck JH, Lamblin G, Ratcliff R, Evans MJ, Colledge WH, Bijman J, Scholte BJ. CFTR expression and mucin secretion in cultured mouse gallbladder epithelial cells. Am. J. Physiol. 271: G1074-G1083 (1996).

• Peterson JW, Dickey WD, Saini SS, Gourley W, Klimpel GR, Chopra AK. Phospholipase A2 activating protein and idiopathic inflammatory bowel disease. Gut 39: 698-704 (1996). *

• Petrunia AM, Enenko IuA. The efficacy of immunomodulating therapy in patients with chronic cholestatic liver diseases. Lik. Sprava. 3-4: 125-127 (1996).

• Pham TH, Kaushik S, Lin BP, Jones DB. Case report: acanthosis nigricans in association with primary biliary cirrhosis: resolution after liver transplantation. J. Gastroenterol. Hepatol. 11: 1021-1023 (1996).

• Picarelli A, Maiuri L, Mazzilli MC, Coletta S, Ferrante P, Di Giovambattista F, Greco M, Torsoli A, Auricchio S. Gluten-sensitive disease with mild enteropathy. Gastroenterology 111: 608-616 (1996). *

• Pilette C, Kirstetter P, Sogni P, Cailmail S, Moreau R, Lebrec D. Dose-dependent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hypertension in conscious rats. J. Gastroenterol. Hepatol. 11: 1-6 (1996).

• Pillot J. Hepatitis viruses: from the old ones to the new ones. Will the alphabet be enough to list them all? Presse. Med. 25: 333-336 (1996).

• Plevy SE, Targan SR, Yang H, Fernandez D, Rotter JI, Toyoda H. Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6. Gastroenterology 110: 1053-1060 (1996). *

• Podda M, Crosignani A, Battezzati PM, Quagliuolo M, Valsania C, Invernizzi P, Zuin M. Ursodeoxycholic acid therapy in primary biliary cirrhosis. Ital. J. Gastroenterol. 28: 114-117 (1996).

• Podil'chak MD, Vdovychenko VI, Terlets'ka LM. Lipid peroxidation and blood serum peroxidase activity in diseases of the hepatobiliary system. Lik. Sprava. 1-2: 110-112 (1996).

• Poethke R, Mader M, Zedler I, Beuche W, Felgenhauer K, Kolbus N. A putative enzyme from various secretions specifically inhibits antibody-antigen interactions. J. Immunol. Methods 191: 149-157 (1996). *

• Polzien F, Ramadori G. Increased intercellular adhesion molecule-1 serum concentration in cholestasis. J. Hepatol. 25: 877-886 (1996). *

• Poniachik J, Bernstein DE, Reddy KR, Jeffers LJ, Coelho-Little ME, Civantos F, Schiff ER. The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest. Endosc. 43: 568-571 (1996).

• Pons Romero F, Casafont F. Autoantibodies in liver diseases: interpretation and pathogenic importance. Gastroenterol. Hepatol. 19: 326-333 (1996).

• Portell DP, Figueroa G, Toledo MS, Troncoso M, Acuna R. Prospective study of erradication of Helicobacter pylori in patients with duodenal ulcer: analysis of antral and gastric body biopsies. Rev. Med. Chil. 124: 21-25 (1996).

• Poupon RE, Huet PM, Poupon R, Bonnand AM, Nhieu JT, Zafrani ES. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group. Hepatology 24: 1098-1103 (1996). *

• Powell JJ, Ainley CC, Harvey RS, Mason IM, Kendall MD, Sankey EA, Dhillon AP, Thompson RP. Characterisation of inorganic microparticles in pigment cells of human gut associated lymphoid tissue. Gut 38: 390-395 (1996). *

• Prantera C, Zannoni F, Scribano ML, Berto E, Andreoli A, Kohn A, Luzi C. An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am. J. Gastroenterol. 91: 328-332 (1996).

• Pratt DS, Flavin DP, Kaplan MM. The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine. Gastroenterology 110: 271-274 (1996). *

• Price MR, Sartorelli KH, Karrer FM, Narkewicz MR, Sokol RJ, Lilly JR. Management of esophageal varices in children by endoscopic variceal ligation. J. Pediatr. Surg. 31: 1056-1059 (1996).

• Price VH, Colombe BW. Heritable factors distinguish two types of alopecia areata. Dermatol. Clin. 14: 679-689 (1996).

• Probert CS, Bhakta P, Bhamra B, Jayanthi V, Mayberry JF. Diet of South Asians with inflammatory bowel disease. Arq. Gastroenterol. 33: 132-135 (1996).

• Probert CS, Chott A, Turner JR, Saubermann LJ, Stevens AC, Bodinaku K, Elson CO, Balk SP, Blumberg RS. Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease. J. Immunol. 157: 3183-3191 (1996).

• Protzer U, Duchmann R, Hohler T, Hitzler W, Ewe K, Wanitschke R, Meyer zum Buschenfelde KH, Marker-Hermann E. Enteropathic spondylarthritis in chronic inflammatory bowel diseases: prevalence, manifestation pattern and HLA association. Med. Klin. (Munich) 91: 330-335 (1996).

• Pryhuber KG, Murray KJ, Donnelly P, Passo MH, Maksymowych WP, Glass DN, Giannini EH, Colbert RA. Polymorphism in the LMP2 gene influences disease susceptibility and severity in HLA-B27 associated juvenile rheumatoid arthritis. J. Rheumatol. 23: 747-752 (1996).

• Pullan RD. Colonic mucus, smoking and ulcerative colitis. Ann. R. Coll. Surg. Engl. 78: 85-91 (1996).

• Qiu BS, Pfeiffer CJ, Keith JC Jr. Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats. Dig. Dis. Sci. 41: 1625-1630 (1996).

• Rabelo R, Reyes C, Schifman A, Silva JE. A complex retinoic acid response element in the uncoupling protein gene defines a novel role for retinoids in thermogenesis. Endocrinology 137: 3488-3496 (1996). *

• Radford-Smith G, Jewell DP. Cytokines and inflammatory bowel disease. Baillieres Clin. Gastroenterol. 10: 151-164 (1996).

• Raederstorff D, Pantze M, Bachmann H, Moser U. Anti-inflammatory properties of docosahexaenoic and eicosapentaenoic acids in phorbol-ester-induced mouse ear inflammation. Int. Arch. Allergy Immunol. 111: 284-290 (1996).

• Raffy O, Sleiman C, Vachiery F, Mal H, Roue C, Hadengue A, Jebrak G, Fournier M, Pariente R. Refractory hypoxemia during liver cirrhosis. Hepatopulmonary syndrome or "primary" pulmonary hypertension? Am. J. Respir. Crit. Care Med. 153: 1169-1171 (1996).

• Rahman SM, Itakura H, Motoda A. Regenerative pattern of liver cells in primary biliary cirrhosis, alcoholic cirrhosis, posthepatitic cirrhosis (HBV-related) and hepatocellular carcinoma: comparative analysis by computerized morphometry. Pathol. Int. 46: 267-273 (1996).

• Rain F, Durieu I, Mackiewitz R, Levrat R. Dermatopolymyositis and primary biliary cirrhosis. A rare association. Presse. Med. 25: 581-582 (1996).

• Ramanathan M, Wahinuddin S, Kew ST. Glibenclamide induced chronic cholestasis simulating primary biliary cirrhosis: a case report. Med. J. Malaysia 51: 140-143 (1996).

• Rambjor GS, Walen AI, Windsor SL, Harris WS. Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans. Lipids 31: S45-S49 (1996).

• Ravnik-Glavac M, Glavac D, di Sant' Agnese P, Chernick M, Dean M. Cystic fibrosis gene mutations detected in hereditary pancreatitis. Pflugers Arch. 431: R191-R192 (1996).

• Reimund JM, Duclos B, Baumann R. Genetics and chronic idiopathic inflammatory diseases of the intestines. Ann. Med. Interne. (Paris) 147: 178-184 (1996).

• Reimund JM, Wittersheim C, Dumont S, Muller CD, Baumann R, Poindron P, Duclos B. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J. Clin. Immunol. 16: 144-150 (1996).

• Reimund JM, Wittersheim C, Dumont S, Muller CD, Kenney JS, Baumann R, Poindron P, Duclos B. Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 39: 684-689 (1996). *

• Reinshagen M, Loeliger C, Kuehnl P, Weiss U, Manfras BJ, Adler G, Boehm BO. HLA class II gene frequencies in Crohn's disease: a population based analysis in Germany. Gut 38: 538-542 (1996). *

• Reiser H, Stadecker MJ. Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N. Engl. J. Med. 335: 1369-1377 (1996). *

• Remmel T, Piirsoo A, Koiveer A, Remmel H, Uibo R, Salupere V. Clinical significance of different antinuclear antibodies patterns in the course of primary biliary cirrhosis. Hepatogastroenterology 43: 1135-1140 (1996).

• Remmel T, Remmel H, Salupere V. Aminoterminal propeptide of type III procollagen and hyaluronan in patients with primary biliary cirrhosis: markers of fibrosis in primary biliary cirrhosis. J. Gastroenterol. Hepatol. 11: 1016-1020 (1996).

• Ren B, Thelen A, Jump DB. Peroxisome proliferator-activated receptor alpha inhibits hepatic S14 gene transcription. Evidence against the peroxisome proliferator-activated receptor alpha as the mediator of polyunsaturated fatty acid regulation of S14 gene transcription. J. Biol. Chem. 271: 17167-17173 (1996). *

• Reveille JD, Alarcon GS, Fowler SE, Pillemer SR, Neuner R, Clegg DO, Mikhail IS, Trentham DE, Leisen JC, Bluhm G, Cooper SM, Duncan H, Tuttleman M, Heyse SP, Sharp JT, Tilley B. HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in Rheumatoid Arthritis. Arthritis Rheum. 39: 1802-1807 (1996).

• Riegler JL. Preneoplastic conditions of the liver. Semin. Gastrointest. Dis. 7: 74-87 (1996).

• Rietschel ET, Brade H, Holst O, Brade L, Muller-Loennies S, Mamat U, Zahringer U, Beckmann F, Seydel U, Brandenburg K, Ulmer AJ, Mattern T, Heine H, Schletter J, Loppnow H, Schonbeck U, Flad HD, Hauschildt S, Schade UF, Di Padova F, Kusumoto S, Schumann R. Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr. Top. Microbiol. Immunol. 216: 39-81 (1996).

• Riordan SM, McIver CJ, Wakefield D, Duncombe VM, Bolin TD, Thomas MC. Luminal immunity in small-intestinal bacterial overgrowth and old age. Scand. J. Gastroenterol. 31: 1103-1109 (1996).

• Riordan SM, McIver CJ, Wakefield D, Duncombe VM, Bolin TD, Thomas MC. Mucosal cytokine production in small-intestinal bacterial overgrowth. Scand. J. Gastroenterol. 31: 977-984 (1996).

• Rioux KP, Sharkey KA, Wallace JL, Swain MG. Hepatic mucosal mast cell hyperplasia in rats with secondary biliary cirrhosis. Hepatology 23: 888-895 (1996). *

• Rizzi PM, Ryder SD, Portmann B, Ramage JK, Naoumov NV, Williams R. p53 Protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis. Gut 38: 265-268 (1996). *

• Roberton DM, Cabral DA, Malleson PN, Petty RE. Juvenile psoriatic arthritis: followup and evaluation of diagnostic criteria. J. Rheumatol. 23: 166-170 (1996).

• Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology 110: 848-857 (1996). *

• Roda E, Pezzoli A, Fusaroli P, Fabbri C, Jaboli F, Marchetto S, Azzaroli F, Mazzella G. Intrahepatic cholestasis in chronic liver disease. Ann. Ital. Med. Int. 11 Suppl. 2: 48S-52S (1996).

• Rodrigues CM, Kren BT, Steer CJ, Setchell KD. Formation of delta 22-bile acids in rats is not gender specific and occurs in the peroxisome. J. Lipid Res. 37: 540-550 (1996). *

• Roediger WE, Babidge W, Millard S. Methionine derivatives diminish sulphide damage to colonocytes - implications for ulcerative colitis. Gut 39: 77-81 (1996). *

• Rojas G, Siegel F, Jorquera J, Ardiles L, Valderrama G, Mezzano S. Antineutrophil cytoplasmic antibodies and nonspecific ulcerative colitis. Rev. Med. Chil. 124: 449-455 (1996).

• Rollo EE, Laskin DL, Denhardt DT. Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages. J. Leukoc. Biol. 60: 397-404 (1996). *

• Romagnani S, Parronchi P, D'Elios M, Romagnani P, Annunziato F, Menghetti M, Maggi E, Del Prete G. Immune mechanisms in the pathogenesis of inflammatory gastrointestinal disorders. Ital. J. Gastroenterol. 28 Suppl. 2: 11-17 (1996).

• Roman ID, Johnson GD, Coleman R. S-Adenosyl-L-methionine prevents disruption of canalicular function and pericanalicular cytoskeleton integrity caused by cyclosporin A in isolated rat hepatocyte couplets. Hepatology 24: 134-140 (1996). *

• Romics L, Nemesanszky E, Szalay F, Csaszar A, Tresch J, Karadi I. Lipoprotein(a) concentration and phenotypes in primary biliary cirrhosis. Clin. Chim. Acta 255: 165-171 (1996). *

• Roschmann E, Wienker TF, Volk BA. Role of T cell receptor delta gene in susceptibility to celiac disease. J. Mol. Med. 74: 93-98 (1996).

• Rosenthal P. Living-related liver transplants for adults? The time has come! J. Pediatr. Gastroenterol. Nutr. 23: 335-336 (1996). *

• Rothwell PM, Grant R. Cerebral vasculitis following allopurinol treatment. Postgrad. Med. J. 72: 119-120 (1996). *

• Rozmahel R, Wilschanski M, Matin A, Plyte S, Oliver M, Auerbach W, Moore A, Forstner J, Durie P, Nadeau J, Bear C, Tsui LC. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat. Genet. 12: 280-287 (1996). *

• Rudi J, Schonig T, Stremmel W. Therapy with ursodeoxycholic acid in primary biliary cirrhosis in pregnancy. Z. Gastroenterol. 34: 188-191 (1996).

• Rudwaleit M, Tikly M, Khamashta M, Gibson K, Klinke J, Hughes G, Wordsworth P. Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J. Rheumatol. 23: 1725-1728 (1996).

• Russel MG, Stockbrugger RW. Epidemiology of inflammatory bowel disease: an update. Scand. J. Gastroenterol. 31: 417-427 (1996).

• Sachar DB. Maintenance strategies in Crohn's disease. Hosp. Pract. (Off Ed.) 31: 99-106 (1996).

• Sadeghi N, Fumiere E, Durez P, Matos C, Struyven J. Primary biliary cirrhosis and bone changes. J. Belge. Radiol. 79: 160-161 (1996).

• Saini SK, Rose CD. Liver involvement in familial granulomatous arthritis (Blau syndrome). J. Rheumatol. 23: 396-399 (1996).

• Sakane T, Miura K. Research for basic and clinical aspects of Behcet's disease - recent advance and future. Nippon Rinsho 54: 870-884 (1996).

• Sakoda K, Fujiwara M, Arai S, Suzuki A, Nishikawa J, Imagawa M, Nishihara T. Isolation of a genomic DNA fragment having negative vitamin D response element. Biochem. Biophys. Res. Commun. 219: 31-35 (1996). *

• Sanchez-Pobre P, Castellano G, Colina F, Dominguez P, Rodriguez S, Canga F, Herruzo JA. Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis? J. Clin. Gastroenterol. 23: 191-198 (1996).

• Sandborn WJ, Landers CJ, Tremaine WJ, Targan SR. Association of antineutrophil cytoplasmic antibodies with resistance to treatment of left-sided ulcerative colitis: results of a pilot study. Mayo Clin. Proc. 71: 431-436 (1996). *

• Sandig V, Strauss M. Liver-directed gene transfer and application to therapy. J. Mol. Med. 74: 205-212 (1996).

• Sankaranarayanan R, Mathew B. Retinoids as cancer-preventive agents. IARC Sci. Publ. 139: 47-59 (1996).

• Sartor RB, Rath HC, Lichtman SN, van Tol EA. Animal models of intestinal and joint inflammation. Baillieres Clin. Rheumatol. 10: 55-76 (1996).

• Sasaki M, Nakanuma Y. Frequent expression of MUC1 apomucin on biliary epithelial cells of damaged small bile ducts in primary biliary cirrhosis and chronic viral hepatitis: an immunohistochemical study. Hepatology 23: 1313-1317 (1996). *

• Satsangi J, Grootscholten C, Holt H, Jewell DP. Clinical patterns of familial inflammatory bowel disease. Gut 38: 738-741 (1996). *

• Satsangi J, Parkes M, Jewell DP. Genetics of ulcerative colitis. Lancet 348: 624-625 (1996). *

• Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K, Terwilliger JD, Lathrop GM, Bell JI, Jewell DP. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat. Genet. 14: 199-202 (1996). *

• Satsangi J, Welsh KI, Bunce M, Julier C, Farrant JM, Bell JI, Jewell DP. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 347: 1212-1217 (1996).

• Sauer P, Rudolph G, Endele R, Senn M, Theilmann L, Otto G, Stremmel W, Stiehl A. Kinetics of primary bile acids in patients after orthotopic liver transplantation. Eur. J. Clin. Invest. 26: 979-982 (1996).

• Sauter G, Berr F, Beuers U, Fischer S, Paumgartner G. Serum concentrations of 7alpha-hydroxy-4-cholesten-3-one reflect bile acid synthesis in humans. Hepatology 24: 123-126 (1996). *

• Sauter G, Fischer S, Pahernik S, Koebe HG, Paumgartner G. Formation of cholic acid and chenodeoxycholic acid from 7 alpha-hydroxycholesterol and 27-hydroxycholesterol by primary cultures of human hepatocytes. Biochim. Biophys. Acta 1300: 25-29 (1996).

• Savige JA, Chang L, Wilson D, Buchanan RR. Autoantibodies and target antigens in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. Rheumatol. Int. 16: 109-114 (1996).

• Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J, Robertson N, Clayton D, Goodfellow PN, Compston A. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat. Genet. 13: 464-468 (1996). *

• Schapiro M. Cancer surveillance colonoscopy in ulcerative colitis: sense or nonsense? Schweiz. Med. Wochenschr. Suppl. 79: 5S-8S (1996).

• Schimanski U, Stiehl A, Stremmel W, Theilmann L. Low prevalence of alterations in the pancreatic duct system in patients with primary sclerosing cholangitis. Endoscopy 28: 346-349 (1996).

• Schlager SI, Hanauer SB. New therapeutic approaches to peptic ulcer disease: the role of Helicobacter pylori. Am. J. Ther. 3: 586-596 (1996).

• Schmassmann A, Zehnder P, Gebbers JO, Wildisen A. Severe self limiting sclerosing cholangitis after pancreaticoduodenectomy due to autoimmune pancreatitis. Gut 55: 1361-1362 (1996). *

• Schmidt HH, Manns MP. Should we treat cholestatic liver disease with cholesterol synthesis inhibitors? Am. J. Gastroenterol. 91: 406-407 (1996).

• Schmucker DL, Heyworth MF, Owen RL, Daniels CK. Impact of aging on gastrointestinal mucosal immunity. Dig. Dis. Sci. 41: 1183-1193 (1996).

• Schnabel A, Hauschild S, Gross WL. Anti-neutrophil cytoplasmic antibodies in generalized autoimmune diseases. Int. Arch. Allergy Immunol. 109: 201-206 (1996).

• Schoonjans K, Staels B, Auwerx J. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta 1302: 93-109 (1996).

• Schoonjans K, Staels B, Auwerx J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 37: 907-925 (1996). *

• Schreiber S, Howaldt S, Schnoor M, Nikolaus S, Bauditz J, Gasche C, Lochs H, Raedler A. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N. Engl. J. Med. 334: 619-623 (1996). *

• Schuetz EG, Schinkel AH, Relling MV, Schuetz JD. P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans. Proc. Natl. Acad. Sci. U.S.A. 93: 4001-4005 (1996). *

• Schwarz M, Lund EG, Setchell KD, Kayden HJ, Zerwekh JE, Bjorkhem I, Herz J, Russell DW. Disruption of cholesterol 7alpha-hydroxylase gene in mice. II. Bile acid deficiency is overcome by induction of oxysterol 7alpha-hydroxylase. J. Biol. Chem. 271: 18024-18031 (1996). *

• Scudeletti M, Musselli C, Lanza L, Peirano L, Puppo F, Indiveri F. The immunological activity of corticosteroids. Recenti Prog. Med. 87: 508-515 (1996).

• Seibold F, Klein R, Jakob F. Polymyositis, alopecia universalis, and primary sclerosing cholangitis in a patient with Crohn's disease. J. Clin. Gastroenterol. 23: 121-124 (1996).

• Seibold F, Weber P, Schoning A, Mork H, Goppel S, Scheurlen M. Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens? Eur. J. Gastroenterol. Hepatol. 8: 1095-1100 (1996).

• Selby W, Pokorny C, Gallagher ND, McCaughan G. Re: Biliary tract calculi and primary sclerosing cholangitis. Am. J. Gastroenterol. 91: 408 (1996).

• Sendid B, Colombel JF, Jacquinot PM, Faille C, Fruit J, Cortot A, Lucidarme D, Camus D, Poulain D. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin. Diagn. Lab. Immunol. 3: 219-226 (1996). *

• Senoo H, Imai K, Sato M, Kojima N, Miura M, Hata R. Three-dimensional structure of extracellular matrix reversibly regulates morphology, proliferation and collagen metabolism of perisinusoidal stellate cells (vitamin A-storing cells). Cell Biol. Int. 20: 501-512 (1996).

• Setchell KD, Rodrigues CM, Podda M, Crosignani A. Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis. Gut 38: 439-446 (1996). *

• Shaldon S. Bactericidal/permeability increasing factors. J. Am. Soc. Nephrol. 7: 2268 (1996). *

• Shalev A, Siegrist-Kaiser CA, Yen PM, Wahli W, Burger AG, Chin WW, Meier CA. The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin. Endocrinology 137: 4499-4502 (1996). *

• Sharma BC, Saraswat VA, Choudhuri G, Das A, Ghoshal UC, Pandey R. Primary biliary cirrhosis without pruritus - an Indian variant. Trop. Gastroenterol. 17: 176-177 (1996).

• Shaw MA, Clayton D, Atkinson SE, Williams H, Miller N, Sibthorpe D, Blackwell JM. Linkage of rheumatoid arthritis to the candidate gene NRAMP1 on 2q35. J. Med. Genet. 33: 672-677 (1996). *

• Sheil AG. The new age of liver transplantation. Aust. N.Z. J. Surg. 66: 698-706 (1996).

• Shekels LL, Beste JE, Ho SB. Tauroursodeoxycholic acid protects in vitro models of human colonic cancer cells from cytotoxic effects of hydrophobic bile acids. J. Lab. Clin. Med. 127: 57-66 (1996). *

• Shekels LL, Lyftogt CT, Ho SB. Bile acid-induced alterations of mucin production in differentiated human colon cancer cell lines. Int. J. Biochem. Cell. Biol. 28: 193-201 (1996). *

• Shen GQ, Ojo-Amaize EA, Agopian MS, Peter JB. Silicate antibodies in women with silicone breast implants: development of an assay for detection of humoral immunity. Clin. Diagn. Lab. Immunol. 3: 162-166 (1996). *

• Sheng R, Campbell WL, Zajko AB, Baron RL. Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: evidence of recurrent disease. AJR Am. J. Roentgenol. 166: 1109-1113 (1996). *

• Sheppard DN, Ostedgaard LS. Understanding how cystic fibrosis mutations cause a loss of Cl- channel function. Mol. Med. Today 2: 290-297 (1996).

• Shiga H, Shioda T, Tomiyama H, Takamiya Y, Oka S, Kimura S, Yamaguchi Y, Gojoubori T, Rammensee HG, Miwa K, Takiguchi M. Identification of multiple HIV-1 cytotoxic T-cell epitopes presented by human leukocyte antigen B35 molecules. AIDS 10: 1075-1083 (1996).

• Shigematsu M, Masuda H. Usage of T cell receptor (TCR) V beta gene in ulcerative colitis. J. Clin. Lab. Immunol. 48: 177-186 (1996).

• Shimomura I, Takase Y, Matsumoto S, Kuyama J, Nakajima T, Maeda H, Sugase T, Hata A, Hanada M, Okuno M. Primary sclerosing cholangitis associated with increased peripheral eosinophils and serum IgE. J. Gastroenterol. 31: 737-741 (1996).

• Shindo M, Mullin GE, Braun-Elwert L, Bergasa NV, Jones EA, James SP. Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB). Clin. Exp. Immunol. 105: 254-259 (1996). *

• Shinoda M, Haruta J, Tanimoto M, Ando T, Hosokawa T, Ina K, Kusugami K. Lamina propria mononuclear cells express and respond to interleukin-2 differently in Crohn's disease and ulcerative colitis. Intern. Med. 35: 679-685 (1996). *

• Shirley MA, Bennani YL, Boehm MF, Breau AP, Pathirana C, Ulm EH. Oxidative and reductive metabolism of 9-cis-retinoic acid in the rat. Identification of 13,14-dihydro-9-cis-retinoic acid and its taurine conjugate. Drug Metab. Dispos. 24: 293-302 (1996). *

• Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39: 690-697 (1996). *

• Shrestha R, Bilir BM, Everson GT, Steinberg SE. Endoscopic stenting of gallbladder for symptomatic cholelithiasis in patients with end-stage liver disease awaiting orthotopic liver transplantation. Am. J. Gastroenterol. 91: 595-598 (1996).

• Shyjan AM, Bertagnolli M, Kenney CJ, Briskin MJ. Human mucosal addressin cell adhesion molecule-1 (MAdCAM-1) demonstrates structural and functional similarities to the alpha 4 beta 7-integrin binding domains of murine MAdCAM-1, but extreme divergence of mucin-like sequences. J. Immunol. 156: 2851-2857 (1996).

• Silvennoinen J. Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease. J. Intern. Med. 239: 131-137 (1996).

• Sindermann J, Foerster E, Kienast J. Severe hepatobiliary complication in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid. Acta Oncol. 35: 499-501 (1996).

• Sinha A, Clatch RJ, Stuck G, Blumenthal SA, Patel SA. Isoflurane hepatotoxicity: a case report and review of the literature. Am. J. Gastroenterol. 91: 2406-2409 (1996).

• Sleasman JW. The association between immunodeficiency and the development of autoimmune disease. Adv. Dent. Res. 10: 57-61 (1996). *

• Smith SR, Terminelli C, Denhardt G, Narula S, Thorbecke GJ. Administration of interleukin-10 at the time of priming protects Corynebacterium parvum-primed mice against LPS- and TNF-alpha-induced lethality. Cell. Immunol. 173: 207-214 (1996). *

• Snook NJ, O'Beirne HA, Enright S, Young Y, Bellamy MC. Use of recombinant human erythropoietin to facilitate liver transplantation in a Jehovah's Witness. Br. J. Anaesth. 76: 740-743 (1996). *

• Sobajima J, Ozaki S, Okazaki T, Osakada F, Sumita S, Mori K, Nakao K. Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: anti-cathepsin G and a novel antibody correlate with a refractory type. Clin. Exp. Immunol. 105: 120-124 (1996). *

• Soderbergh A, Winqvist O, Norheim I, Rorsman F, Husebye ES, Dolva O, Karlsson FA, Kampe O. Adrenal autoantibodies and organ-specific autoimmunity in patients with Addison's disease. Clin. Endocrinol. (Oxf.) 45: 453-460 (1996).

• Sontheimer RD. Photoimmunology of lupus erythematosus and dermatomyositis: a speculative review. Photochem. Photobiol. 63: 583-594 (1996).

• Spagnuolo MI, Iorio R, Vegnente A, Guarino A. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study. Gastroenterology 111: 716-719 (1996). *

• Sprenkels SH, Uksila J, Vainionpaa R, Toivanen P, Feltkamp TE. IgA antibodies in HLA-B27 associated acute anterior uveitis and ankylosing spondylitis. Clin. Rheumatol. 15 Suppl. 1: 52-56 (1996).

• Sprenkels SH, Van Kregten E, Feltkamp TE. IgA antibodies against Klebsiella and other Gram-negative bacteria in ankylosing spondylitis and acute anterior uveitis. Clin. Rheumatol. 15 Suppl. 1: 48-51 (1996).

• Staal A, van Wijnen AJ, Birkenhager JC, Pols HA, Prahl J, DeLuca H, Gaub MP, Lian JB, Stein GS, van Leeuwen JP, Stein JL. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. Mol. Endocrinol. 10: 1444-1456 (1996).

• Staal A, Van Wijnen AJ, Desai RK, Pols HA, Birkenhager JC, Deluca HF, Denhardt DT, Stein JL, Van Leeuwen JP, Stein GS, Lian JB. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements. Endocrinology 137: 2001-2011 (1996).

• Stanley AJ, MacGregor IR, Dillon JF, Bouchier IA, Hayes PC. Neutrophil activation in chronic liver disease. Eur. J. Gastroenterol. Hepatol. 8: 135-138 (1996).

• Stazi F, Farello P, Stazi C. Intrahepatic cholestasis Clin. Ter. 147: 575-583 (1996).

• Stephensen CB, Moldoveanu Z, Gangopadhyay NN. Vitamin A deficiency diminishes the salivary immunoglobulin A response and enhances the serum immunoglobulin G response to influenza A virus infection in BALB/c mice. J. Nutr. 126: 94-102 (1996). *

• Sterchele PF, Sun H, Peterson RE, Vanden Heuvel JP. Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver. Arch. Biochem. Biophys. 326: 281-289 (1996). *

• Steuer A, McCrea DJ, Colaco CB. Primary Sjogren's syndrome, ulcerative colitis and selective IgA deficiency. Postgrad. Med. J. 72: 499-500 (1996). *

• Stiehl A. Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis. Ital. J. Gastroenterol. 28: 178-180 (1996).

• Stoffel MP, Csernok E, Herzberg C, Johnson T, Carroll SF, Gross WL. Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders. Clin. Exp. Immunol. 104: 54-59 (1996). *

• Strassburg CP, Alex B, Zindy F, Gerken G, Luttig B, Meyer zum Buschenfelde KH, Brechot C, Manns MP. Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases. J. Hepatol. 25: 859-866 (1996).

• Strautnieks SS, Kagalwalla AF, Tanner MS, Gardiner RM, Thompson RJ. Locus heterogeneity in progressive familial intrahepatic cholestasis. J. Med. Genet. 33: 833-836 (1996). *

• Stravitz RT, Vlahcevic ZR, Russell TL, Heizer ML, Avadhani NG, Hylemon PB. Regulation of sterol 27-hydroxylase and an alternative pathway of bile acid biosynthesis in primary cultures of rat hepatocytes. J. Steroid Biochem. Mol. Biol. 57: 337-347 (1996).

• Stretch GL, Campbell BJ, Dwarakanath AD, Yaqoob M, Stevenson A, Morris AI, Rhodes JM. 5-Aminosalicylic acid absorption and metabolism in ulcerative colitis patients receiving maintenance sulphasalazine, olsalazine or mesalazine. Aliment. Pharmacol. Ther. 10: 941-947 (1996).

• Sugano S, Suzuki T, Makino H, Yanagimoto S, Nishio M, Onmura H, Iinuma M, Matuda T, Shinozawa Y. Budd-Chiari syndrome attributed to protein C deficiency. Am. J. Gastroenterol. 91: 777-779 (1996).

• Sugiyama T, Oishi Y, Sueishi M, Matsumura R, Tomioka H, Akikusa B. Diffuse proliferative lupus nephritis in a patient with ulcerative colitis. Ryumachi 36: 651-655 (1996).

• Swanink CM, Vercoulen JH, Galama JM, Roos MT, Meyaard L, van der Ven-Jongekrijg J, de Nijs R, Bleijenberg G, Fennis JF, Miedema F, van der Meer JW. Lymphocyte subsets, apoptosis, and cytokines in patients with chronic fatigue syndrome. J. Infect. Dis. 173: 460-463 (1996).

• Tai TA, Jennermann C, Brown KK, Oliver BB, MacGinnitie MA, Wilkison WO, Brown HR, Lehmann JM, Kliewer SA, Morris DC, Graves RA. Activation of the nuclear receptor peroxisome proliferator-activated receptor gamma promotes brown adipocyte differentiation. J. Biol. Chem. 271: 29909-29914 (1996). *

• Tajima S, Tsuji K, Ebihara Y, Sui X, Tanaka R, Muraoka K, Yoshida M, Yamada K, Yasukawa K, Taga T, Kishimoto T, Nakahata T. Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells. J. Exp. Med. 184: 1357-1364 (1996). *

• Takahashi M, Mimura Y, Hamano H, Haneji N, Yanagi K, Hayashi Y. Mechanism of the development of autoimmune dacryodenitis in the mouse model for primary Sjogren's syndrome. Cell. Immunol. 170: 54-62 (1996).

• Takamiya Y, Sakaguchi T, Miwa K, Takiguchi M. Role of HLA-B*5101 binding nonamer peptides in formation of the HLA-Bw4 public epitope. Int. Immunol. 8: 1027-1034 (1996). *

• Takeuchi F, Kuwata S, Nakano K, Nabeta H, Hong GH, Shibata Y, Tanimoto K, Ito K. Association of TAP1 and TAP2 with systemic sclerosis in Japanese. Clin. Exp. Rheumatol. 14: 513-521 (1996).

• Takeuchi F, Nakano K, Nabeta H, Hong GH, Kuwata S, Ito K. Polymorphisms of the TAP1 and TAP2 transporter genes in Japanese SLE. Ann. Rheum. Dis. 55: 924-926 (1996). *

• Takikawa H. Organic anion carriers. Nippon Rinsho 54: 646-651 (1996).

• Tamai H, Sudo T, Kimura A, Mukuta T, Matsubayashi S, Kuma K, Nagataki S, Sasazuki T. Association between the DRB1*08032 histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves disease. Ann. Intern. Med. 124: 490-494 (1996). *

• Tan EM. Pathophysiology of antinuclear antibodies in systemic lupus erythematosus and related diseases. Adv. Dent. Res. 10: 44-46 (1996). *

• Tanaka A, Kasahara M, Miyawaki T, Yahata K, Hashimoto H, Sugawara A, Ueda S, Matsuo T, Kuwahara T. A case of selective IgM deficiency associated with systemic lupus erythematosus. Nippon Jinzo Gakkai Shi 38: 185-190 (1996).

• Tanaka A, Tanaka K, Shinohara H, Hatano E, Sato S, Kanazawa A, Kitai T, Higashiyama H, Nakamura Y, Yamamoto Y, Okajima H, Egawa H, Ikai I, Uemoto S, Satomura I, Ozaki N, Inomata Y, Yamaoka Y. Extension of the indication for living related liver transplantation from children to adults based on resolution of graft size mismatch in relation to tissue oxygenation and metabolic load: a case report. Transpl. Int. 9 Suppl. 1: S174-S177 (1996).

• Tanaka H, Makino I. Bile acids and immune regulation. Nippon Shokakibyo Gakkai Zasshi 93: 693-699 (1996).

• Tanaka H, Makino Y, Miura T, Hirano F, Okamoto K, Komura K, Sato Y, Makino I. Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. Repression of IFN-gamma-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway. J. Immunol. 156: 1601-1608 (1996).

• Tanaka Y, Takahashi A, Watanabe K, Takayama K, Yahata T, Habu S, Nishimura T. A pivotal role of IL-12 in Th1-dependent mouse liver injury. Int. Immunol. 8: 569-576 (1996). *

• Taneja V, Giphart MJ, Verduijn W, Naipal A, Malaviya AN, Mehra NK. Polymorphism of HLA-DRB, -DQA1, and -DQB1 in rheumatoid arthritis in Asian Indians: association with DRB1*0405 and DRB1*1001. Hum. Immunol. 46: 35-41 (1996).

• Tarcsa E, Marekov LN, Mei G, Melino G, Lee SC, Steinert PM. Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J. Biol. Chem. 271: 30709-30716 (1996). *

• Tebano MT, Traversa G, Da Cas R, Loizzo A. Prescriptions for mesalazine and sulphasalazine: a prevalence estimate of patients treated for inflammatory bowel disease in Rome. Aliment. Pharmacol. Ther. 10: 659-663 (1996).

• Tee LB, Kirilak Y, Huang WH, Smith PG, Morgan RH, Yeoh GC. Dual phenotypic expression of hepatocytes and bile ductular markers in developing and preneoplastic rat liver. Carcinogenesis 17: 251-259 (1996). *

• Teirstein AS, Padilla ML, De Palo LR, Schilero GJ. Sarcoidosis mythology. Mt. Sinai J. Med. 63: 335-341 (1996).

• Teller K, Budhai L, Zhang M, Haramati N, Keiser HD, Davidson A. HLA-DRB1 and DQB typing of Hispanic American patients with rheumatoid arthritis: the "shared epitope" hypothesis may not apply. J. Rheumatol. 23: 1363-1368 (1996).

• Tesar V, Rychlík I, Bartunkova J, Stejsakalova A, Zabka J, Janatkova I, Fucíkova T, Becvar R. Renal vasculitis and glomerulonephritis with anti-neutrophil cytoplasmic antibody positivity. Cas. Lek. Cesk. 135: 79-83 (1996).

• Tezuka K, Denhardt DT, Rodan GA, Harada S. Stimulation of mouse osteopontin promoter by v-Src is mediated by a CCAAT box-binding factor. J. Biol. Chem. 271: 22713-22717 (1996). *

• Theal RM, Scott K. Evaluating asymptomatic patients with abnormal liver function test results. Am. Fam. Physician 53: 2111-2119 (1996).

• Theodorou V, Fioramonti J, Bueno L. Integrative neuroimmunology of the digestive tract. Vet. Res. 27: 427-442 (1996).

• Theophilos MB, Cox DW, Mercer JF. The toxic milk mouse is a murine model of Wilson disease. Hum. Mol. Genet. 5: 1619-1624 (1996). *

• Thomas GA, Rhodes J, Ragunath K, Mani V, Williams GT, Newcombe RG, Russell MA, Feyerabend C. Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 8: 769-776 (1996).

• Thompson MB. Bile acids in the assessment of hepatocellular function. Toxicol. Pathol. 24: 62-71 (1996). *

• Thompson NP, Driscoll R, Pounder RE, Wakefield AJ. Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ 312: 95-96 (1996). *

• Tivol EA, Schweitzer AN, Sharpe AH. Costimulation and autoimmunity. Curr. Opin. Immunol. 8: 822-830 (1996).

• Todd JA, Farrall M. Panning for gold: genome-wide scanning for linkage in type 1 diabetes. Hum. Mol. Genet. 5: S1443-S1448 (1996).

• Todorovic V, Janic B, Koko V, Micev M, Nikolic JA, Ratkovic M, Leposavic G, Jankovic T, Knezevic-Usaj S, Milicevic Z. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis - a radioimmunoassay and immunohistochemical study. Hepatogastroenterology 43: 483-488 (1996).

• Tokoi S, Ohkusa T, Okayasu I, Nakamura K. Population changes in immunoglobulin-containing mononuclear cells in dextran sulfate sodium-induced coltitis. J. Gastroenterol. 31: 182-188 (1996).

• Tokuyama Y, Tokuyama H. Retinoids as Ig isotype-switch modulators. Cell. Immunol. 170: 230-234 (1996).

• Tokuyama Y, Tokuyama H. Retinoids as Ig isotype-switch modulators. The role of retinoids in directing isotype switching to IgA and IgG1 (IgE) in association with IL-4 and IL-5. Cell. Immunol. 170: 230-234 (1996). *

• Tonjes RR, Lower R, Boller K, Denner J, Hasenmaier B, Kirsch H, Konig H, Korbmacher C, Limbach C, Lugert R, Phelps RC, Scherer J, Thelen K, Lower J, Kurth R. HERV-K: the biologically most active human endogenous retrovirus family. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13 Suppl. 1: S261-S267 (1996).

• Torchia EC, Cheema SK, Agellon LB. Coordinate regulation of bile acid biosynthetic and recovery pathways. Biochem. Biophys. Res. Commun. 225: 128-133 (1996). *

• Traber MG, Sies H. Vitamin E in humans: demand and delivery. Annu. Rev. Nutr. 16: 321-347 (1996). *

• Tracy TF Jr, Dillon P, Fox ES, Minnick K, Vogler C. The inflammatory response in pediatric biliary disease: macrophage phenotype and distribution. J. Pediatr. Surg. 31: 121-125 (1996).

• Tragnone A, Corrao G, Miglio F, Caprilli R, Lanfranchi GA. Incidence of inflammatory bowel disease in Italy: a nationwide population-based study. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Int. J. Epidemiol. 25: 1044-1052 (1996). *

• Traianedes K, Martin TJ, Findlay DM. Regulation of osteopontin expression by type I collagen in preosteoblastic UMR201 cells. Connect. Tissue Res. 34: 63-74 (1996).

• Trapp T, Holsboer F. Nuclear orphan receptor as a repressor of glucocorticoid receptor transcriptional activity. J. Biol. Chem. 271: 9879-9882 (1996). *

• Tromp G, Kuivaniemi H, Raphael S, Ala-Kokko L, Christiano A, Considine E, Dhulipala R, Hyland J, Jokinen A, Kivirikko S, Korn R, Madhatheri S, McCarron S, Pulkkinen L, Punnett H, Shimoya K, Spotila L, Tate A, Williams CJ. Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16. Am. J. Hum. Genet. 59: 1097-1107 (1996). *

• Trotter JF, Fitz JG, Clavien PA. Liver transplantation. Patient selection and organ allocation. N. C. Med. J. 57: 249-252 (1996).

• Tsai SL, Lai MY, Chen DS. Analysis of rearranged T cell receptor (TCR) V beta transcripts in livers of primary biliary cirrhosis: preferential V beta usage suggests antigen-driven selection. Clin. Exp. Immunol. 103: 99-104 (1996). *

• Tsai WC, Matsumura K, Sonoo M, Motoyoshi Y, Shiga J, Shimizu T. Dystrophin abnormality in a patient with polymyositis associated with primary biliary cirrhosis and myocardial injury. Rinsho Shinkeigaku 36: 876-880 (1996).

• Tsujimura T. Role of c-kit receptor tyrosine kinase in the development, survival and neoplastic transformation of mast cells. Pathol. Int. 46: 933-938 (1996).

• Tsuneoka Y, Fukushima K, Matsuo Y, Ichikawa Y, Watanabe Y. Genotype analysis of the CYP2C19 gene in the Japanese population. Life Sci. 59: 1711-1715 (1996). *

• Tsuzuki Y, Miura S, Suematsu M, Kurose I, Shigematsu T, Kimura H, Higuchi H, Serizawa H, Yagita H, Okumura K, Ishil H. alpha 4 Integrin plays a critical role in early stages of T lymphocyte migration in Peyer's patches of rats. Int. Immunol. 8: 287-295 (1996). *

• Tuchweber B, Desmouliere A, Bochaton-Piallat ML, Rubbia-Brandt L, Gabbiani G. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab. Invest. 74: 265-278 (1996).

• Tugwood JD, Aldridge TC, Lambe KG, Macdonald N, Woodyatt NJ. Peroxisome proliferator-activated receptors: structures and function. Ann. N. Y. Acad. Sci. 804: 252-265 (1996). *

• Ueno Y, Phillips JO, Ludwig J, Lichtman SN, LaRusso NF. Development and characterization of a rodent model of immune-mediated cholangitis. Proc. Natl. Acad. Sci. U.S.A. 93: 216-220 (1996). *

• Ulgiati D, Abraham LJ. Comparative analysis of the disease-associated complement C4 gene from the HLA-A1, B8, DR3 haplotype. Exp. Clin. Immunogenet. 13: 43-54 (1996).

• Urnovitz HB, Murphy WH. Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease. Clin. Microbiol. Rev. 9: 72-99 (1996). *

• Valente AI, Almeida A, Gouveia A, Serejo F, Ramalho F, Baptista A, Saragoca A, Moura MC. Prevalence of chronic hepatic disease in Portugal. Apropos of a review carried out in a hepatology unit. Acta Med. Port. 9: 197-202 (1996).

• Valverde MA, Bond TD, Hardy SP, Taylor JC, Higgins CF, Altamirano J, Alvarez-Leefmans FJ. The multidrug resistance P-glycoprotein modulates cell regulatory volume decrease. EMBO J. 15: 4460-4468 (1996). *

• van Dam GM, Gips CH. Primary biliary cirrhosis (PBC) in an European country - a description of death rates in The Netherlands (1979-1992). Hepatogastroenterology 43: 906-913 (1996).

• van de Meeberg PC, Portincasa P, Wolfhagen FH, van Erpecum KJ, VanBerge-Henegouwen GP. Increased gall bladder volume in primary sclerosing cholangitis. Gut 39: 594-599 (1996). *

• van de Meeberg PC, Wolfhagen FH, Van Berge-Henegouwen GP, Salemans JM, Tangerman A, van Buuren HR, van Hattum J, van Erpecum KJ. Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response. J. Hepatol. 25: 887-894 (1996). *

• Van de Water J, Gerson LB, Ferrell LD, Lake JR, Coppel RL, Batts KP, Wiesner RH, Gershwin ME. Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. Hepatology 24: 1079-1084 (1996). *

• van den Hazel SJ, Speelman P, Dankert J, Huibregtse K, Tytgat GN, van Leeuwen DJ. Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography. A randomized, controlled trial. Ann. Intern. Med. 125: 442-447 (1996).

• van der Burg B, van der Saag PT. Nuclear factor-kappa-B/steroid hormone receptor interactions as a functional basis of anti-inflammatory action of steroids in reproductive organs. Mol. Hum. Reprod. 2: 433-438 (1996). *

• van der Hulst RR, von Meyenfeldt MF, Soeters PB. Glutamine: an essential amino acid for the gut. Nutrition 12: S78-S81 (1996).

• van Elburg RM, Uil JJ, van Aalderen WM, Mulder CJ, Heymans HS. Intestinal permeability in exocrine pancreatic insufficiency due to cystic fibrosis or chronic pancreatitis. Pediatr. Res. 39: 985-991 (1996). *

• van Erpecum KJ, Smits SJ, van de Meeberg PC, Linn FH, Wolfhagen FH, vanBerge-Henegouwen GP, Algra A. Risk of primary sclerosing cholangitis is associated with nonsmoking behavior. Gastroenterology 110: 1503-1506 (1996). *

• van Helvoort A, Smith AJ, Sprong H, Fritzsche I, Schinkel AH, Borst P, van Meer G. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87: 507-517 (1996). *

• van Hoek B. The spectrum of liver disease in systemic lupus erythematosus. Neth. J. Med. 48: 244-253 (1996).

• van Hogezand RA, Verspaget HW. Selective immunomodulation in patients with inflammatory bowel disease - future therapy or reality? Neth. J. Med. 48: 64-67 (1996).

• van Milligen de Wit AW, van Bracht J, Rauws EA, Jones EA, Tytgat GN, Huibregtse K. Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis. Gastrointest. Endosc. 44: 293-299 (1996).

• Van Nieuwkerk CM, Oude Elferink RP, Groen AK, Ottenhoff R, Tytgat GN, Dingemans KP, Van Den Bergh Weerman MA, Offerhaus GJ. Effects of ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. Gastroenterology 111: 165-171 (1996). *

• van Obbergh L, Vallieres Y, Blaise G. Cardiac modifications occurring in the ascitic rat with biliary cirrhosis are nitric oxide related. J. Hepatol. 24: 747-752 (1996). *

• van Oosten BW, Barkhof F, Truyen L, Boringa JB, Bertelsmann FW, von Blomberg BM, Woody JN, Hartung HP, Polman CH. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47: 1531-1534 (1996).

• Van Steenbergen W, Sciot R, Van Eyken P, Desmet V, Fevery J. Combined treatment with methotrexate and ursodeoxycholic acid in non-cirrhotic primary biliary cirrhosis. Acta Clin. Belg. 51: 8-18 (1996).

• van Vliet T, van Schaik F, Schreurs WH, van den Berg H. In vitro measurement of beta-carotene cleavage activity: methodological considerations and the effect of other carotenoids on beta-carotene cleavage. Int. J. Vitam. Nutr. Res. 66: 77-85 (1996).

• van Vliet T, van Vlissingen MF, van Schaik F, van den Berg H. beta-Carotene absorption and cleavage in rats is affected by the vitamin A concentration of the diet. J. Nutr. 126: 499-508 (1996). *

• Vanlemmens C, Miguet JP, Bresson-Hadni S. Liver transplantation in adults. Indications and results. Presse. Med. 25: 1952-1960 (1996).

• Vasiliauskas EA, Plevy SE, Landers CJ, Binder SW, Ferguson DM, Yang H, Rotter JI, Vidrich A, Targan SR. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology 110: 1810-1819 (1996). *

• Vaughan JH. Viruses and autoimmune disease. J. Rheumatol. 23: 1831-1833 (1996).

• Venneker GT, van Meegen M, de Kok-Nazaruk M, Hulsmans RF, de Waall LP, Bos JD, Asghar SS. Incomplete functional deficiencies of the fourth (C4) and second (C2) components of complement in a patient with linear frontoparietal scleroderma and his family. Deficiencies determined by a gene not linked to human leukocyte antigen system. Exp. Clin. Immunogenet. 13: 104-111 (1996).

• Vergani D, Mieli-Vergani G. Autoimmune hepatitis. Ann. Ital. Med. Int. 11: 119-124 (1996).

• Verhoef J, Hustinx WM, Frasa H, Hoepelman AI. Issues in the adjunct therapy of severe sepsis. J. Antimicrob. Chemother. 38: 167-182 (1996). *

• Vilagut L, Pares A, Rodes J, Vila J, Vinas O, Gines A, Jimenez de Anta MT. Mycobacteria - related to the aetiopathogenesis of primary biliary cirrhosis? J. Hepatol. 24: 125 (1996). *

• Vlahcevic ZR, Jairath SK, Heuman DM, Stravitz RT, Hylemon PB, Avadhani NG, Pandak WM. Transcriptional regulation of hepatic sterol 27-hydroxylase by bile acids. Am. J. Physiol. 270: G646-G652 (1996).

• Vogelsang H, Hamwi A, Ferenci P. Elevated liver isoenzymes of alkaline phosphatase and disease activity in patients with Crohn's disease. Digestion 57: 11-15 (1996).

• Vollmer P, Walev I, Rose-John S, Bhakdi S. Novel pathogenic mechanism of microbial metalloproteinases: liberation of membrane-anchored molecules in biologically active form exemplified by studies with the human interleukin-6 receptor. Infect. Immun. 64: 3646-3651 (1996). *

• von der Mohlen MA, van der Poll T, Jansen J, Levi M, van Deventer SJ. Release of bactericidal/permeability-increasing protein in experimental endotoxemia and clinical sepsis. Role of tumor necrosis factor. J. Immunol. 156: 4969-4973 (1996).

• von Herrath MG, Oldstone MB. Virus-induced autoimmune disease. Curr. Opin. Immunol. 8: 878-885 (1996).

• von Schonfeld J, Zotz R, Mahl M, Beste M, Breuer N, Goebell H. Primary sclerosing cholangitis: conventional and quantitative liver function tests during long-term therapy with ursodeoxycholic acid. Z. Gastroenterol. 34: 123-127 (1996).

• Vu-Dac N, Schoonjans K, Kosykh V, Dallongeville J, Heyman RA, Staels B, Auwerx J. Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor. Mol. Cell Biol. 16: 3350-3360 (1996). *

• Wagner N, Lohler J, Kunkel EJ, Ley K, Leung E, Krissansen G, Rajewsky K, Muller W. Critical role for beta7 integrins in formation of the gut-associated lymphoid tissue. Nature 382: 366-370 (1996). *

• Wagner S, Gebel M, Meier P, Trautwein C, Bleck J, Nashan B, Manns MP. Endoscopic management of biliary tract strictures in primary sclerosing cholangitis. Endoscopy 28: 546-551 (1996).

• Wakai T, Shirai Y, Tsukada K, Aono T, Kurosaki I, Hatakeyama K. Hepatocellular carcinoma associated with precirrhotic primary biliary cirrhosis successfully treated by a right hepatic lobectomy: report of a case. Surg. Today 26: 723-726 (1996).

• Wallace BH, Lott JA, Griffiths J, Kirkpatrick RB. Isoforms of alkaline phosphatase determined by isoelectric focusing in patients with chronic liver disorders. Eur. J. Clin. Chem. Clin. Biochem. 34: 711-720 (1996).

• Walmsley RS, Ibbotson JP, Chahal H, Allan RN. Antibodies against Mycobacterium paratuberculosis in Crohn's disease. QJM 89: 217-321 (1996).

• Walsh DS, Thavichaigarn P, Dheeradhada C, Jiarakul N, Pearce FC, Wiesmann WP, Cioffi WG, Webster HK. Prolonged alteration in gut permeability following nonthermal injury. Injury 27: 491-494 (1996).

• Walter L, Fischer K, Gunther E. Physical mapping of the Ring1, Ring2, Ke6, Ke4, Rxrb, Col11a2, and RT1.Hb genes in the rat major histocompatibility complex. Immunogenetics 44: 218-221 (1996).

• Wang Z, Schultheis PJ, Shull GE. Three N-terminal variants of the AE2 Cl-/HCO3- exchanger are encoded by mRNAs transcribed from alternative promoters. J. Biol. Chem. 271: 7835-7843 (1996). *

• Wanless IR. Noncirrhotic portal hypertension: recent concepts. Prog. Liver Dis. 14: 265-278 (1996).

• Ward JM, Anver MR, Haines DC, Melhorn JM, Gorelick P, Yan L, Fox JG. Inflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus. Lab. Anim. Sci. 46: 15-20 (1996).

• Ward JM, Benveniste RE, Fox CH, Battles JK, Gonda MA, Tully JG. Autoimmunity in chronic active Helicobacter hepatitis of mice. Serum antibodies and expression of heat shock protein 70 in liver. Am. J. Pathol. 148: 509-517 (1996). *

• Ward LD, Hammacher A, Howlett GJ, Matthews JM, Fabri L, Moritz RL, Nice EC, Weinstock J, Simpson RJ. Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric IL-6.receptor complex. J. Biol. Chem. 271: 20138-20144 (1996). *

• Wareing M, Mitchell D. Drug induced otalgia due to mesalazine and sulphasalazine. J. Laryngol. Otol. 110: 466-467 (1996).

• Warren S, Svenson L, Woodhead S, Warren KG. Parental ancestry and risk of multiple sclerosis in Alberta, Canada. Neuroepidemiology 15: 1-9 (1996).

• Warren SA, Warren KG. Influence of gender on susceptibility to multiple sclerosis and age of onset in concordant sibships. Int. J. Epidemiol. 25: 142-145 (1996). *

• Washington K, Stenzel TT, Buckley RH, Gottfried MR. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am. J. Surg. Pathol. 20: 1240-1252 (1996).

• Waxman DJ. Role of metabolism in the activation of dehydroepiandrosterone as a peroxisome proliferator. J. Endocrinol. 150: S129-S147 (1996).

• Webb PM, Knight T, Elder JB, Newell DG, Forman D. Is Helicobacter pylori transmitted from cats to humans? Helicobacter 1: 79-81 (1996).

• Wenisch C, Wenisch H, Bankl HC, Exner M, Graninger W, Looareesuwan S, Rumpold H. Detection of anti-neutrophil cytoplasmic antibodies after acute Plasmodium falciparum malaria. Clin. Diagn. Lab. Immunol. 3: 132-134 (1996). *

• Wesierska-Gadek J, Hohenauer H, Hitchman E, Penner E. Anti-gp210 antibodies in sera of patients with primary biliary cirrhosis. Identification of a 64 kD fragment of gp210 as a major epitope. Hum. Antibodies Hybridomas 7: 167-174 (1996).

• Wesierska-Gadek J, Hohenuer H, Hitchman E, Penner E. Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis. Gastroenterology 110: 840-847 (1996). *

• Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, Martin SP, Gates LK Jr, Amann ST, Toskes PP, Liddle R, McGrath K, Uomo G, Post JC, Ehrlich GD. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat. Genet. 14: 141-145 (1996). *

• Whitcomb DC, Preston RA, Aston CE, Sossenheimer MJ, Barua PS, Zhang Y, Wong-Chong A, White GJ, Wood PG, Gates LK Jr, Ulrich C, Martin SP, Post JC, Ehrlich GD. A gene for hereditary pancreatitis maps to chromosome 7q35. Gastroenterology 110: 1975-1980 (1996). *

• White JA, Guo YD, Baetz K, Beckett-Jones B, Bonasoro J, Hsu KE, Dilworth FJ, Jones G, Petkovich M. Identification of the retinoic acid-inducible all-trans-retinoic acid 4-hydroxylase. J. Biol. Chem. 271: 29922-29927 (1996). *

• Wiedermann U, Chen XJ, Enerback L, Hanson LA, Kahu H, Dahlgren UI. Vitamin A deficiency increases inflammatory responses. Scand. J. Immunol. 44: 578-584 (1996).

• Wiedermann U, Tarkowski A, Bremell T, Hanson LA, Kahu H, Dahlgren UI. Vitamin A deficiency predisposes to Staphylococcus aureus infection. Infect. Immun. 64: 209-214 (1996). *

• Wiesner RH, Porayko MK, Hay JE, LaRusso NF, Steers JL, Krom RA, Dickson ER. Liver transplantation for primary sclerosing cholangitis: impact of risk factors on outcome. Liver Transpl. Surg. 2: 99-108 (1996).

• Wietholtz H, Marschall HU, Sjovall J, Matern S. Stimulation of bile acid 6 alpha-hydroxylation by rifampin. J. Hepatol. 24: 713-718 (1996). *

• Willenbucher RF. Inflammatory bowel disease. Semin. Gastrointest. Dis. 7: 94-104 (1996).

• Willson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, Prakash SR, Beck KD, Moore LB, Kliewer SA, Lehmann JM. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J. Med. Chem. 39: 665-668 (1996). *

• Willson TM, Lehmann JM, Kliewer SA. Discovery of ligands for the nuclear peroxisome proliferator-activated receptors. Ann. N. Y. Acad. Sci. 804: 276-283 (1996). *

• Wilson WA. Histocompatibility genes in antiphospholipid antibody syndrome. Lupus 5: 259-262 (1996).

• Wirth JA, Jensen KA, Post PL, Bement WM, Mooseker MS. Human myosin-IXb, an unconventional myosin with a chimerin-like rho/rac GTPase-activating protein domain in its tail. J. Cell Sci. 109: 653-661 (1996). *

• Wisse E, Braet F, Luo D, De Zanger R, Jans D, Crabbe E, Vermoesen A. Structure and function of sinusoidal lining cells in the liver. Toxicol. Pathol. 24: 100-111 (1996).

• Wolf JL. Liver disease in pregnancy. Med. Clin. North Am. 80: 1167-1187 (1996).

• Wolkoff AW. Hepatocellular sinusoidal membrane organic anion transport and transporters. Semin. Liver Dis. 16: 121-127 (1996).

• Wong MH, Rao PN, Pettenati MJ, Dawson PA. Localization of the ileal sodium-bile acid cotransporter gene (SLC10A2) to human chromosome 13q33. Genomics 33: 538-540 (1996). *

• Wong SS, Lawton JW. Case report: anti-proteinase 3 antibody activity in a patient with primary sclerosing cholangitis: clinical remission following ursodeoxycholic acid therapy. J. Gastroenterol. Hepatol. 11: 1161-1163 (1996).

• Woodward DF, Nieves AL, Friedlaender MH. Characterization of receptor subtypes involved in prostanoid-induced conjunctival pruritus and their role in mediating allergic conjunctival itching. J. Pharmacol. Exp. Ther. 279: 137-142 (1996).

• World MJ, Stevens PE, Ashton MA, Rainford DJ. Mesalazine-associated interstitial nephritis. Nephrol. Dial. Transplant. 11: 614-621 (1996).

• Wu PC, Fang JW, Lau VK, Lai CL, Lo CK, Lau JY. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am. J. Pathol. 149: 1167-1175 (1996).

• Yabut B, Werlin SL, Havens P, Bohorfoush A, Brown CW, Harb J. Endoscopic retrograde cholangiopancreatography in children with HIV infection. J. Pediatr. Gastroenterol. Nutr. 23: 624-627 (1996). *

• Yacyshyn B, Meddings J, Sadowski D, Bowen-Yacyshyn MB. Multiple sclerosis patients have peripheral blood CD45RO+ B cells and increased intestinal permeability. Dig. Dis. Sci. 41: 2493-2498 (1996).

• Yamazaki K, Nakadate I, Suzuki K, Sato S, Masuda T. Eosinophilia in primary biliary cirrhosis. Am. J. Gastroenterol. 91: 516-522 (1996).

• Yanagawa T, DeGroot LJ. HLA class II associations in African-American female patients with Graves' disease. Thyroid 6: 37-39 (1996).

• Yanchar NL, Shapiro AM, Sigalet DL. Is early response to portoenterostomy predictive of long-term outcome for patients with biliary atresia? J. Pediatr. Surg. 31: 774-778 (1996).

• Yang JJ, Tuttle R, Falk RJ, Jennette JC. Frequency of anti-bactericidal/permeability-increasing protein (BPI) and anti-azurocidin in patients with renal disease. Clin. Exp. Immunol. 105: 125-131 (1996). *

• Yap I, Wee A, Tay HH, Guan R, Kang JY. Primary biliary cirrhosis - an uncommon disease in Singapore. Singapore Med. J. 37: 48-50 (1996).

• Yaqoob M, West DC, McDicken I, Bell GM. Monitoring of endothelial leucocyte adhesion molecule-1 in anti-neutrophil-cytoplasmic-antibody-positive vasculitis. Am. J. Nephrol. 16: 106-113 (1996).

• Yasunaga S, Kimura A, Hamaguchi K, Ronningen KS, Sasazuki T. Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM). Tissue Antigens 47: 37-48 (1996).

• Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J. Biol. Chem. 271: 13055-13060 (1996). *

• Yen PM, Liu Y, Sugawara A, Chin WW. Vitamin D receptors repress basal transcription and exert dominant negative activity on triiodothyronine-mediated transcriptional activity. J. Biol. Chem. 271: 10910-10916 (1996). *

• Yeung RS, Penninger JM, Kundig T, Khoo W, Ohashi PS, Kroemer G, Mak TW. Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen-induced septic shock. Eur. J. Immunol. 26: 1074-1082 (1996).

• Yip TT, Van de Water J, Gershwin ME, Coppel RL, Hutchens TW. Cryptic antigenic determinants on the extracellular pyruvate dehydrogenase complex/mimeotope found in primary biliary cirrhosis. A probe by affinity mass spectrometry. J. Biol. Chem. 271: 32825-32833 (1996). *

• Yoshida EM, Nantel SH, Owen DA, Galbraith PF, Dalal BI, Ballon HS, Kwan SY, Wade JP, Erb SR. Case report: a patient with primary biliary cirrhosis and autoimmune hemolytic anemia. J. Gastroenterol. Hepatol. 11: 439-442 (1996).

• Zanelli E, Krco CJ, Baisch JM, Cheng S, David CS. Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 93: 1814-1819 (1996). *

• Zdanov A, Schalk-Hihi C, Wlodawer A. Crystal structure of human interleukin-10 at 1.6 A resolution and a model of a complex with its soluble receptor. Protein Sci. 5: 1955-1962 (1996). *

• Zhang J, Zhou F, Ai R. Study on some susceptible genes of systemic lupus erythematosus in Han nationality of China. Zhonghua Nei Ke Za Zhi 35: 19-22 (1996).

• Zhao MH, Jayne DR, Ardiles LG, Culley F, Hodson ME, Lockwood CM. Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis. QJM 89: 259-265 (1996).

• Zhao MH, Lockwood CM. A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extract. J. Immunol. Methods 197: 121-130 (1996).

• Zhao MH, Lockwood CM. ANCA defines the clinical disease manifestations of vasculitis. Sarcoidosis Vasc. Diffuse Lung Dis. 13: 221-226 (1996).

• Zhao MH, Lockwood CM. Azurocidin is a novel antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in systemic vasculitis. Clin. Exp. Immunol. 103: 397-402 (1996). *

• Zhong F, McCombs CC, Olson JM, Elston RC, Stevens FM, McCarthy CF, Michalski JP. An autosomal screen for genes that predispose to celiac disease in the western counties of Ireland. Nat. Genet. 14: 329-333 (1996). *

• Zimmermann H, Kurzen P, Klossner W, Renner EL, Marti U. Decreased constitutive hepatic nitric oxide synthase expression in secondary biliary fibrosis and its changes after Roux-en-Y choledocho-jejunostomy in the rat. J. Hepatol. 25: 567-573 (1996). *

• Zumla A, James DG. Granulomatous infections: etiology and classification. Clin. Infect. Dis. 23: 146-158 (1996).

Number of references = 1016

www psc-literature.org